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Achilles tendinopathy is a prevalent, highly debilitating condition. It is believed to result from 
repetitive overuse, which creates micro-damage tendon, and initiates a catabolic cell response. 
The aetiology of tendinopathy remains poorly understood, therefore appropriate treatment 
remains unclear. 
Current data support the use of shock wave therapy and eccentric exercise as some of the more 
effective treatment options for tendinopathy. Studies have shown that these treatments generate 
perturbations within tendon at a frequency of approximately 8-12Hz. Consequently, it is 
hypothesised that 10Hz loading initiates increased anabolic tenocyte behaviour promoting 
tendon repair. The primary aim of this thesis is to investigate the effects of 10Hz perturbations 
on tenocyte metabolism, comparing tenocyte gene expression in response to a 10Hz and 1Hz 
loading profile.  
A variety of in vitro models for mechanically stimulating cells were explored, comparing tissue 
explants with isolated cells on a 2D or within a 3D collagen gel. The mechanical environment 
of each model was investigated, in addition to cell viability and gene stabilisation following 
strain, as needed for future cell studies. 3D collagen gels arose as the most suitable model. 
Human tenocytes from healthy semitendinosus and tendinopathic Achilles tendons were 
seeded into 3D collagen gels and subjected to cyclic strain at 10Hz and 1Hz to establish cell 
response. Tenocyte gene expression was characterised using qRT-PCR. 
Healthy tenocytes showed increased expression of all analysed genes in response to loading. 
Furthermore, the increase was significantly larger in the 10Hz loading group. Tendinopathic 
tenocytes showed a more varied response, possibly indicative of an early healing response. 
Nevertheless, the response to 10Hz loading was consistently greater than seen with 1Hz 
loading. Analysis of the signalling pathways involved suggested that the IL1 signalling 
pathway may be involved in the strain response reported.  
This study has demonstrated for the first time that loading at a frequency of 10Hz may enhance 
metabolic response in healthy tenocytes. 
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Tendons are fibrous connective tissues, composed of cells within a complex extracellular 
matrix (ECM) containing collagens, glycoproteins and water. Tendons connect muscle to bone 
and are passive structures concerned with the function of force transmission [Witvrouw et al., 
2007]. They can be classified into two major groups, depending on the characteristics of the 
tendon and type of activities they perform, as either energy storing (ES) tendons or positional 
tendons [Thorpe et al., 2013a]. Positional tendons are those which simply act to position limbs, 
while ES tendons are high strain tendons with an additional function to stretch, to store and 
then release elastic potential energy during locomotion (i.e. running, walking, jumping and 
hopping). ES tendons are more prone to injury and micro-damage because of their function. 
They are exposed to higher stresses and strains during use and require a greater ability to stretch 
and recoil under load to ensure efficient return of stored potential energy [Thorpe et al., 2013b]. 
The high strains these tendons must withstand makes them prone to highly debilitating and 
painful injuries known as tendinopathies.  
Tendinopathies are a range of diseases associated with impaired tendon function and pain, and 
represent a substantial proportion of the musculoskeletal injuries referred to general 
practitioners [Institute of Sport Exercise and Health, 2014]. Although these conditions do not 
have an immediate risk of mortality, patients suffer with a decrease in quality of life, involving 
pain and decreased mobility, which lead to numerous other health problems, including 
cardiovascular disease and obesity. Characteristic symptoms of tendinopathy include chronic 
pain, swelling, localised tenderness and impaired movement [Koutouris and Cook, 2007; Birch 
et al., 1998]. Vascular profusion, impingement, trauma and repetitive unequally distributed 
strain have all been implicated in the development of tendinopathy [Cook and Purdam, 2009]. 
However, we have very limited understanding of the aetiology and pathophysiology of 
tendinopathy [Kader et al., 2002]. This makes the condition very difficult to treat, despite an 
increase in prevalence [Cassel et al., 2014].  




1.2 TENDON HIERARCHICAL STRUCTURE AND FUNCTION 
Tendon vary widely in shape from wide and flat to cylindrical/rounded cords, encompassing 
strap-like bands, flattened ribbons and fan shapes [Sharma and Maffulli, 2006; Devkota, 2006]. 
Tendon contains 60-80% water, while the remaining dry matter is composed mainly of type I 
collagen that is arranged in a hierarchical structure [Kannus, 2000] (Figure 1.1). 
 
The hierarchical structure of tendon begins with collagen molecules, grouped together in a 
highly ordered fashion to form fibrils, which in turn aggregate into fibres surrounded by non-
collagenous matrix. Fibres further aggregate to form fascicles surrounded by interfascicular 
matrix, a loose connective tissue that binds them together to form a whole tendon [Thorpe et 
al., 2016a; Thorpe et al., 2015a]. 
Figure 1.1:  Schematic showing the hierarchical structure of tendon. Triple helical collagen molecules are arranged 
in a highly ordered, quarter-stagger pattern to form fibrils, which are grouped together to form fibres, 
fascicles, and finally tendon. Proteoglycan-rich matrix intersperses collagen at each hierarchical level of 
tendon. [Thorpe et al., 2012; Kastelie et al., 1978] 




As an aligned fibre composite material, the hierarchical structure of tendon enables it to 
withstand high tensile forces, but also results in complex anisotropic and viscoelastic 
mechanical characteristics. The ability of tendon to carry out its function of force transfer is 
determined by the composition and organization of the matrix at each structural level and the 
way in which each structural level contributes to tensile loading [Thorpe et al., 2012]. However, 
the relationships between structure and function throughout the tendon hierarchy remain 
unclear. A number of studies have characterised some of the structure-function mechanics of 
the hierarchical collagenous matrix that makes up the majority of the tendon substance [Cheng 
and Screen, 2007; Sharma and Maffulli, 2006; Devkota, 2006; Kannus, 2000], with the most 
recent work focused on how the interfascicular matrix contributes to the mechanics of the 
whole tendon. Recent studies by Thorpe et al. [2012], suggest that the interfascicular matrix 
functions mainly to facilitate the high strain characteristics of ES tendons by controlling sliding 
between adjacent fascicles when tendon is strained. 
The interfascicular matrix, also referred to as endotenon, is a thin reticular network of 
connective tissue, composed of collagen type III, proteoglycans, glycoproteins, blood vessels, 
lymphatics and nerves, and is synthesized and maintained by the population of interfascicular 
fibroblasts [Sharma and Maffulli, 2006; Devkota, 2006]. Similarly, the whole tendon is 
bounded by a sheath of a fine loose connective tissue also containing blood vessels, lymphatics, 
nerves, collagen fibrils (type I and III), and some elastic fibrils [Sharma and Maffulli, 
2006;Devkota, 2006]. The tendon sheath is often subdivided into layers. The upper layer is 
called the paratenon, which is a loose areolar connective tissue. Underneath the paratenon is 
the epitenon, a dense fibrillar network of collagen, and finally the inner most layer is called the 
endotenon, which is a thin reticular network of connective tissue [Kannus, 2000]. These sheaths 
help reduce friction between the tendon and adjacent tissues thereby facilitating tendon sliding 
during use [Wang, 2006]. 
1.2.1  GROSS ANATOMY OF ACHILLES TENDON 
The Achilles tendon (AT) is the strongest, thickest and largest human tendon, connecting the 
triceps surae muscle group (two heads of the gastrocnemius and the soleus) to the calcaneus 
(Figure 1.2) [Ranson and Young, 2011]. The gastrocnemial parts of the tendon (11-26cm long), 
are broad and flat near their origin, and become more round and narrow distally, while the 
soleus part (3-11cm long), begins as a band proximally on the posterior surface of the soleus 
muscle and becomes the anterior part of the tendon, ending medially to the soleus muscle at 




the insertion (calcaneal bone). The AT is 15cm long on average but can be up to 26cm in 
humans while the width varies longitudinally from around 6.8cm (range 4.5-8.6cm) at the 
origin, to 1.8cm (range 1.2-2.6cm) in the mid portion [Doral et al., 2010].  
The AT can experience forces of up to 12.5 times body weight during activities such as running 
leaving it susceptible to both acute and chronic injuries [Doral et al., 2010; Nunley, 2009].  
 
The gastrocnemius muscle is activated when jumping and running and is composed 
predominantly of fast-twitch (type II) muscle fibres [Fugle-Meyer et al., 1979]. In contrast, the 
soleus muscle has more of a stabilizing function, especially when standing, and consists 
predominantly of slow-twitch (type I) muscle fibres [Garret et al., 1984]. The triceps surae 
muscle undergoes both eccentric (lengthening) and concentric (shortening) contractions during 
walking and running [Teitz et al., 1997]. 
The fibers of the AT are not vertically aligned but rotate by roughly 90 degrees when 
descending from the proximal muscle attachment to the calcaneal bone insertion. Accordingly, 
the soleus fibres insert medially at the calcaneus whereas the gastrocnemius fibres insert 
laterally [Root et al., 1977]. Doral et al. [2010] noted that the extent of angular rotation in the 
Achilles tendon depends on the position of the fusion between the two muscles i.e. a more 
Figure 1.2: Gross anatomy and structure of the Achilles tendon, showing the tendon emerge from the distal 
confluence of the gastrocnemius and the soleus muscles and insert into the calcaneus, with the 
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distal fusion, result in a tighter rotation. The fibre twisting is necessary for vascular network 
constriction and also means less fibre buckling when the tendon is lax and less deformation of 
individual fascicles during tension [Doral et al., 2010].   
1.2.2  TENDON BIOMECHANICS 
Tendon is a viscoelastic composite material consisting of collagen components embedded in a 
softer non-collagenous matrix throughout the hierarchy [Puxkandl, et al., 2002]. The elastic 
component is provided mainly by the collagenous matrix whereas viscosity is provided largely 
by the non-collagenous fraction of the matrix [Puxkandl, et al., 2002]. The collagen fibres are 
crimped in the unloaded state, but crimping is lost when the stretch exceeds  ̴ 2% while 
macroscopic rupture occur between 8-22% [Maganaris et al., 2008; Maffulli, et al., 2004] 
(Figure 1.3). The huge range in reported mechanical properties stems from the different 
behaviours of functionally distinct tendons, in addition to the effects of different testing 
protocols on resulting mechanical parameters. 
The human Achilles tendon, an energy storing tendon, experiences peak stresses of between 
42 and 110 MPa and strains of between 6.2 - 10.3% in vivo [Birch, 2007; Lichtwark and 
Wilson, 2005; Wren et al., 2001]. In contrast, positional tendons like the anterior tibalis tendon 
have been observed to have much lower in vivo stresses and strains of  ̴ 30MPa and  ̴ 3.1% 
respectively [Wren et al., 2001; Maganaris and Paul, 2000].  


















Figure 1.3: Graphic representation of tendon mechanical behaviour. The curve is generally considered to 
consist of three regions, for which different structural behaviours can be accredited: Toe 
region – the nonlinear region of the curve where the collagen un-crimps and orients in the 
direction of the load and stretch; Linear elastic region – the physiological load region where 
the collagen fibrils continues to orient themselves in the direction of the load and stretch; Yield 
and failure region – the region where the tendon stretches beyond its physiological limit and 
fails. 
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1.3 COMPOSITION OF TENDON 
By dry weight, tendon tissue is composed primarily of collagen type I (approximately 70-90%), 
but also contains collagen types III and V (approximately 3-5%), and trace amounts of types 
II, IV, VI, IX, X, XI, XII and XIV [Hampson et al., 2008; Graham, 2007; Devkota, 2006]. 
Tendon also contains a range of glycoproteins, the most abundant of which are proteoglycans 
(approximately 1-5%), and also elastin (approximately 1-2%), cells (less than 10%) and 
inorganic components (of approximately 0.2%), which include copper, magnesium, 
manganese, cadmium, cobalt, zinc, nickel, lithium, lead, fluoride, phosphor and silicon 
[Rumian et al., 2007; Wang, 2006; Nordin and Frankel, 2001; Kannus, 2000; Kastelic et al., 
1978].   
1.3.1  COLLAGENS 
To date, 29 different collagen types have been described in the literature with different 
structures, functions and tissue distributions [Pingel et al., 2013; Jelinsky et al., 2011; Nagase 
et al., 2006; Ireland et al., 2001]. Collagens are generally composed of a triple helix formed of 
homo or heterotrimers polypeptides chains (α-chains) that play a vital role in tissue architecture 
and strength [Kadler et al., 1996]. Of the different collagen types in tendon, type I collagen is 
by far the most abundant. The type I collagen molecule triple helix is made of two α1 chains 
and one α2 chain. Each chain has approximately 1000 amino acids and is rich in glycine, which 
can be found at every third amino acid residue [Lodish et al., 2000]. The Type I collagen 
molecule is about 280-300nm long and 1.5nm thick [Jozsa and Kannus, 1997].  
Type III collagen is the second most abundant collagen in the tendon, comprising about 1-5% 
tendon dry weight and is made up of three α1 chains and forms smaller, less organized fibrils, 
which may result in decreased mechanical strength in tendon [Wang, 2006]. However, Type 
III collagen is essential for normal fibrillogenesis and regulation of type I collagen fibril size 
[Kadler et al., 1990]. Type V collagen consist of two α1 and one α2 chains, and also provides 
an essential template for fibrillogenesis [Wenstrup et al., 2004; Kadler et al., 1996]. Collagen 
is constantly turned over in human tendon, enabling the ECM to adapt to changes in the 
mechanical environment [Kjær et al., 2005]. Collagen turnover rates in tendon are generally 
thought to be low, however, it could be hypothesised that collagen turnover will be faster in 
ES tendons because they experience higher levels of micro-damage due to the higher stresses 
and strains they are exposed to, thus requiring a greater capacity for matrix turnover. 




Unexpectedly, findings by Heinemeier et al. [2013] proves otherwise, suggesting that healthy 
human Achilles tendons experience limited collagen turnover, being practically inert during 
adult life.  
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Abbreviation: FACIT – Fibril Associated Collagen with Interrupted Helix 
1.3.1.1  COLLAGEN SYNTHESIS  
Collagen synthesis occurs within the cell in a precursor form known as preprocollagen 
consisting of a three-dimensional stranded structure with the amino acids glycine and proline 
as its principal components. The procollagen undergoes hydroxylation by the addition 
of hydroxyl groups to the amino acids proline and lysine, catalysed by lysyl-oxydase enzyme. 
This step is imperative for later glycosylation and collagen formation [Hutson and Canty, 
2011]. Collagen synthesis involves steps both inside and outside of the cell (Figure 1.4). All 29 
types of collagens are triple helical structures, but their differences depend on the alpha 
peptides. 





Within the nucleus, a number of genes are associated with collagen formation, each coded with 
a specific mRNA sequence. DNA are unwound by RNA polymerase to form mRNA. This 
process is referred to as mRNA transcription. The mRNA that codes for preprocollagen enters 
into the cytoplasm of the cell, where it is detected by signal peptides and directed to the rough 
endoplasmic reticulum (RER) of the cell [Riley, 2005]. This process is referred to as the 







  Figure 1.4:  Overview of the steps involved in the production of collagen fibrils from procollagen to a single collagen 
fibril [adapted from Holmes et al.(2001); Canty and Kadler, (2005); Hutson and Canty, (2011) and 
Chhabra, (2013)]. 




Transcription and Translation 
The process of transcription begins when an enzyme called RNA polymerase attaches to the 
template DNA strand and begins to catalyse production of complementary RNA. RNA 
polymerase reads the template DNA strand and adds nucleotides from the DNA upstream five-
prime (5’) of the gene at a specialized sequence called a promoter to the three-prime (3’) end 
of a growing RNA transcript [Gelse et al., 2003]. When RNA polymerase reaches a termination 
sequence on the DNA template strand, the pre-mRNA transcript and RNA polymerase are 
released from the complex. The pre-mRNA contains introns and exons which are either spliced 
or included, giving rise to several different possible mRNA products in a process called RNA 
splicing [Rossert et al., 2002]. 
The process of translation involves transportation of the mRNA out of the nucleus, into the 
cytoplasm, to the ribosome (rRNA and proteins). The ribosome binds to the mRNA at a specific 
area and starts matching tRNA anticodon sequences to the mRNA codon sequence to form a 
polypeptide chain [Clancy et al., 2008]. The ribosome continues until it hits a stop sequence, 
then it releases the polypeptide and the mRNA. The polypeptide chain is translated into a 
protein, in this case a preprocollagen molecule which protrude into the lumen of the rough 
endoplasmatic reticulum with the help of a signal recognition domain recognized by the 
corresponding receptors [Gelse et al., 2003]. 
Post-translational Modifications of Collagen 
Within the lumen of the RER, the signal peptides that direct the preprocollagen to the RER are 
removed to form a procollagen chain. This process is referred to as post-translational 
processing. The procollagen chain undergoes hydroxylation, which is catalysed by two 
different enzymes: prolyl-4-hydroxylase and lysyl-hydroxylase to form specific residues (so 
proline and lysine form hyroxyproline and hydroxylysine) to aid cross-linking of the alpha 
peptides (Gly-X-Y). Procollagen is made up of a repeating sequence of Gly-X-Y, Gly is 
Glycine, while the X and Y can be any amino acid but are usually proline and hyroxyproline 
respectively (with amino acid polypeptide extensions at the C- and N- terminals). The 
hydroxylated procollagen chain then forms a triple helix by forming intra/inter-chain 
disulphide bonds within the C-propeptides and intra-chain disulphide bonds within the N-
propeptides [Bullied et al., 1997]. The C-propeptides are essential for the early stage of 
procollagen assembly and in ensuring the correct association of the individual procollagen 




chains to form a trimeric molecule, but are not in essential in triple helix nucleation and 
alignment of the α-chains [Bulleid et al., 1997]. Glycosylation occurs by adding either glucose 
or galactose monomers onto the hydroxy groups that are placed onto lysines, but not on 
prolines. The hydroxylated and glycosylated propeptides twist to form a triple helix [Lamande 
and Bateman, 1999].  
The procollagen chain is translocated to the Golgi apparatus where it is converted into a 
procollagen molecule with an inter-chain disulphide bond within the N-propeptide. This 
process is referred to as nucleation, and alignment of the trimerised α-chains occurs by a 
sequence of propagation/folding from the C- to the N- terminus [Buchner and Moroder, 2009]. 
Following nucleation of the triple-helix, the procollagen is secreted into the extracellular matrix 
(ECM) where the C- and N- terminals are cleaved by enzymes carboxyproteinase and 
aminoproteinase and ADAMTS 2, 3 and 14 respectively [Buchner and Moroder, 2009]. The 
cleaving of the procollagen ends with the release of the triple helical collagen molecule. 
Fibrillogenesis 
In the extracellular space, the resulting collagen molecules assemble instinctively into quarter-
staggered fibrils in a process known as fibrillogenesis. This assembly is stimulated by the 
presence of clusters of hydrophobic residues and of charged amino acids on the surface of the 
molecules [Rossert et al., 2002]. During fibrillogenesis, some lysyl and hydroxylysyl residues 
are deaminated by oxiadation, which deaminates the –NH2 group, giving rise to aldehyde 
derivatives [Rossert et al., 2002]. These aldehydes associate with adjacent lysyl or 
hydroxylysyl residue spontaneously, by the –NH2 groups, forming interchain cross-links. 
These cross-links increase the tensile strength of the fibrils considerably. 
1.3.2  NON-COLLAGENOUS COMPONENTS 
The non-collagenous matrix components of the ECM are thought to play a vital role in ensuring 
tendon viscoelasticity and lubrication, as well as allowing spacing for fibre gliding and cross-
tissue interactions [Maffulli et al., 2005]. They are also vital membrane proteins, essential for 
cell-cell interactions [O’Brien, 1997]. The most abundant non-collagenous matrix molecules 
are glycoproteins and proteoglycans. The non-collagenous matrix also include the fibrous 
protein elastin that forms part of elastic fibres (see table 1.2 for summary).  




1.3.2.1  ELASTIN 
Elastin is a hydrophobic protein with an ability to stretch to over 100% of its original length 
with fully elastic recovery [Grant et al., 2013]. Elastin is formed from tropoelastin and becomes 
insoluble and stable once fully formed into elastic fibres. 
Elastin is the major component of the elastic fibre, which has been hypothesised to be essential 
for tendon strength and elasticity during movement as well as the preservation of the crimp 
[O’Brien, 1997]. Studies have reported the presence of elastin in tendon at about 1-2% by dry 
weight [Hutson and Speed, 2011]. The distribution of elastin is yet to be fully determined, but 
may vary across a tendon depending on the mechanical environment that the tendon is exposed 
to [Thorpe et al., 2013c]. Some studies have reported that elastic fibres in tendon are found 
within the tenocytes and between fascicles localised to the interfascicular matrix (IFM) where 
the presence of elastin in the IFM is thought to influence fascicle sliding and recoil [Thorpe et 
al., 2016b; Grant et al., 2013; Thorpe et al., 2013c]. By contrast, some data suggests that elastic 
fibre concentration is highest at the insertional regions, due the high tension the area undergoes, 
whilst it is minimal at the fibrocartilageous areas [Grant et al., 2013].  
1.3.2.2  GLYCOPROTEINS 
Glycoproteins are large macromolecules that consist of a large protein component and small 
carbohydrate component. There are numerous glycoproteins, of which proteoglycans are the 
most abundant.  Of other glycoproteins, the most abundant in tendon are cartilage oligomeric 
matrix protein (COMP), tenascin-C, fibrillin, fibronectin, laminin, thrombospondin (Tsp) and 
tenomodulin [Juneja and Veillette, 2013].  
1.3.2.3  PROTEOGLYCANS 
Proteoglycans (PGs) are a specific class of glycoproteins, and are the most abundant non-
collagenous proteins in tendon. PGs are composed of a core protein attached to one or several 
polysaccharide chains which contain amino sugars. The polysaccharide chains are called 
glycosaminoglycan (GAG) side chains and are linked to the core protein by covalent bonds 
(Figure 1.5) [Nordin and Frankel, 2001; Clark, 1996]. Sulphated GAGs such as 
heparin/heparan sulphate (HS), chondroitin sulphate (CS), dermatan sulphate (DS), keratan 
sulphate (KS) and hyaluronan can form part of a proteoglycan molecule [Varki et al., 2009]. 
Tendons have different total GAG percentages according to their function. GAG content is 




known to be highest in compressive regions of tendon (about 3.5%) relative to about 0.2% in 
the tensile regions within tendon [Yoon and Halper, 2005]. 
 
PGs are negatively charged hydrophilic molecules that can hold water up to 50% of their weight 
[Hutson and Speed, 2011]. The ability of PGs to attract water is useful in maintaining fluid and 
electrolyte balance within a tissue, thereby keeping the ECM and resident cells hydrated, and 
providing high resistance to compression forces. However, PGs not only function as structural 
features of tendon but are also essential for cellular processes like cell-cell, cell-matrix and 
ligand-receptor interactions, and also signal transduction processes [Perrimon and Bernfield, 
2001]. PGs can be categorised as small leucine rich proteoglycans (SLRPs) or large 
aggregating proteoglycans.   
It has been proposed that PGs may play a role in functions such as fibrillogenesis and fibre 
lubrication, which may be the reason for the presence of PGs in the IFM of the tendon [Thorpe 
et al., 2015a]. However, some studies also suggest that PGs play a mechanical role, modulating 
tendon mechanics. Due to the hydrophilic nature of PGs and their non-covalent bond to the 
fibrils, PGs can associate and dissociate along the fibrils causing them to break and reform 
[Cribb and Scott, 1995]. This promote fibril elongation and decrease in diameter under tension 
demonstrating that the PGs promote deformation, and stiffening of tendon matrix [Cribb and 
Scott, 1995]. The mechanical role of PGs in tendon remains controversial, with some studies 
demonstrating an important role and others reporting no role [Matuszewski et al., 2012]. 
  Figure 1.5: The proteoglycan complex 
[adapted from Gupta, 2012] 




 Small Leucine Rich Proteoglycans (SLRPs) 
The SLRPs are named owing to their small core proteins (~40kDa) and long 20-30 amino acids 
chains containing high levels of leucine [Matuszewski et al., 2012; Merline et al., 2009].  The 
SLRPs present in tendon are decorin, biglycan, fibromodulin and lumican, with decorin and 
biglycan being the most abundant [Stanton et al., 2011]. Decorin consists of a core protein 
bound to just one GAG chain of CS or DS which is nearly always one DS in tendon [Watanabe, 
et al., 2012; Yan et al., 2011]. The role of decorin in tendon function remains controversial but 
it is thought to assist in maintaining tendon tensile strength mechanically link adjacent collagen 
fibrils and enabling inter-fibril load sharing [Rigozzi et al., 2012; Parkinson et al., 2011]. 
Biglycan consists of a core protein with two GAG chains of either CS or DS; two CS chains 
are more common in tendon [Yan et al., 2011]. Fibromodulin consists of a core protein bound 
to 100 KS or 21 CS GAG chains, while lumican is a core protein bound to 21 CS GAG chains 
[Parkinson et al., 2011]. 
Decorin, biglycan, fibromodulin and lumican are able to bind to fibrillar collagens (type I and 
II), and via interaction with their core proteins regulate collagen fibrillogenesis [Matuszewski 
et al., 2012]. These PGs play a key role in the fibril formation process by timing fibril alignment 
and aggregation, which ultimately alters the thickness of the fibrils [Milan et al., 2005].  
 Large Proteoglycans 
Aggrecan and versican are both members of the family of large aggregating PGs. Aggrecan 
(~250kDa) contains large numbers of CS and KS GAG chains and is located in compressive 
areas of tendon [Matuzewski et al., 2012]. Versican (~380kDa) consist of a large CS GAG 
chain, located in fibrous, tensile-load bearing regions [Hutson and Speed, 2011; Theocharis et 
al., 2002]. In the Achilles tendon, versican was identified as the major large PG in the tendon 
mid-substance whilst there was more aggrecan at the insertion. Site-specific variation in PGs 
are related to the mechanical history and function of the tendon [Hutson and Speed, 2011], and 
the capacity to resist the high compressive and tensile forces associated with loading and 
mobilization [Yoon and Halper, 2005]. 
 
 





The literature describing proteoglycan synthesis is not as extensive as that for collagen. 
However, the synthesis process follows the same route from the RER to the Golgi apparatus 
and finally to the ECM [Zhang et al., 1995]. Within the RER, the protein is synthesized, and 
glycosylation begins (protein folding, N-linkage). Glycosylation is an enzyme-directed 
chemical process involving the addition and subsequent processing of carbohydrate [Lodish et 
al., 2000].  The presence of the carbohydrate residue on the protein acts as a marker, facilitating 
protein movement from the RER to the Golgi. At the Golgi where glycosylation ends, the 
protein folding is completed by the addition of further N-linkages and O-linkages held by 
glycosidic bonds (Figure 1.6). After the linkage, GAGs attach to the Ser residue by a 
tetrasaccharide link to the core protein, forming a primer for polysaccharide growth [Gupta, 
2012]. The Ser residue is generally in the sequence -Ser-Gly-X-Gly- (where X can be any 
amino acid residue), although not every protein with this sequence has an attached GAG 
[Gupta, 2012; Zhang et al., 1995]. Carbohydrates are added one at a time by glycosyl 






  Figure 1.6: Representation of the N- and O- linkage that occurs during protein 
glycosylation [adapted from Zhang et al., 1995]  





Table 1.2: Non-Collagenous components of tendon ECM (Juneja and Veillette, 2013) 
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Fibrillin  - Linear arrays 
Essential for the formation 
of elastic fibres 
(elastogenesis) 
Omelyanenko 
et al., 2014 
Fibronectin ̴ 250kDa Modular protein 
Mediates interactions 
between cell and 
surrounding matrix in 
normal tissues as well as 
in repair and pathology 
Riley, 2005 
Laminin ̴ 400kDa Modular protein 
Found in vascular walls of 
tendon and myotendinous 
junction.                    
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tenocyte proliferation and 
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et al., 2014 












Located in pressure / 
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accounts for ̴ 65% of the 
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Riley, 2005 
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aggregating PG.                      
Modular 
(lectican).  
Low levels in tensional 
zone compared to 
compressive zone 
(fibrocartilage).      
Interacts with collagen.         
Contributes to tendon 
viscoelasticity.                       
Acts as a lubricant by 
allowing fascicle sliding. 
Yoon and 
Halper, 2005 
Versican ̴ 265-370kDa 
Large 
aggregating PG.                     
Modular 
(lectican). 
Also contributes to tendon 
viscoelasticity.           
Support cell shape 






1.3.3  TENDON CELLS 
Tendon cells, called tenocytes, are responsible for the synthesis and maintenance of the tendon 
ECM. The cells adhere to the ECM through specific cell surface receptors, particularly 
integrins [Franchi et al., 2007]. Through these receptors, mechanical signals are transmitted 
between the ECM and the cells [Franchi et al., 2007].  
Tendon has a comparatively low cell content at less than 10% of the tendon composition. 
Around 90% - 95% of the cells are tenocytes and tenoblasts [Franchi et al., 2007]. The 
remaining 5% -10% of cells are of variable origin, with chondrocytes at the insertion sites and 
in the areas which undergo compression, and synovial and vascular cells (such as capillary 
endothelial cells and smooth muscle cells) in the endo- and epitenon, as well as myofibroblast-
like contractile cells (responsible for the modulation of contraction-relaxation of the muscle-
tendon complex) [Hampson et al., 2008; Kannus, 2000]. In pathological conditions, cells such 
as inflammatory cells, progenitor cells and macrophages can also be found in tendon tissue, 
contributing to healing [Dyment, et al., 2014; Kannus, 2000]. Tenocytes and tenoblasts both 
have a mesenchymal origin and the terms appear to be used interchangeably in the literature. 
However, they can be differentiated based on their shape. Tenocytes are elongated, spindle 
shaped cells with elongated nuclei, which reside on collagen fibers. In contrast, tenoblasts are 
more variable in shape (i.e. elongated, rounded or polygonal) and size (i.e. from 20µm to 70µm 
in length and 8µm to 20µm in width) [Cowin and Doty, 2007]. Tenoblasts are mainly found in 
immature/young tendon and are transformed into tenocytes with age or injury [Maffulli et al., 




2005]. Tenoblasts are thought to have increased metabolic activity compared to tenocytes. 
Nonetheless, the different roles that tenocytes and tenoblasts may play are unclear. 
  




1.4 TENDON INJURY 
In most everyday activities, the loads measured in tendons are comparatively low and well 
below the tissue’s ultimate tensile strength. Conversely, in fast eccentric movements like 
running and hopping where a limb must be rapidly decelerated, more significant stresses can 
be measured [Schechtman & Bader, 1997]. As a result of these high in vivo loads, tendons such 
as the Achilles and patellar are particularly prone to overuse injuries, often referred to as 
tendinopathies (Fung et al., 2010). However, mechanical loading can create not only structural 
damage, but can also initiate a cell response to remodel the matrix [Kjær et al., 2009; Franchi 
et al., 2007; Wang, 2006]. This is because an intimate interplay exists between mechanical 
loading, cell response and biochemical changes within the tendon extracellular matrix, 
resulting in adaptations in tendon morphology, structure and material properties in response to 
applied loads [Kjær et al., 2009]. This interplay between mechanically induced and cell induced 
matrix changes is poorly understood and has led to considerable debate concerning the 
aetiology of tendon injuries. 
1.4.1  TENDINOPATHY 
Birch et al., [1998] highlighted how tendinopathy is frequently preceded by degenerative 
changes to the extracellular matrix rather than occurring as a result of a single overload event. 
However, the factors that cause the initial degradation remain unclear. Kountouris and Cook 
[2007] state that tendinopathy might be due to overuse and other additional factors such as 
inefficient lower limb biomechanics and musculoskeletal function. Nevertheless, they went on 
to highlight that the exact aetiology of this condition is unknown. There is also some debate as 
to genetic factors influencing tendinopathy. Cook and Purdam [2009] referred to tendinopathy 
as failed healing, and a degenerative response, in which overload may be a contributing factor. 
However, they argue that the pathology (cell and matrix changes) observed in a tendon with 
tendinopathy are the same whether the tendon was unloaded (stress-shielded) or overloaded, 
indicating an important cellular role.  
Tendinopathy can certainly be described as a painful condition occurring in and around the 
tendon, most frequently encountered in the Achilles tendon [Alfredson and Cook, 2007]. To 
summarise the current view point, tendinopathy is thought to occur due to one, or a combination 
of the following; 




- A failed healing response. 
- Breakdown of the normal maintenance of the tissue. 
- Excessive repetitive overload  
- Load following a period of no load or under load. 
Achilles tendinopathy is a common injury amongst athletes and non-athletes. It accounts for 
about 30-50% of all sport injuries; particularly sports incorporating high stretch-shortening 
cycles (SSC) such as found in running related sports like tennis (40% injuries), basketball (32% 
injuries) and volleyball (45% injuries) [Wilde, et al., 2011; Sharma and Maffulli, 2006; Lian et 
al., 2005]. However, tendinopathy is not only limited to those participating in sporting activities 
but is also common among sedentary populations, with 33% of patients with tendon injuries 
participating in no sports [Samiric et al., 2009; Kingma et al., 2007]. 
 
  




1.5 TENDINOPATHY TREATMENT 
There remains no clear evidence-based treatment for tendinopathy due to the limited 
understanding of the underling aetiology and pathogenesis of the condition.  
Prior to the 1990s, tendinopathy was consistently referred to as tendinitis (also spelt tendonitis) 
which would imply inflammatory processes in and around the lesion [Rees et al., 2013; Stanish 
et al., 1986].  This was because the condition was associated with pain in response to overuse 
[Khan et al., 2002]. Not surprisingly, most of the treatment modalities proposed at this time 
aimed at controlling the inflammation, such as non-steroidal anti-inflammatory drugs 
(NSAIDS) and corticosteroid injections [Alfredson and Cook, 2007]. However, these treatment 
options reported limited success. As the understanding of tendinopathy evolved, a number of 
studies began providing evidence to support the ideology that tendinopathy was a degenerative 
process that did not demonstrate an inflammatory response, thus eliminating the term tendinitis 
and instead using tendinosis [Khan et al., 1999; Jozsa et al., 1997; Astrom and Rausing, 1995]. 
Some of the evidence supporting a diagnosis of tendinosis were the presence of collagen 
separation, thinning, and disruption with the absence of inflammatory cell infiltrate [Khan et 
al., 1999]. In addition, researchers also noted that the characteristics of inflammation seen in 
other inflammatory diseases such as rheumatoid disease, were not seen when a tendinopathic 
tissue was observed [Astrom and Rausing, 1995]. These findings resulted in research into new 
treatment methods to target the degeneration, including 
- Treatment using blood and blood products aimed at improving healing and remodelling. 
These include stem cell or gene therapy, or bone marrow-derived cells [Young, 2012; 
Gaida and Cook, 2011]. 
- Treatments aimed at reducing pain rather than healing the tendon itself, such as 
sclerosant or high volume injections, or the application of glyceryltrinitrate patches 
(GTN) [Wilde, et al., 2011; Gaida and Cook, 2011]. 
- Extracorporeal shock wave therapy [Waugh et al., 2015; Alfredson and Cook, 2007].  
- Exercise-based physical therapy which includes eccentric and concentric exercises for 
the associated muscle [Lorenz and Reiman, 2011]. 
Currently, the term tendinopathy is preferred to describe tendon injury, a term that assumes no 
knowledge about the underlying pathology. This is because the importance of inflammation in 
both the pathogenesis of tendon injury and the healing process has been contentious in recent 




years and remains poorly understood. Recent studies suggest that a finely balanced 
inflammatory response is necessary for tendon healing, at least at the early stage of the healing 
process [Dakin, et al., 2014].  
Injections of blood or platelet-rich plasma, as well as stem cell or gene therapy have been 
reported to ‘regenerate connective tissues’ [Young, 2012; Gaida and Cook, 2011]. However, 
these treatment options are unproven and still in the experimental stages. The injections contain 
saline solution and also a local anaesthetic, with or without cortisteroid, which may influence 
outcome. Further, the act of injecting a solution can separate the tendon sheath from the tendon 
and disrupt surrounding vessels and nerves, also thought to improve tendinopathy [Wheeler, 
2014]. Indeed, this approach is often adopted directly, and sclerosing injections and high 
volume injections have demonstrated a positive outcome in a number of studies, and are 
hypothesised to work on the principle that tendinopathy is associated with pain and 
neovascularisation which the injections prevent [Wilde, et al., 2011; Gaida and Cook, 2011]. 
However, there was no significant association between a decrease in neovascularisation and 
functional outcome [O’Neill et al., 2015; Tol et al., 2012]. Thus, evidence pertaining to these 
treatment is insufficient, requiring more investigation and randomised trials to support their 
efficacy [Lohrer et al., 2016; Scott et al., 2013; Magnussen et al., 2009].  
The use of extracorporeal shock wave therapy has more recently been suggested as an option 
in treating several tendon and fascial injuries, with some evidence of success [Alfredson and 
Cook, 2007]. However, according to Sems et al., [2006] the efficacy of shock wave therapy 
remains controversial. This could be as a result of the multiple variables associated with this 
therapy, such as the amount of energy delivered, the method of focusing the shock waves, the 
frequency and timing of shockwave delivery, and whether or not anaesthetics are used 
alongside treatment [Wilson and Stacy, 2011; Sems et al., 2006].  However, over the last twenty 
years, the one treatment that has consistently been promoted and has the strongest evidence of 
efficacy has been eccentric exercise [Lorenz and Reiman, 2011]. Eccentric exercise has been 
consistently effective in improving tendon function and reducing pain. These two treatments 
are now considered in greater detail. 
 
 




1.5.1  EXTRACORPOREAL SHOCK WAVE THERAP Y (ESWT) 
In a clinical setting, extracorporeal shock wave therapy (ESWT) involve a device that passes 
kinetic energy in the form of acoustic shockwaves through tissues. Shockwaves are pressure 
waves, characterised by a rapid rise in positive pressure and high peak pressure amplitude, 
followed by a fall in pressure below ambient, i.e. negative pressure (Figure 1.7). The waves are 
concentrated on the area of pain and pathology, therefore applying mechanical forces to the 
tissue [Waugh e al., 2015]. There are three methods through which shock wave can be 
generated; electrohydraulic, electromagnetic, and piezoelectric / pneumatic [Wang, 2012; 
Wilson and Stacy, 2011]. Although the methods of generating the shock wave may vary, the 
principles of how they interact with tissue remain same. The electrohydraulic method of shock 
wave application uses an underwater explosion with a high-voltage electrode spark discharge 
to produce a vaporization bubble of high-energy pressure waves. The electromagnetic method 
uses a coil that induces a strong magnetic field in a metallic membrane which is then transferred 
to a fluid medium to produce shock waves. Finally, the piezoelectric method uses piezocrystals 
mounted in a sphere to produce a rapid electrical discharge.  
 
Shock waves produce two basic effects in tissues. The primary effect is where direct 
mechanical forces of pulse energy are directed to the tissue target point [Wang et al., 2012]. 
However, ESWT also causes cavitation, characterised by the formation of gas bubbles. The 
implosion of the bubbles with the rise in pressure from the subsequent shock wave produces a 
secondary energy wave, which also provides a mechanical stimulus [Wang et al., 2012; Ogden 
Or 500 bar 
Figure 1.7: A typical shock wave therapy machine, with details of the pressure pulse it generates. There is a rapid rise 
in positive pressure and high peak pressure amplitude, which is eventually followed by a variable negative 
pressure. This generates shock waves at a frequency of around 10Hz in the tissue [adapted from Ogden et 
al., 2001]. 




et al., 2001]. Shock waves augment tissue density as a result of the positive and negative phases 
of the propagating wave passing through it, and in doing so deliver direct mechanical 
perturbations to the tissue at around 8-10Hz [Waugh et al., 2015]. 
There is considerable research evidence concerning the effectiveness of shock wave in treating 
tendinopathy demonstrating decreased pain and improved tissue function post ESWT [Mani-
Babu et al., 2014; Al-Abbad and Simon, 2013; Wang, 2012; Wilson and Stacy, 2011; Rompe 
et al., 2007]. Generally, most applications of shockwave for Achilles tendinopathy takes about 
3-4 sessions of approximately 30 minutes treatment depending on the severity of the condition 
[Wilson and Stacy, 2011]. A study by Wang et al., [2003], stated that EWST promoted pain 
relief and tissue repair at the tendon-bone junction of the Achilles tendon in rabbits. The study 
demonstrated that EWST induced the in-growth of neovascularization within the tendon and 
enhanced angiogenesis, which may play a role in improving blood supply and in turn promote 
tissue regeneration. Another study by Chen et al., [2004], demonstrated that ESWT promoted 
cell proliferation and tissue regeneration in rat Achilles tendon with increased expression of 
growth factors such as TGFβ1. In addition, a study by Bosch et al., [2009], demonstrated that 
ESWT prompted collagen metabolism in the equine superficial digital flexor tendon. Short-
term studies by Rompe et al., [2007] compared eccentric exercise, ESWT, and a wait-and-see 
policy for the treatment of midportion Achilles tendinopathy in humans over a 4 months period. 
At the end of the 4 months, the Victorian Institute of Sports Assessment – Achilles 
Questionnaire (VISA-A) scores of patients’ improvements were 60% for eccentric exercise, 
52% for ESWT and 24% for the wait-and-see policy. 
Some studies show no effect, hence, more clinical trials are needed to fully evaluate efficacy 
of ESWT. In addition, the in vivo mechanism by which ESWT may promote tendon healing is 
yet to be understood.  
1.5.2  EXERCISE BASED TREATMENT                                                                         
The concept of exercise based treatment for the rehabilitation of tendon injuries was introduced 
in the mid-1980s by Stanish et al. [1986], after which it became embedded in rehabilitation 
regimes by Alfredson a decade later [Alfredson et al., 1998]. Ever since then, exercise therapy 
has been continually reviewed and developed to try and maximize its effectiveness. Muscles 
can undergo eccentric, concentric and isomeric contraction. Eccentric loading involves the 
lengthening of the muscle-tendon unit during contraction (Figure 1.8). Concentric loading 




involves shortening of the muscle-tendon unit during contraction (Figure 1.8), and isometric 
loading is strength training in which the joint angle and muscle length do not change. Use of 
these different loading modalities in exercising the muscle-tendon complex of a tendinopathic 
tendon have been compared against one another and against other treatments, with eccentric 
loading consistently reporting the most promising outcomes. Eccentric exercise training has 
thus been applied since the 1980’s as a key component of tendon injury rehabilitation [Stanish 
et al., 1986]. 
A study by Rompe et al. [2007] compared the efficacy of eccentric exercise relative to no 
treatment (a wait-and-see approach) on chronic Achilles tendinopathy. The VISA-A success 
rates were 24% for the wait-and-see policy (with paracetamol offered when necessary), 
compared to 60% for eccentric loading exercises. By contrast, there have been a wide number 
of studies that have compared the efficacy of eccentric exercises relative to concentric exercises 
[Kaux et al., 2011; Allison and Purdam, 2009; Rees et al., 2008; Wasielewski et al., 2007]. 
Generally these studies have reported superior outcomes with eccentric exercise, reporting pain 
relief and patient satisfaction for 82% of patient participants while concentric training only 
reported patient satisfaction for 36% of participants [Mafi et al., 2001].  
 
Table 1.3 reports the results of different eccentric loading studies generally demonstrating good 
outcomes from a 12 week training programme. Some studies have suggested that eccentric 
loading is more successful in treating mid-portion tendinopathy, with the clinical evaluation 
satisfaction percentage for Achilles tendon showing 83.3±17.3 for mid-portion and 77.9±17.6 
for insertional while the Visual Analogue Scale (VAS) decreased after an eccentric load 
Figure 1.8: Schematic of illustrating the protocol 
involved in eccentric and concentric 
contraction [Brady, 2012] 
Concentric loading involves shortening 




Eccentric loading involves lengthening 
of the muscle-tendon unit during 
contraction   




training programme from 66.8±19.8 to 10.2±13.7 for mid-portion and 68.3±7.0 to 13.3±13.2 
for insertional tendon [Fahlstrom et al., 2003]. However, the satisfaction percentage between 
mid-portion and insertional Achilles tendon are hardly significant to confirm the efficacy and 
outcome of the study. Nonetheless, the statement of better clinical result in mid-portion than 
insertional tendon was supported by a later study in 2007 that evaluated the effects of non-
surgical treatment option including eccentric exercise, which reported 90% clinical success for 
mid-portion Achilles tendon compared to 30% for insertional Achilles tendon [Alfredson and 
Cook, 2007]. However, the reasons behind this are unclear.  
  




Table 1.3: Trial studies of eccentric exercise treatment protocols for tendinopathy and their outcome measures. Data from several sources have demonstrated success of 
eccentric loading using different time periods (12 and 52 weeks) and investigating tendinopathy in different tendon regions (mid-portion and insertional area). 
Affected 
area 









Entire body on injured leg standing upright on a 25° decline 
board then knee slowly flexed to 70°  
3 sets of 15 repetitions 2 
times daily, 7 days a 
week  









Entire body in upright position then heel raise with the non-
injured leg, then transferred to injured leg. From heel raise to 
heel lowered slowly 
3 sets of 15 repetitions 2 
times daily, 7 days a 
week 
12 VAS decrease from 
69.9±18.9 to 
21.0±20.6  






Entire body on injured leg, forefoot on step, going from 
maximum heel lift to maximal dorsal flexion in ankle joint and 
using non-injured leg to lift back to start position 
3 sets of 15 repetitions 2 
times daily, 7 days a 
week 
12 VAS decrease from 









Entire body weight on injured leg, to all body weight on the 
forefoot with the ankle in plantar flexion. Then the calf muscles 
were loaded with knee straight and again with knee slightly bent 
3 sets of 15 repetitions 2 
times daily, 7 days a 
week 
12 VAS decrease from 
66.8±19.4 to 
10.2±13.7 
 VAS decrease 












Entire body in upright position on small step hereafter the 
weight is transferred to injured leg and the heel slowly lowered 
as far as possible until maximal stretch of the calf muscles 
and/or the Achilles tendon. 
3 sets of 15 repetitions  12 and 52 KOOS 
questionnaire 
reported marked  
improvements of 








Entire body on a 10cm at 25° inclined board and perform single 
leg squats on the injured leg 
3 sets of 15 repetitions 12 and 52 VAS decrease from 
30 to 18 (after 12 
weeks) and 10 
(after 52 weeks) 
Young et al., 
2005 
Abbreviation: VAS – Visual Analogue Scale from 0 (no pain) to 100 (severe pain)  
                      KOOS – Knee Injury and Osteoarthritis Outcome Score from 0 (mild pain) to 4 (extreme pain)  
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Initially it was believed that the improved efficacy of eccentric loading resulted from the tendon 
experiencing higher forces during eccentric than concentric exercise, resulting in more tendon 
remodelling in response to the higher strain. However, in vivo studies in healthy humans have 
reported no differences in peak Achilles tendon force during eccentric and concentric loading 
regimes [Chaudhry et al., 2015; Galloway et al., 2013].  However, while there are no difference 
in the peak forces experienced by the tendon when performing eccentric and concentric 
exercises, recent studies have demonstrated that eccentric training generates high frequency 
perturbations of between 8-12Hz in the muscle-tendon complex, which are not apparent in 
concentric training (Figure 1.9) [Chaudhry et al., 2015; Grigg et al., 2013; Henriksen et al., 
2010; Semmler et al., 2007]. Data confirms that this 8-12Hz frequency is coming 
predominantly from medial soleus and medial gastrocnemius muscle activity where the force 
is generated and transferred to the tendon [Chaudhry et al., 2015]. As such, it has been 
hypothesised that these high frequency perturbations maybe the important driver of repair in 
tendinopathic tendon, as they may promote more stimulus for tendon remodelling and 
formation of new collagen [Chaudhry et al., 2015; Kaux et al., 2011; Tan and Chan, 2008].  
 
Based on these findings, one could hypothesis that the efficacy of both eccentric exercise and 
ESWT in treating tendinopathy is a result of the vibrations at approximate 10Hz applied to 
tendon during the treatment. Research by Yamamoto et al. [2005] demonstrated that the 








  CL – Concentric Loading 
EL – Eccentric loading  
Figure 1.9: Schematic of eccentric and concentric contraction of the triceps surae and a graph comparing the 
perturbation frequencies observed in the tendon from both exercise modalities [Chaudhry et al., 
2015; Grigg et al., 2012] 
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properties of cultured collagen fascicles. However, very little is known about tendon 
perturbations and how they may influence tendon turnover or repair. Nevertheless, it is well 
established that tendon cells (tenocytes), like all connective tissue cells are mechano-
responsive to varying magnitude and frequencies of applied strain [Khan and Scott, 2009].  
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1.6 CELLULAR MECHANOTRANSDUCTION 
Tendons are dynamic mechanoresponsive tissues that adapt to loading and unloading 
[Andarawis-Puri and Flatow, 2011; Neviaser et al., 2012]. It is now well accepted that 
mechanical forces or deformations applied to cells lead to chemical cascades that crucially 
influence the form and function of cells in a process referred to as mechanotransduction [Orr 
et al., 2006; Jaalouk and Lammerding, 2009; Hoffman et al., 2011].  
An example of the effect of mechanotransduction in tissue development has been described in 
bone [Jaalouk and Lammerding, 2009]. Compact bone consists of concentric layers of bone 
matrix, wherein small cavities called lacunae are distributed in regular intervals. These lacunae 
contain cells called osteocytes and are connected to one another and to the Haversian canal 
through a network of interconnecting canals called canaliculi. Weight bearing and muscle 
contraction during movement generates gravitational and compressive forces that result in 
small deformations of the poroelastic bone, resulting in pressure gradients that drive interstitial 
fluid flow through the lacunae–canalicular network. This load induced fluid flow is thought to 
stimulate localized bone remodelling and optimize the physical performance of the bone 
through mechanotransduction signalling [Orr et al., 2006; Jaalouk and Lammerding, 2009]. 
Studies also indicate frequency dependence to matrix metabolism in bone cells, specifically 
suggesting that higher frequencies may promote more rapid healing in bone tissues [Zhang et 
al., 2007]. Similarly, chondrocytes (the main cells that comprise cartilage) respond to 
mechanical loading with cell proliferation and an increase in cartilage matrix synthesis [Iqbai 
and Zaidi, 2005; Jaalouk and Lammerding, 2009].  
 




Figure 1.10 gives a general overview of some of the mechanisms through which cellular 
mechanotransduction can occur. Mechanical stimuli creates an interaction between the ECM 
and cell adhesion molecules (integrins, cadherins, dystroglycans, proteoglycans or tyrosine 
kinase receptors) [Kjær, 2004]. The interaction leads to activation of a series of downstream 
secondary messenger / signalling pathways and cytoskeletal rearrangements [Cooper, 2000; 
Kjær, 2004]. The various signalling pathways results in changes in the nucleus in response to 
the mechanical stimuli.  
Within tendon tissues, mechanical forces are transmitted by cell focal adhesion sites, composed 
primarily of integrins. Integrins play a vital role in tendon mechanotransduction because they 
are believed to be the main receptor between the cell and the ECM that sense tensile strain 
[Kjær, 2004]. Integrins are large cell surface receptors that link the ECM to the cell 
cytoskeleton via molecular bridges of actin-associated proteins such as talin, vinculin, zyxin 
  Figure 1.10: Schematic depicting some of the known mechanisms of cellular mechanotranduction: a) applied 
load causes the ion channels in the membrane to open allowing the influx of calcium and other ions 
that initate further downstream signalling, b) glycocalix (a layer of carbohydrate-rich protein) 
mediate mechanotransduction signalling in response to fluid shear stress, c) cell to cell junctional 
receptors d) Cell to ECM junction central adhesion to the environment, e) force induced unfolding 
ECM proteins such as fibronectin, mediate mechanotransduction signalling outside the cell, f) 
activation of signalling pathways, g) the nucleus acts as a mechanosensor to sense mechanical 
signals, h) cell to surface adhesion to influence a change in the inter-cellular space  [Jaalouk and 
Lammerding, 2009] 
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and paxillin [Schnatwinkel and Bryant, 2014; Wang et al., 2009]. Tension applied to tendon 
tissue, may lead to the activation of the stretch-sensitive ion channels (Ca2+), depending on the 
integrins involved [Ingber, 2006]. Activation of the ion channels causes an influx of 
extracellular and intercellular Ca2+ from intercellular stores, through intracellular messengers 
such as inositol trisphosphate (IP3) and diacylglycerol (DAG) [Wall and Banes, 2005]. The 
mechanical signals are then transferred to the nucleus via cytoskeletal filaments that connect 
to the nucleus to influence matrix production. In normal conditions, this process simply 
maintains tendon homeostasis, breaking down and replacing damaged molecules to maintain 
tissue structure and the mechanical properties of the extracellular matrix (ECM) that are 
fundamental to cellular and tissue health [Humphrey et al., 2014]. In tissue development, the 
change could be for cell proliferation, differentiation and migration [DuFort et al., 2011]. 
However, in the case of injury, the change could be for tissue development, regulating both 
anabolic (ECM, collagen and proteoglycan synthesis) and catabolic (MMPs and ADAMTs 
expression) matrix turnover [Popov et al., 2015]. 
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1.7 TENOCYTE RESPONSE TO LOADING 
Mechanical loading induces cell deformation which initiates changes in gene expression and 
growth factors responsible for catabolic and/or anabolic cellular and molecular responses (e.g. 
synthesis of collagen and matrix proteins). These initial responses may proceed to induce long-
term tendon structural modifications that may affect tendon material and morphological 
properties [Galloway et al., 2013; Heinemeier and Kjaer, 2011; Wang, 2006]. In particular, 
studies have shown that collagen synthesis and procollagen expression are mediated by growth 
factors such as insulin-like growth factor 1 (IGF-I), transforming growth factor-ß-1 (TGFß-1) 
as well as interleukin-6, whose interstitial concentration increased with exercise [Heinemeier 
et al., 2012; Kjaer et al., 2009; Wang, 2006]. Consequently, collagen synthesis has been shown 
to increase from 1% at rest to 2-3% after exercise, and remained elevated for at least 3 days 
[Miller et al., 2005].  
The increase of metabolic activities observed in tendon when subjected to mechanical loading 
like exercise shows that the tendon is not just a passive connector between muscles and bone, 
but is an active tissue that responds to applied mechanical loading [Kalliokoski et al., 2005; 
Kjaer et al., 2005]. However, whether different amounts of mechanical loading induce 
differential expression of tenocyte and non-tenocyte related genes, remains unknown. 
Furthermore, the mechanotransduction mechanisms, by which cells sense mechanical loading 
and translate them into the biochemical signals that induce tissue adaptive responses, are still 
not completely understood [Heinemeier and Kjaer, 2011; Wang, 2006].  
While the mechanism of action of eccentric loading is poorly understood, the new studies 
demonstrate that the differential component of loading during eccentric loading and ESWT is 
the 10Hz vibrations, which may provide useful insight [Chaudhry et al., 2015; Sweeney et al., 
2011; Rees et al., 2008]. However, no one has yet investigated how 10Hz loading may 
influence tendon cell mechanotransduction.  
Therefore, this study is designed to further understand the effects of 10Hz mechanical loading 
on tenocyte metabolism, comparing cell response to that seen with 1Hz loading, as most 
commonly seen in other studies. 
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1.8 HYPOTHESES, AIMS AND OBJECTIVES 
Hypotheses 
Clinical data indicates that mechanical loading may be involved in tendon healing with 
eccentric loading and ESWT studies indicating that tendon vibrations at 10Hz might be 
important for repair, therefore this study hypothesise that: 
1) Mechanical loading will initiate increased metabolic activity of tenocytes, upregulating 
anabolic and catabolic gene expression enabling increased matrix turnover.  
2) Mechanical loading at 10Hz will lead to an augment tenocyte response relative to 
loading at 1Hz. 
3) Cells response to mechanical loading will differ between healthy and tendinopathy 
tenocytes. 
Aim 
The study aims to measure tenocyte metabolic activity in response to mechanical loading, 
investigating a broad range of metalloproteinases and matrix genes as a basis for trying to 
understand cell response to mechanical loading. Secondly, it aims to further characterise 
tenocyte mechanotransduction behaviour, by probing the signalling pathways involved in the 
mechanoregulation of gene expression.  
Objectives 
1. Set up system(s) to enable the application of high frequency (10Hz) loading to tendon 
cells while maintaining cell viability (chapter 2). 
2. Compare cell response to mechanical loading at low (1Hz) and high (10Hz) loading 
frequencies (chapter 3). 
3. Compare the metabolic activity of healthy and tendinopathic tenocytes to mechanical 
loading (chapter 3). 
4. Investigate the signalling pathways involved in the tenocyte response to mechanical 













IN VITRO MODELS 
  




It is well known that mechanical load promotes tissue remodelling in tendon [Rees et al., 2008]. 
A number of studies looking at the effects of cyclic strain on tendon cells have demonstrated 
that the strain magnitude, strain frequency, strain rate and duration of strain application can all 
influence the cellular biochemical responses [Arampatzis et al., 2007]. However, there is little 
consensus about how different load magnitudes or frequencies affects cell behaviour, and poor 
understanding of how available data relate to in vivo loading. To begin to address the 
associations between in vivo loading and cell response, several studies have developed 
methods to probe the loads on tendon in vivo and subsequently estimate the strains 
experienced by cells [Chaudhry et al., 2015; Henriksen et al., 2009; Rees et al., 2008] . 
There are then a number of methods through which tenocyte mechanobiology in 
response to these strains can be investigated using experimental set ups.  
It is possible to simulate in vivo load conditions directly with in vivo animal models, 
in which tendons are subject to defined loading protocols . However, not only do such 
experiments require the use of animals, but the in vivo situation is also very complex. 
Factors such as the animal’s age, gender, physiology, genetics, behaviour and nutrition may all 
have an effect on the study outcome, or be confounding variables in the research process. 
Research done in vitro allows for a single experimental variable to be manipulated, hence 
mechanobiology studies using in vitro models can offer great insights when analysing 
the effect of various physiological and pathological load conditions on cell behaviour. 
However, they are some shortcomings with in vitro models also.  
An ideal in vitro system would need to fully replicate the mechanical environment of 
the cells in vivo. Tissue explant models are closest to achieving this, providing a normal cell 
matrix interface and more realistic physiological cues, but while the chemical environment is 
more easily controlled than in vivo, it remains a less defined and variable parameter [Devkota 
and Weinhold, 2005]. Complete environmental control can be achieved by isolating cells from 
a tissue and seeding them into a new fully defined material for further characterisation. 
However, such approaches lose the physiological cell-matrix interface and simplify the cell 
strain environment. The simplest of such approaches adopts two-dimensional (2D) models, 
in which cells are cultured on an elastic membrane and subjected to a variety of 
mechanical stimulation regimes [Bayer et al., 2014]. 2D models provide a uniform 
cell seeding platform and the capacity to apply well defined strains but do not create 
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an environment similar to the native tissue environment [Thomopoulos et al., 2013]. 
Tenocytes in situ are known to form a three-dimensional (3D) communicating network that can 
be subjected to tensile, compressive and shear strains [Maeda et al., 2009]. Therefore, a model 
that supports this 3D organisation has some advantages over 2D systems, as it may be able to 
maintain tenocyte morphology and intercellular network organization, thus providing a more 
physiologically relevant local strain environment for cells when the material is subjected to a 
variety of mechanical stimulation regimes [Phillips and Brown, 2011]. 3D models unlike 2D 
models provide uniform mechanical stimulation through the scaffold thickness, hence across 
the cell body, whilst in 2D systems, cell attachment occurs on one side of the cell (that which 
is in contact with the 2D surface) [Thomopoulos et al., 2013]. Nevertheless, whilst cell 
attachment may be more physiological, the structure of 3D scaffolds remain poorly matched to 
the complex hierarchical organisation of ECM in tissues.  
This chapter provides a brief overview of the in vitro models that were developed and tested in 
this research. For each model, the rationale for, and pertinent findings concerning, its use in 
future work are discussed, before selecting an appropriate in vitro platform for the remaining 
experimental work. 
  














2.2    EXPLANT MODELS 
 
  




The need for reliable in vitro models as alternatives to traditional in vivo studies has 
increasingly become imperative in basic research. As such, explant models have been used to 
both minimize the number of animal/human samples required (since numerous explants can be 
obtained from one animal/human) and also to prevent any suffering associated with in vivo 
animal work. In addition, tissue explants to some extent mimic the in vivo cell environment, 
by retaining cells in situ in their native matrix [Patterson-Kane et al., 2012]. Nevertheless, it 
must be recognised that in vitro explants are often not representative of the in vivo situation in 
terms of cell population, nutrient supply and mechanical loading [Fisher, 2005].  
In tendon research, tissue explants have been used to understand the composition, properties 
and mechanics of tendon [Thorpe et al., 2014; Thorpe et al., 2013b; Wren et al., 2001], and to 
study how cyclic loading under creep or stress deprivation conditions alter cell and tissue 
mechanobiology [Weinhold et al., 2001]. Of particular interest to the current project, a number 
of studies have been successful in investigating cell response to strain in cultured tissue 
explants. In 2005, Screen and colleagues reported an upregulation in collagen production in 
response to cyclic tensile strain using rat fascicles, demonstrating that the application of cyclic 
tensile strain to isolated tendon fascicles would initiate anabolic matrix metabolism [Screen et 
al., 2005]. Tenocytes respond to mechanical stimulus by altering the balance between anabolic 
and catabolic processes. Maeda et al. [2010] showed increased anabolic cell response in rat tail 
tendon subjected to cyclic tensile strain (3% amplitude superimposed on a 2% static strain) for 
1 or 24 hr. The anabolic response was more pronounced as the number of strain cycles was 
increased, with the 1hr of cyclic strain showing a significant upregulation in gene expression 
of growth factors including basic fibroblast growth factor (bFGF) and vascular endothelial 
growth factor, while the 24hr cyclic strain showing increased expression of types VI and VIII 
collagen, aggrecan, TGF-β1, vascular endothelial growth factor, and bone morphogenetic 
protein 2 expression [Maeda et al., 2010]. In the current study, the potential to use tendon 
explants to investigate cell response to 10Hz loading was explored.  























2.3.1.1 SAMPLE COLLECTION AND PREPARATION 
The feet of healthy bovines (male steers between 18 and 36 months) with no observed tendon 
injury were sourced from a local abattoir. The extensor tendons were removed within 24 hour 
of slaughter under sterile conditions, and wrapped in tissue paper dampened with sterile 
Dulbecco's Modified Eagle Medium (DMEM) ready for explant dissection (Figure 2.1). The 
extensor tendons of the bovine foot were selected in preference to the flexor tendons, as the 
extensor fascicles run in straight lines, and are visible to the naked eye, thus minimizing the 
likelihood of damage during dissection. During explant dissection, hydration was maintained 
with DMEM. Tissue explants (containing 5-8 fascicles; 0.4-0.6mm diameter and 20 mm 
length) were isolated from the bovine extensor tendons by cutting with a scalpel longitudinally 
through the tendon using previously established protocols [Legerlotz et al., 2013] . Hydration 
in isolated explants was maintained by storing them wrapped in tissue paper dampened with 
DMEM prior to testing.  
 
 
Figure 2.1:  A. Bovine hoof skinned to access the Extensor tendons,  B. Extensor tendon 
dissected from the bovine hoof ready for dissection into explants (inset) 
A B 
Explants dissected 
off the tendon 
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Figure 2.2: Flow diagram of experiments performed on bovine explants to investigate their mechanical behaviour and cell viability over the 
duration of loading experiments. Four loading regimes are proposed for future studies; cyclic loading at 1Hz and 10Hz to strains 
of 5% ± 0.2% and 5% ± 1%. N (number of biological repeat) = 2, n (technical repeats). 
Bovine Explant Experimental Set Up 
Mechanical characterisation 
over 6hrs of loading 
n = 3-4 
Cell viability at 0, 6, 12 or 24hrs  
n = 2 each time points 
Bovine explants  







5% ± 0.2% 
at 1Hz 
5% ± 0.2% 
at 10Hz 
5% ± 1% 
at 1Hz 
5% ± 1% 
at 10Hz 
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To establish if explants may be appropriate for mechanobiology studies, explant viability was 
investigated with and without the application of cyclic mechanical stimuli. In addition to 
viability assessment, the mechanical response of the explants to the required mechanical stimuli 
was assessed, to confirm if the cells will experience strain throughout any further experiments. 
A flow diagram outlining the experimental groups is shown in Figure 2.2. 
2.3.1.2 BOVINE EXPLANTS MECHANICAL CHARCTERISATION 
For mechanical characterisation explant diameters were measured using a non-contact laser 
micrometre (LSM-501, Mitotuyo, Japan; resolution = 0.5μm) following previously established 
protocol [Shepherd et al., 2014]. Each explant was moved through the laser beam taking 10 
evenly spaced diameter measures along the 10mm length, of which the minimum value was 
recorded and used to calculate the cross sectional area of the explant, assuming a circular shape. 
Explants were secured in custom designed stainless steel loading chambers at a grip-to-grip 
distance of 10 mm (Figure 2.3). The chambers were filled with DMEM then sealed with the 
surrounding glass tube allowing full hydration at all times. Each chamber was secured in a 
mechanical loading frame (TA ElectroForce) with a 225N load cell, housed in an incubator to 
maintain samples in 5% CO2 at 37ᵒC as shown in Figure 2.3. The loading frame then applied 
the required mechanical stimuli to the sample for a 6hr period, recording displacement and 
maximum and minimum peak loads. The loading conditions and technical repeats assessed 
were: 
 Low magnitude Low frequency: 5%  ± 0.2% at 1Hz (n = 4) 
 Low magnitude High frequency: 5% ± 0.2% at 10Hz (n = 3) 
 High magnitude Low frequency: 5% ± 1% at 1Hz (n = 4) 
 High magnitude High frequency: 5% ± 1% at 10Hz (n = 3)  
A student's t-test was used to investigate significant differences in load relaxation between 
loading groups. Significance was defined as p ≤ 0.05. 




2.3.1.3 BOVINE EXPLANT CELL VIABILITY ANALYSIS 
Spatial assessment of cell viability in explant tissues was performed using visual live/dead 
staining on a confocal microscope, adopting a previously established protocol [Thorpe et al., 
2014]. The stains used were Calcein AM and Ethidium homodier; the live cells metabolize 
Calcein AM and show green fluorescence, while the membranes of the dead cells are penetrated 
by Ethidium homodier and show red fluorescence.  
After subjecting explants to the mechanical testing conditions of interest, explants were 
incubated in 2ml of DMEM, containing Calcein AM (0.01mg/ml) and Ethidium homodimer 
(3.75µM/ml) at 37ᵒC for 1 hour 30 minutes, to allow the dye penetrate the tissue. During 
incubation, the sample was covered with aluminium foil to protect the dye and sample from 
light and photo bleaching. After incubation, explants were washed in Dulbecco’s Phosphate-
Buffered Saline (DPBS) and transferred to a microscopy slide, covered with a coverslip, and 






Figure 2.3: Photograph of an explant secured in a loading chamber and within the incubator ready for testing. The schematic 
of the chamber highlights its components. The explant was secured between two metal plate grips tightened with 
screws, the chamber filled with medium and sealed with a Plexiglas cylinder. O-rings at the top and bottom of the 
chamber prevent the medium from leaking out. The chamber is then secure in the mechanical loading frame. 
Schematics of loading chamber [adapted from Legerlotz et al., 2013]. 
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magnification, where the laser line was excited at 488 nm for Calcein AM and 568mm for 
ethidium homodimer. Fluorescence was collected at 525 ± 10 nm for Calcein AM and at 
620±10 nm for ethidium homodimer.  
Cell viability was assessed as a percentage of live to dead cells. Two fields of view were 
randomly selected for each sample (one at the periphery and one in the core region), and the 
number of live cells and dead cells within each field of view counted to determine viability 
using equation 2.1.  
% 𝑐𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 𝑖𝑛 𝑓𝑖𝑒𝑙𝑑 𝑜𝑓 𝑣𝑖𝑒𝑤
=
Live cells 
Total number of cells (live + dead cells)
𝑥100  −  −  − −𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2.1  
Cell viability was analysed after the following loading conditions; 
 Unstrained for 0, 6, 12, and 24hrs  
 5% Static strain for 6, 12, and 24hrs  
 High magnitude Low frequency loading: 5% ± 1% at 1Hz for 6, 12, and 24hrs  
 High magnitude High frequency loading: 5% ± 1% at 10Hz for 6, 12, and 24hrs   




2.3.2.1 BOVINE EXPLANTS MECHANICAL TEST CHARACTERISATION 
Typical stress relaxation curves for explants subjected to each cyclic strain condition are shown 
in Figure 3.4 with mean data for stress relaxation at 6hrs across samples (calculated using 
equation 2.2) shown in Figure 3.5. Data indicate significantly greater stress relaxation with low 
frequency (1Hz) loading compared with high frequency (10Hz) loading and relaxation was also 
greater when the applied strains were higher.  
 
% 𝑀𝑎𝑥 𝑠𝑡𝑟𝑒𝑠𝑠 𝑟𝑒𝑙𝑎𝑥𝑡𝑖𝑜𝑛
=
maximum peak stress − minimum peak stress
maximum peak stress
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Figure 2.4: Typical stress relaxation curves from bovine explants subject to cyclic strain. A) 5%±0.2% strain at 1 Hz B) 5%±1% 







































2.3.2.2 BOVINE EXPLANTS CELL VIABILITY 
Live and dead cells were counted and viability expressed as percentage of the total cell number. 
Figure 2.6 show representative images of the cells after 24hrs of loading (strain of 5% ± 1% at 
10Hz) whilst table 2.1 reports mean viability in the periphery and core across all samples. All 
















5% ± 0.2% at
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Figure 2.5: Mean stress relaxation of bovine tendon explants after 6hrs of loading, comparing each 
loading condition. Stress relaxation was greatest with the higher magnitude of applied strain 
and the slower loading frequency. Error bars show standard deviation from the mean. * = 








Table 2.1: Cell viability results, showing the mean percentage of live cells at the periphery (left-
hand columns) and core (right-hand columns) of explants, comparing response in unloaded 
samples with those subject to different load conditions. Biological repeats, N = 2 with the number 
of optical viewpoints ranging from 3 to 5 for each repeat experiment. 
 Percentage viability at the 
periphery of the fascicles 
[Mean (%)  standard 
deviation] 
Percentage viability  at the core of the fascicles 
[Mean (%)  standard deviation] 
Duration 
(hrs) 




0 22 ± 1.2 - 44 ± 0.8 51 ± 18.4 - - 
6 18 ± 7.6 19 ± 2.9 39 ± 8.7 40 ± 6.3 21 ± 8.9 32 ± 10.5 
12 9 ± 5.2 6 ± 1.6 29 ± 9 36 ± 1.7 0 0 
24 0 0 27 ± 1.5 30 ± 8.8 0 0 
Figure 2.6: Typical images of bovine explants subjected to strain of 5% ± 1% at 10Hz for 24hrs, stained to show 
live and dead cells after loading. Scale bar = 100µm. Live cells emits green fluorescence while dead 
cells emits red fluorescence. A) Representative images at the periphery of the explants, B) 
Representative images at the core of the explants.  
A 
B 
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Cell viability from 0 to 12hrs was between 9 and 22% at the periphery of explants and not 
influenced by the application of static strain. By 24hrs, the cell viability at the periphery was 
0%. Viability was somewhat improved in the core of explants, but still low, ranging from 21-
51% (see table 2.1). Whilst not affected by static loading, the cell viability at the core after 
12hrs of cyclic loading was 0% indicating 100% cell death with cyclic loading.  
  




This study has examined the efficacy of using bovine explants to test the hypothesis that high 
frequency loading differentially influence tenocyte mechanobiology. Tendon is known to be 
viscoelastic [Peltonen et al., 2013; Duenwald et al., 2009], hence to better understand the 
effects of cyclic loading on cells, the mechanical properties of explants must be characterised, 
to establish how the tendon will behave under the described loading conditions. Cell viability 
must also be analysed to ensure the cells within the explants remain viable.  
The stress relaxation data (Figure 2.5) showed that all samples exhibited stress relaxation 
supporting existing literature [Shepherd et al., 2014; Screen et al., 2013; Duenwald, et al., 
2010]. Stress relaxation was greatest under the higher strain and slower loading frequency 
conditions. Studies have shown that stress relaxation occur as a result of structural 
rearrangement within the samples thus, when load is applied more slowly, more time facilitates 
greater levels of stress relaxation [Shepherd et al., 2014]. It is important that the explant does 
not stress relax to the point where no strain is experienced by the cells, or their response to the 
desired loading regime cannot be examined. Data confirmed that samples experienced load 
throughout the test period. However, the magnitude of cell strains will be influenced by the 
stress relaxation behaviour. 
Cyclic loading of explants can also result in damage, presenting as kinking of the collagen 
fibres and widening of the inter-fibre space. Such damage is likely to elicit a response from the 
resident cells, which may well take an active role in controlling further tendon behaviour and 
may affect later gene expression analysis [Shepherd et al., 2014]. In the current study, explants 
contained 0.3mm diameter of fascicles and were cyclically loaded to 5% strain at 1Hz or 10Hz 
for 21600 cycles. Shepherd et al. [2014] have previously established that cyclic stress 
relaxation of single fascicles from bovine extensor and flexor tendons, showed some degree of 
collagen matrix disorganisation after 1800 cycles of 14% strain at 1Hz. Whilst the loading 
conditions in the current study were notably less severe, it is feasible the loading may lead to 
some matrix disorganisation. It would be important to avoid this in the current study, where 
the goal is to investigate cell response to different loading frequencies.  
However, as a result of cell viability data, this was not explored further. The cell viability data 
in Figure 2.6 and table 2.1 clearly showed that the bovine explants exhibited pronounced cell 
death with the applied loading conditions. Cell death at the periphery of an explant has been 
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reported previously, likely a result of the damage generated by the scalpel. However, previous 
studies had shown the core fascicles remain viable in the equine model [Thorpe et al., 2015b]. 
This was clearly not the case in the bovine model, possibly as explants had a slightly smaller 
diameter. Upon cell death, factors stored in the cytosol may be released causing inflammation 
[Kondratko-Mitttnacht et al., 2015], potentially affecting gene expression data and subsequent 
tissue remodelling and repair process. These findings highlighted that bovine explants could 
not be utilised for further studies. Owing to this major limitation, alternative explant sources 
were examined, in which dissection was less extensive. 
  
























Individual tendon explants can easily be removed from rats with no need for dissection, as they 
can simply be pulled out from the tendon sheath. It was therefore hypothesised the cell viability 
would not be affected by sample preparation using the rat model (either Achilles tendon or tail 
tendon fascicles). Samples were tested to confirm cell viability with and without loading and 
also to assess the effects of explant preparation on gene expression and determine how long 
explant gene expression takes to stabilise post removal. Further research into the potential 
mechanical stimuli generated by ESWT or eccentric loading identified that the magnitude of 
vibrations is likely to be very small. As such, the loading conditions have been altered to apply 
1% ± 1% cyclic strain from this point onwards 
 
Rat Explant Experimental Set Up 
Gene stabilisation analysis 
at 0, 18, 24 or 48hrs  
Cell viability at  
0, 6, 12 or 24hrs  
Figure 2.7: Flow diagram of experiments performed on rat explants. Cell viability was investigated in cyclically strained 
samples, strained at 1% ± 1% strain while the unstrained samples were left unloaded in the incubator for the 
specified time. Number of biological repeats, N = 2, n is the number of technical repeats 
Secured in chambers 
Rat tail explants  
N = 2 
Rat Achilles  
N = 2 
Cyclically strained samples 
1% ± 1% at 10Hz 
n = 2 for each time point (rat tail) 
n = 1 each time point (rat Achilles) 
Unstrained samples   
n = 2 each time point (rat tail) 
n = 1 each time point (rat Achilles) 
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2.4.1.1 SAMPLE COLLECTION AND PREPARATION 
Adult female Sprague Dawley rats, each weighing 200g, were used in this study. Tails and legs 
from the rats were obtained as waste tissue from an experiment that took place in the university 
medical campus in Whitechapel, carrying out a neurological experiment on the brain and spine, 
which had no effect on the tendons. Rat tail and Achilles tendon explant were obtained 
following a previously established protocol [Screen et al., 2004]  
Rat Tendon Tail Explant 
Individual fascicles of approximately 20mm length were carefully dissected from the proximal 
end of the tail within a sterile hood (n = 5). The rat tail has six tendons surrounding the tail 
vertebrae [Bruneau et al., 2010] (Figure 2.8) and fascicles are separate entities within each 
tendon, so can be removed with ease. During dissection, special care was taken not to load the 
fascicles while separating them from the bony attachments, and the main securing force was 
placed on the tail backbone itself, not on the tendon being dissected. Fascicles were obtained 
from each tendon by carefully pulling them out of their sheath, and placing them in DMEM-
soaked blue paper roll to maintain hydration.  
 
Rat Achilles Tendon Explant 
In a sterile hood, the rat Achilles tendon was carefully dissected from the muscle attachment 
points and the tuber calcanei, and maintained in paper towel soaked in DMEM in order to 




Figure 2.8: The rat tail is a long cylinder consisting of three concentric layers. The innermost core of 
the tail is bone (vertebra). The bone is surrounded by a layer of tendons (labelled 1-6), and 
the tendons are surrounded by a layer of skin. Cross sectional image of a rat tail [adapted 
from Bruneau et al., 2010]. 
Skin 
Fascicles 
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from each of the three tricep surae muscles (the medial head of the gastrocnemius muscle, the 
lateral head of the gastrocnemius muscle and the plantaris tendon) (Figure 2.9). At the muscle 
attachment end, the three single strands of the Achilles tendon are loosely connected to one 
another with a soft proteoglycan rich matrix, which is easily transected during dissection. 
However, the fusion between the individual parts of the Achilles tendon by the tuber calcanei 
is distinctly stronger and required the use of a scalpel. The individual parts of the Achilles 
tendon were separated to give three samples of which one was used as an unstrained control, 
the explant from the lateral head of the gastrocnemius muscle (the longest of the three).  
 
Samples were secured in individual custom designed stainless steel loading chambers at a grip-
to-grip distance of 10 mm (Figure 2.3). The chambers were filled with DMEM then sealed in 
the glass surround, maintaining full hydration. Rat tail explants secured in chambers (up to 6 
at a time) were connected to a single actuator arm and secured within a BOSE loading frame 
housed in an incubator to maintain samples in 5% CO2 at 37ᵒC as shown in Figure 2.3 then 
1a 
2a 
3 2 1 
3a 
Figure 2.9: The rat Achilles tendon joins the three tricep surae muscles and inserts at the tuber calcanei. Rat 
Achilles tendon from the right leg;      1 – the medial head of the gastrocnemius muscle; 1a – the 
fascicle from the medial head of the gastrocnemius muscle; 2 – the lateral head of the 
gastrocnemius muscle; 2a – the fascicle from the lateral head of the gastrocnemius muscle; 3 – the 
plantaris muscle; 3a – the fascicle from the plantaris muscle; 4 – the tuber calcanei. 
4 
Chapter 2  In Vitro Models 
 
61 
subjected to cyclic strain of 1% ± 1% at 10Hz for 24hrs. Unloaded controls from rat tail and 
rat Achilles explants were secured in chambers also but the chambers were simply housed in 
the 5% CO2 at 37ᵒC incubator for 24hrs.
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2.4.1.2 RAT EXPLANTS CELL VIABILITY ANALYSIS 
For viability analysis, rat tail explants were placed in the Calcein AM / Ethidium homodimer 
dye mix described in chapter 2.2.1 at 37ᵒC for 1 hour, while the rat Achilles samples were 
incubated at 37ᵒC for 1 hour 30 minutes. All samples were removed from the dye, rinse in 
DMEM, and then placed on a coverslip to be viewed under the laser scanning confocal 
microscope (Perkin Elmer), using an X20 objective. Three images were collected across the 
length of the explant at a depth (z) of 0.2mm, with images of red and green fluorescence 
collected at each view point.  
2.4.1.3 RAT EXPLANTS GENE STABILISATION CHECK 
A time course analysis of selected genes (MMP3, MMP13, COL1A1, COL3A1, IL6, and 
Decorin) was carried out to investigate how sample dissection and preparation may influence 
gene expression, and the time period required for gene expression to stabilise prior to 
mechanical loading experiments. Samples were dissected, and immediately secured in 
chambers and maintained unloaded until the appropriate time points (0, 18, 24 or 48hrs) when 
they were removed, and immediately placed in a 1mm cryotube and immersed in liquid 
nitrogen for 3-5 minutes before storing at -80ᵒC for later gene analysis. 
RNA Extraction 
RNA was isolated as described previously, using a tri-spin protocol [Ireland et al., 2001]. In 
detail, samples were removed from the -80ᵒC freezer and homogenised using a Sartorius 
Mikro-Dismembrator (Figure 2.10). A ball was added to the cryotube and the sample was 
homogenised using a dismembrator set at 2000 RPM for one minute. The cryotube was 
removed from the dismembrator, 1ml Trizol reagent added to each tube and left to incubate at 
room temperature for 5 minutes to allow complete dissociation of nucleoprotein complexes. 
125µg/ml (25µl) glycogen was then added to each cryotube, the tube inverted and incubated at 
room temperature for another 5 minutes. Glycogen binds to RNA and assists in visualising the 
RNA pellet obtained at a later stage of this protocol by making it cloudy. 




Empty phase lock gels tubes were centrifuged at 10000g for 1 minute to collect the gel at the 
bottom of the tube. After centrifugation, the sample solution (trizol + glycogen) was transferred 
to the phase lock gel tubes and 1/5 sample volume of chloroform was added to the samples, 
which were then shaken vigorously for 15 seconds and incubated at room temperature for 3 
minutes. Samples were centrifuged at 12000g for 15 minutes at 4ºC. The phase lock gels 
allowed a clear separation of the phenol-chloroform organic phase and the interface material 
containing the nucleic acid. The interface material in the upper aqueous phase was transferred 
into a new tube (volume of the aqueous phase is about 60% of the volume of trizol reagent) for 
RNA precipitation while the phase lock gel tubes and remaining content were discarded. 
Propan-2-ol was added to the fresh tube containing the colourless aqueous phase at a 1:1 ratio. 
For precipitation of the nucleic acid, the fresh tube was then inverted 5 times and the samples 
were incubated at room temperature for at least 10 minutes. Samples were centrifuged for 10 
minutes at 12000g at 4ºC. RNA precipitate formed at the bottom of the tube as a cloudy gel-
like pellet. 
The supernatant was removed completely and RNA pellets washed twice with 1ml of 70% 
ethanol, centrifuging samples at 7500g for 5 minutes at 4ºC after each wash. Ethanol was then 
removed completely. This was repeated twice. 
Figure 2.10: A dismembrator with cryotube attached, set at 2000 RPM for one 
minute to homogenise a sample into powder form, aiding complete 
homogenisation with Trizol. 
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Samples were air dried for 15-20 minutes (until pellets appeared transparent) after which the 
RNA was dissolved and re-suspended in 30µl of nuclease free water. Samples were incubated 
at room temperature for 10 minutes and mixed by flicking tubes gently, before storing at -80ºC 
until ready for analysis. 
Samples were removed from the -80ºC freezer, thawed at room temperature for 5 minutes and 
then centrifuged at 10000g for 1 minute. RNA concentration and quality was estimated using 
a nanodrop spectrophotometer. 1µl of sample was directly placed onto the fiber optic 
measurement surface of the nanodrop spectrometer where it was held in place by surface 
tension, eliminating the need for cuvettes or capillaries. When the upper fiber optic tip engages 
the sample, a liquid column of controlled path length is formed. A full-spectrum absorbance 
measurement is automatically made through the hourglass-shaped sample column at both a 
1mm and 0.2mm path length. The absorbance (A) ratio of these measures is calculated as an 
indicator of RNA quality. A260:A280 of ≥ 1.6 is considered acceptable with an optimum value 
of 2. After nanodrop analysis, samples were returned to -80ºC for later gene analysis. 
Reverse Transcription and Quantitative Real Time PCR 
Samples were removed from -80ºC freezer and thawed at room temperature for 5 minutes ready 
for gene transcription and qRT-PCR following previously described protocols [Jones, 2012]. 
All RNA samples were diluted in RNA free water, so all samples in an experimental set were 
at the same concentration. From each sample, 9.5µl was pipetted into separate wells of a 96 
well plate and centrifuged at 2000g for 1 minute. RNA was primed with 1.5µl of random 
hexamers (concentration – 200ng/µl), centrifuged at 2000g for 10 seconds and incubated in a 
thermocycler at 70ºC for 10 minutes then held at 4ºC until removed. RNA was reverse 
transcribed with 9µl of reverse transcription master mix containing the component outlined in 
table 2.2. Samples were then centrifuged at 2000g for 10 seconds and incubated at 42ºC for 60 
minutes, then 70ºC for 10 minutes and held at 4ºC until removed. The resulting cDNA for each 








Table 2.2: Composition of reverse transcription master mix  
Component (Supplier) Amount (µl) 
Superscript II at 200U/µl concentration (Life Technologies) 1 
5x Sample buffer (Supplied in Superscript II kit) 4.5 
DTT (Dithiothreitol) at 10mM concentration (Supplied in 
Superscript II kit) 
2 
dNTP’s (Deoxy-nucleotide triphosphate) at 2.5mM concentration 
(Promega) 
1 
RNase inhibitor at 20U/µl concentration (Promega) 0.5 
 Total volume = 9 
A cDNA stock solution was made by taking 5µl cDNA from each sample. 5 serial dilutions of 
1:5 were made from the cDNA stock solution (20µl cDNA + 80µl water) to create a 5 point 
standard curve. Standard curves for each assay were used to confirm primer probe efficiency. 
A slope of −3.6 ≥ slope ≥ −3.3 was expected, along with a correlation coefficient or R value of 
1; only primers with similar values to this were accepted (slope ±0.5, R ±0.1). 
10µl of each standard dilution was pipetted into the Taqman plate for a 10ng reaction. A gene 
master-mix was prepared for each gene of interest (table 2.3) and 15µl of gene master-mix was 
pipetted to the Taqman plate. The standard qRT-PCR programme was run using the Applied 
Biosystems 7500 real time PCR system (ThermoFisher Scientific) which took 90mins.  
The thermal cycles were performed at 50°C for 2 minutes, 95°C for 10 minutes, followed by 
40 cycles of 95°C for 15 seconds, and finally 60°C for 1 minute. Relative expression levels of 
each gene of interest were analysed by normalising to endogenous control genes GAPDH (∆Ct 
[endogenous control gene Ct-gene of interest Ct]) and linearising these data by expressing it as 
2∆Ct. Data for loaded samples were then expressed as a fold change from the control (2∆∆Ct 
[strained condition 2∆Ct / Control 2∆Ct]) while data for the vary time points were expressed as a 
fold change from the 0hr control (2∆∆Ct [unstrained time condition 2∆Ct / 0hr unstrained control 
2∆Ct]). Statistical analyses were performed using the student’s t test (two tailed distribution, 
equal variance). 
 
Chapter 2  In Vitro Models 
 
66 
Table 2.3: Composition of gene master-mix 
Component (Supplier) Amount (µl) 
Probe SYBR green Prime 
probe mix 
Forward primer at 10µM concentration (Life 
Technologies) 
0.5 0.5 - 
Reverse primer at 10µM concentration (Life 
Technologies) 
0.5 0.5 - 
Probe at 0.1µM concentration (Life 
Technologies) 
0.5 - - 
SYBR green (Life Technologies) - 0.3 - 
Prime-Probe mix (Life Technologies)   1 
2x Master mix (Life Technologies) 8.33 8.33 8.33 
Analytical grade water (Sigma Aldrich) 5.17 5.37 5.67 
 Total volume = 15 
 
Table 2.4: Primer sequences (Forward and reverse) used for real-time polymerase chain reaction 








GAPDH GGAAAGCTGTGGCGTGAT  
AAGGTGGAAGAATGGGAGTT 
1306 NM_017008 Zhang et al., 
2011 
MMP3 GACCAGGGACCAATGGAGATG  
TGAGCAGCAACCAGGAATAGG 
1771 NM_133523 Zhang et al., 
2011 
MMP13 GGCCAGAACTTCCCAACCA  
ACCCTCCATAATGTCATACCC 




5843 NM_053304 Zhang et al., 
2011 
COL3A1 ATCAAACACGCAAGGCCATG  
AAGCAAACAGGGCCAATGTC 
4792 NM_032085 Gu et al., 
2014 
IL6 ACTTCACAAGTCGGAGGCTT  
AGTGCATCATCGCTGTTCAT    




TGAAGGACTTGCATACCTG   
GTTACTTGTAGTTCCCAAGT 








2.4.2.1 RAT EXPLANTS CELL VIABILITY 
Cell viability were analysed within rat tail fascicles over time. Figure 2.11 shows cell viability 
for a typical region within the core of the rat tail explant. The rat tail tendon explants maintained 
cell viability at around 70% even after loading for 24hrs. Unfortunately, the cell viability within 
the rat Achilles explants could not be analysed using fluorescent dyes, as the dyes were unable 
to penetrate to the tissue, hence could not dye the cells. 
 
Table 2.5: Cell viability results, showing the mean percentage of live cells in rat tail explants after 
different time periods. Biological repeats, N = 2 with the number of optical viewpoints ranging 
from 3 to 5 for each repeat experiment. 
 Percentage viability (Mean (%)  standard deviation) 
Duration Unloaded Loaded at high freq. 
0hrs 90 ± 4.9 - 
6hrs 83 ± 5.7 81 ± 1.4 
12hrs 74 ± 2.8 71 ± 3.5 




Figure 2.11: Images from a typical region, showing calcein AM and ethidium homodimer emission from the 
same region of a rat tail explant after 24hrs of loading. A) Live cells emits green fluorescence B) 
Dead cells emits red fluorescence. 
  
B A 
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2.4.2.2 RAT EXPLANTS GENE STABILISATION CHECK 
Time Course Analysis of Selected Genes 
A time course analysis of selected genes was carried out for the rat tail and Achilles tendon 
explants, comparing gene expression at 0, 18, 24 and 48 hours to see when it stabilised after 
explant dissection and preparation. Data is graphed in Figures 2.12 and 2.13, showing fold 
changes in gene expression at 18, 24 or 48hrs relative to the 0hr time point. Statistical analysis 
showed no significant differences in the expression of any gene between the 18, 24 or 48 hour 































Rat Tail Tendon Explants
18hr 24hr 48hr
Figure 2.12: Gene expression changes in dissected rat tail tendon fascicles over 48hrs. Explants were fixed in a 
custom-made chamber and maintained for 48hrs, assessing changes in gene expression over this time 
period using standard qRT-PCR. Data was normalised to GAPDH and presented as fold changes 
relative to the 0hr time point (2∆∆Ct) [mean ± SD]. The greatest changes were seen in the first 18hrs, 
after which expression largely stabilised. 





Figure 2.13: Gene expression changes in dissected rat Achilles tendon over 48hrs. Explants were fixed in a 
custom-made chamber and maintained for 48hrs, assessing changes in gene expression over this 
time period using standard qRT-PCR. Data was normalised to GAPDH and presented as fold 
change relative to the 0hr time point (2∆∆Ct) [mean ± SD]. The greatest changes were seen in the 

































Rat Achilles Tendon Explants
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The result from this study demonstrated that cell viability was maintained at 70% or higher in 
rat tendon explants confirming the initial hypothesis, that viability is maintained in explants 
when there is no need for extensive dissection. Furthermore, viability was maintained under 
the different under loading conditions, even with the more mechanically extreme 10Hz loading. 
This result supports previous studies which have presented cell viability of over 95% in rat 
fascicles after loading [Kondratko-Mittnacht et al., 2015]. The slightly higher cell death 
observed with loading is possibly because the cells were not well adapted to the long periods 
of loading although they can generally withstand small amounts of normal strains [Kondratko-
Mittnacht et al., 2015]. However, no significant differences in cell viability as a result of 
loading were evident. Therefore, it can be said that the mechanical loading applied in this study 
can be tolerated by the cells.  
Having established a viable explant model, it was next necessary to explore gene expression. 
It is known that cells respond to abrupt environmental changes by altering gene expression 
levels, adjusting cellular physiology and metabolism to the new condition and possibly 
protecting the cells from damage or death [Lopez-Maury et al., 2008]. Changes in gene 
expression levels can be momentary even with tenacious stress, thus, gene expression levels 
can return to its steady-state levels that are close to those in unstressed cells after some time 
[Lopez-Maury et al., 2008]. As such, an initial investigation was carried out to examine gene 
stabilisation in response to dissecting samples and securing them in chambers. Figure 2.12 and 
2.13 showed that gene expression altered notably between 0 and 18hrs, but no significant 
differences were seen between 18, 24 and 48 hours. Pahl and Brune, [2002] in their study of 
gene expression profiling in blood showed how the expression levels of IL-1β decreased 6hrs 
after phlebotomy but had returned to normal after day 1. They used these data to evidence the 
need for gene stabilization after sample preparation; neglecting gene stabilization may lead to 
over or under estimated results in gene expression profiling [Pahl and Brune, 2002]. An in vitro 
study on rat explants was used to investigate time course of gene expression changes associated 
with tissue harvest, mechanical unloading and culture [Leigh et al., 2006]. The study 
demonstrated that type I collagen and decorin stabilised at 24hrs which was seen in this current 
study (Figure 2.12 and 2.13). However, the study showed that MMP3 and MMP13 continued 
to increase throughout the 48hrs experimental period, which was not the case in this current 
study. But the differences in MMPs seen by Leigh and this current study is unknown.  
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Data from the current study demonstrate that rat tendon explants provide an appropriate system 
in which gene expression in response to loading could be further analysed, with viability 
maintained for 48hrs, allowing for a 24hr gene stabilisation period, followed by a 24hr 
experimental period, as proposed for further loading experiments.  
  













2.5 RAT TENDON EXPLANT MODEL – CELL RESPONSE TO 
LOADING 
  




Having validated the use of rat explants, a loading experiment was performed, to investigate 
gene expression in response to the differential loading protocols of interest.  
19 rat tail tendon explants and 3 rat Achilles explants were collected from a single rat and 
prepared following the methods outlined in chapter 2.3.1. Samples were individually secured 
in the custom designed stainless steel loading chambers at a grip-to-grip distance of 10 mm, 
and the chambers filled with DMEM then sealed in the glass surround, maintaining sample 
hydration. All 22 chambers were incubated in a 5% CO2 at 37ᵒC incubator for 24hrs allowing 
time for gene stabilisation as established from previous experiments. After 24hrs, samples were 
split into 3 test groups, with 5-7 tail explants and 1 Achilles explant in each group. 
 Unstrained control 
 High magnitude low frequency loading: 1% ± 1% at 1Hz  
 High magnitude high frequency loading: 1% ± 1% at 10Hz  
The first control group of samples where left in the incubator for an addition 24hrs without 
load, while samples in the remaining 2 loading groups were connected to an electro force 
mechanical loading instrument and subjected to either high magnitude low frequency, or high 
magnitude high frequency loading for 24hrs. 
  




After 48hrs, samples were removed from the chambers and immediately placed in a 1mm 
cryotube and immersed in liquid nitrogen. After 3-5 minutes, the samples were removed from 
liquid nitrogen and stored at -80ᵒC for later gene analysis. RNA extraction, reverse 
transcription and quantitative real time PCR was performed as detailed in chapter 2.3.1. The 






Rat Explants Cell Response Experimental Set Up 
Rat Tail Explants 
n = 19 
Rat Achilles Explants 
n = 3 
Incubated for 24hrs for gene stabilisation 
Cyclically strained samples 
1% ± 1% at 10Hz  
n = 7 rat tail explants 
n = 1 rat Achilles explant 
 
Cyclically strained samples 
1% ± 1% at 1Hz 
n = 7 rat tail explants 
n = 1 rat Achilles explant 
  
Unstrained control 
n = 5 rat tail explants 
n = 1 rat Achilles explant 
Figure 2.14: Flow diagram of experiments performed from on rat explants to investigate the effect of loading 
on tenocyte gene expression. Biological repeat, N = 1. 
Gene expression analysis 
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Table 2.6: Primer sequences (Forward and reverse) used for real-time polymerase chain reaction 








GAPDH GGAAAGCTGTGGCGTGAT  
AAGGTGGAAGAATGGGAGTT 
1306 NM_017008 Zhang et al., 
2011 
MMP3 GACCAGGGACCAATGGAGATG  
TGAGCAGCAACCAGGAATAGG 
1771 NM_133523 Zhang et al., 
2011 
MMP13 GGCCAGAACTTCCCAACCA  
ACCCTCCATAATGTCATACCC 




5843 NM_053304 Zhang et al., 
2011 
COL3A1 ATCAAACACGCAAGGCCATG  
AAGCAAACAGGGCCAATGTC 
4792 NM_032085 Gu et al., 
2014 
IL6 ACTTCACAAGTCGGAGGCTT  
AGTGCATCATCGCTGTTCAT    
1045 NM_012589 Zhang et al., 
2014 
Decorin TGAAGGACTTGCATACCTG   
GTTACTTGTAGTTCCCAAGT 






6939 NM_022190 Zhang et al., 
2011 
ADAMTS-5 CGACAAGAGTCTGGAGGTGAG  
CGTGAGCCACAGTGAAAGC 
2787 NM_198761 Lai et al., 
2012 
TIMP-3 TCTGCAACTCCGACATCG  
GCGTAGTGTTTGGACTGATAGC 
1778 NM_012886 Li and Curry, 
2009 
Data was normalised to the housekeeping gene GAPDH and changes with loading expressed 
as a fold change from the unstrained control (2∆∆Ct).  
  




In response to the loading bout, data from tail explants showed an upregulation of MMP13 and 
a downregulation of MMP3, COL1A1, COL3A1, DCN, ACAN, ADAMTS5 and TIMP3. 
There was no indication of significant differences in the response to high (10Hz) and low (1Hz) 
frequency loading, although the response to high frequency loading appeared more pronounced 
in the majority of genes.  
 
Data from the rat Achilles explants showed a similar profile to that seen in rat tail explants, 
with the downregulation of the majority of genes, except for IL6 which was unchanged with 
loading. However, each data point is a single sample, so it is not possible to make definitive 
statements concerning this response. 
Figure 2.15: Gene expression response in rat tail tendon explants subjected to 24hrs of high or low frequency 
loading shown relative to unstrained controls. Data was normalised to GAPDH and presented as a 
fold change from unstrained samples (2
∆∆Ct
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Figure 2.16: Gene expression response in rat Achilles tendon explants subjected to 24hrs of high or low frequency 
loading shown relative to unstrained controls. Data was normalised to GAPDH and presented as a fold 
change from unstrained samples (2
∆∆Ct
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In response to cyclic loading, rat tendon explants appear to downregulate the majority of 
analysed genes, with the exception of MMP13, in which a notable increase in expression was 
evident, particularly in response to high frequency (10Hz) loading and IL6 that displayed no 
change with loading. It is interesting to note that the downregulated genes included both 
collagens and MMPs. Matrix metalloproteinases (MMPs) belong to a diverse group of enzymes 
which are not only involved in restructuring the extracellular matrix, but also play a major role 
in various pathophysiological conditions by virtue of their complicated expression, activation, 
and regulation processes [Gardner et al., 2008]. MMP13 is a collagenase-3 that induces 
degradation of the extracellular matrix. The upregulation of MMP13 with high frequency 
(10Hz) loading may be indicative of active tissue remodelling, as degradation is important for 
healing and remodelling of connective tissues [Buono et al., 2013]. On the other hand, for 
biologic remodelling to occur, it is expected that there is high levels of changes in gene 
expression of a range of anabolic and catabolic genes [Iatridis et al., 2013; Riley, 2005], which 
is not seen from this data.  
With mechanical loading conditions of 1% ± 1% at 1Hz or 10Hz for 24hrs, there is a 
possibility that the explants have been underloaded with a high expression of MMP13 and 
downregulation of various matrix proteins and proteoglycans. From the literature, underload 
or stress deprivation may contribute to the progression of tendinopathy [Lewis, 2010; Thornton 
et al., 2008]. These studies demonstrated upregulation of MMP13 [Lewis, 2010; Thornton et 
al., 2008] as well as MMP3 and TIMP2 [Thornton et al., 2008] in stress deprived tendons 
relative to cyclically strained tendons. A study by Wang et al. [2013] investigating the response 
of rat Achilles explants, performed cyclic strain at 0.25Hz to 3%, 6% and 9% strain for 6 days, 
loading for 8hrs a day. Data demonstrated that tendons experiencing the lowest strain (3% 
cyclic strain) had moderate matrix deterioration with the highest upregulation of MMP-1, 3, 
and 12, whilst those subjected to 9% strain reported massive rupture of the collagen bundles 
and a significant highest upregulation of COL3A1 [Wang et al., 2013]. The authors 
hypothesised that 3% strain was ‘underload’ whilst 9% strain was ‘overload’ as samples 
subjected to 6% cyclic strain maintained their tissue structure and showed the highest 
expression of COL1A1, lowest expression of MMP-1, 3, and 12 and no expression of COL3A1. 
Nonetheless, it is important to note that Wang and colleagues’ study looked at varying strain 
magnitude at the much lower frequency of 0.25Hz and also investigated longer loading periods, 
which may have differentially impacted the metabolic response of their cells.  
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In this current study, N = 1 is not enough to make any conclusions, therefore, further 
experiments need to be done to verify outcomes. However, these pilot experiments validate the 
potential to use rat explants for further work.  















2.6 2D ISOLATED CELL MODEL 
  




Cells are anchorage-dependent and will grow and function only when adhered to physical 
surfaces, hence the interactions between cells and the extracellular matrix are at the core of 
tissue engineering [Plant et al., 2009]. Porous membranes coated in materials such as collagen 
type I, fibrin, fibronectin, laminin, or basement membrane extract (BME),, that promote cell 
adhesion, spreading and proliferation, are used as a platform on which to seed cells for in vitro 
studies to understand cell behaviour [Moore and Maitland, 2014]. Most mechanobiology 
studies have used traditional 2D systems, where cells are extracted from tissues, seeded on a 
surface of cell-derived matrix, and mechanically loaded on stretching devices like flexcell 
(Flexcell Corporation, FX-4000) [Colombo et al., 2008; Yang et al., 2005]. Collagen type I 
coated membranes are regularly selected, as collagen is a major component of most connective 
tissues.  
A 2D membrane provides a simple, convenient and potentially highly controlled system for 
growing adhesive cells and mechanically loading them by simply stretching the membrane. 
Such systems have subsequently been very popular, however, there are some limitations to the 
use of 2D membranes, as the cells are not in an environment mimicking that seen 
physiologically.   




2.6.2.1 SAMPLE COLLECTION AND PREPARATION 
Bovine tenocytes were derived from bovine extensor tendons by explant outgrowth, following 
previously described protocols [Schulze-Tanzil et al., 2004]. The bovine hoof was washed, and 
transferred to a cell culture hood for aseptic dissection of the extensor tendon. Within the hood, 
the hoof was skinned and all muscle and tissues surrounding the tendon removed. The tendon 
was then extracted, ensuring constant irrigation with DPBS to maintain hydration. Small 
tendon explants, 3mm thick and up to 1mm length, were cut from the middle of the tendon 
away from the sheath. Three explants were placed into each plate of a six-well culture plate, 
evenly separated (Figure 2.17) and covered with a small drop of 50% fetal bovine serum (FBS) 
medium, the composition of which is detailed in table 2.7. 
Table 2.7: Culture media component depending on percentage fetal bovine serum content 




Dulbecco’s modified Eagle’s medium (DMEM) (low 
glucose, pyruvate, no glutamine, no phenol red) 
(ThermoFisher Scientific) 
500 500 
FBS (Sigma Aldrich) 250 50 
Penicillin streptomycin (PS) (Sigma Aldrich) 10 10 
HEPES solution (Sigma Aldrich) 10 10 
L-Glutamine solution (Sigma Aldrich) 5 5 
MEM non-essential amino acid solution (NEAA) 
(Sigma Aldrich) 
5 5 
Sodium Bicarbonate (Sigma Aldrich) 1.85g 1.85g 
 
The plate was placed in a humidified 37ºC, 5% CO2 incubator. After 24hrs, an additional drop 
of 50% FBS medium was added and after 48hrs, further 50% FBS medium was applied to 
Figure 2.17:  A. Bovine hoof skinned to access the extensor tendon, B. Small pieces 
of tendon (explants) placed in a 6 well plate for culture 
A B 
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cover the entire surface of the plate while ensuring that the tendon explants did not float. The 
additional medium increased the area for tenocyte growth, encouraging tenocyte proliferation 
and outgrowth across the well. 50% FBS medium was replaced every 2 to 3 days just covering 
the surface of the well each time until cells reached confluence. At this point, the explants were 
removed and disposed of, after which the cells were released from the surface of the culture 
plate, to reseed for further cell culture. Cells were released by removing the media and adding 
0.25% trypsin-EDTA (trysinization) for 5mins. Released cells were pipetted into a corning 
flask, centrifuged at 2000 rpm for 5 minutes before the supernatant was removed, leaving cell 
pellets at the base of each tube. The cells were then re-suspended in 10% FBS culture medium, 
and divided into cell culture flasks for further growth. Cells were cultured for up to 3 passages 
before use.  
At passage three, to avoid the cell differentiation observed with further passaging [Mazzocca 
et al., 2012], the cells were trysinized, centrifuged, re-suspended in fresh 10% FBS medium 
and counted. 15µl of the cell suspension and 15µl of trypan blue were added to a tube and 
mixed, then a small amounted pipetted into a haemocytometer. Trypan blue dyes dead cells 
blue while viable live cells are left unstained. Live cells were counted across the 
haemocytometer grid using a microscope and X10 objective (Figure 2.18). 
 
The number of live cells was calculated from the mean cell number multiplied by 2 (dilution 
in trypan blue), multiplied by 104 to obtain the number of cells per ml of each sample. The cell 
suspension was then adjusted (diluted or concentrated) to provide a final concentration of 1 
million cells per ml. 
Collagen coated membranes were prepared for cell straining experiments cutting 2mm wide, 
14mm long strips from sheets of sterile collagen coated membrane (Flexcell International 
Incorporation, Burlington, NC 27215) using a custom made cutter (Figure 2.19). Five strips of 
Figure 2.18:  A haemocytometer – showing the grids in which cells are counted. All cells 
within the central grid, and those touching the top or left perimeter of the grid 
were counted, while those on the bottom or right perimeter were ignored. 
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membrane were placed into each well of a six well plate, and 0.5ml (0.5 million cells) of the 
bovine tenocyte suspension was pipetted into each well to cover the membranes. Membrane 
were incubated at 37°C for 24hrs allowing the cells time to attach.  
 
After seeding membranes, any remaining cell suspension was frozen for long term storage. In 
more detail, cell suspension was centrifuged at 2000 rpm for 5 minutes and the supernatant 
disposed of. Cells were then re-suspended in 10% FBS media also containing 10% Dimethyl 
Sulfoxide (DMSO) (Sigma – Aldrich, 472301) then aliquoted at 1 ml per tube and incubated 
overnight in a Nalgene cryo-freezing container at -80ᵒC. Cells were then transferred to liquid 
nitrogen for longer term storage. 
In order to validate the use of 2D membranes as a loading model, it was necessary to confirm 
the cells were attached to the membrane and remained viable after securing in chambers and 
after mechanical loading. 18 membranes were prepared to investigate attachment. Membranes 
were seeded with cells, and after a 24hr attachment period, were divided into four test groups; 
 Unstrained, free swelling controls 
 Secured in chambers unloaded for 0, 12 or 24 hrs 
 Secured in chambers and loaded with high magnitude low frequency loading: 1% ± 1% 
at 1Hz for 12 or 24 hrs 
 Secured in chambers and loaded with high magnitude high frequency loading: 1% ± 
1% at 10Hz for 12 or 24 hrs 
At the end of the test periods, samples were carefully placed on a coverslip for imaging with a 
X10 magnification lens under bright-field settings (Leica microscope).  
  
Figure 2.19: Picture of the custom-made membrane cutter. 
Dimensions - width 2mm, and length 14mm 
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2D Isolated cell model Experimental Set Up 
Cell seeded membranes incubated for 24hrs for cells to 
attach 
n = 24 
Cyclically strained membranes: 
1% ± 1% at 10Hz for 12 or 
24hrs 
n = 3 for each time point 
Cyclically strained membranes:  
1% ± 1% at 1Hz for 12 or 24hrs 
n = 3 for each time point 
Unstrained control 
membranes: Imaged directly 
after attachment period 
n = 3 
Figure 2.20: Flow diagram of experiments performed on 2D isolated cell model to investigate cell adhesion to the membrane with 
and without loading 
Image analysis: Investigating cell 
attachment 
Unstrained membranes: 
Maintained in chambers for 
0, 12 and 24hrs 
n = 3 for each time point 




Cells were well adhered 24hrs after seeding (Figure 2.21A). However, fixing samples into the 
loading chambers immediately resulted in some cells detaching from the membrane (Figure 
2.21B). Over time, cell detachment from the membrane steadily progressed (Figures 2.21B-D). 










             A                                                         B                                                        C                                                         D 
Figure 2.21: Morphology of bovine cells in 2D collagen coated membrane at varying time points with and without loading observed using a Leica microscope at 10X optical zoom. After a 24hrs 
cell attachment period, cell were imaged immediately (A), or fixed into chambers and then removed and imaged after 0hr (B), 12hrs (C) or 24hrs (D). Additional samples were 
subjected to mechanical loading prior to imaging, comparing 1% ± 1% at 1Hz for 12hrs (E) or 24hrs (F) with 1% ± 1% at 10Hz for 12hrs (G) or 24hrs (H). 
             E                                                         F                                                          G                                                      H 
100µl 100µl 100µl 100µl 
100µl 100µl 100µl 100µl 




The collagen membranes clearly facilitated cell adhesion, and cells were well adhered after 
24hrs seeding, showing elongated cell processes. However, the act of gripping the membrane 
disrupted cell attachment, and the cells appeared more rounded as evident in Figure 2.20B-D. 
Loading further exacerbated the cell disruption showing highly disrupted and rounded cells, 
and possible evidence of apoptosis [Pullan et al., 1996]. The appearance of the cells becoming 
round following loading was also observed by Lavagnino et al. [2015] after they applied a 12% 
strain at 1Hz for 2hrs to rat tail tendon cells using a Flexcell system. The study went on to 
explain that the reason for the cells becoming rounded was possibly due to alteration of the 
cells’ cytoskeletal structure from the tensile strain resulting in loss of tensional homeostatsis 
and change in cell shape [Lavagnino et al., 2015]. However, it is unclear why cells detach from 
the membranes so rapidly after fixing into chambers. Samples were handled carefully during 
preparation, nevertheless any handling disrupted the cells.  
The upright orientation of membranes in chambers may have prompted the cell detachment.  
To reduce cell detachment, other methods of loading the 2D constructs, where samples were 
secured and loaded in a horizontal alignment, were explored. However, both our in-house 
loading system and the commercially available Flexercell system, cannot apply loading at 
sufficiently fast frequencies to test the desired hypotheses. In 2D culture environments, only a 
segment of the cell’s membrane adheres to the collagen membrane, therefore the cell does not 
have the distributed adhesion experienced in a 3D environment (Figure 2.22). Therefore, a 3D 




Figure 2.22: Schematics showing cell adhesion on a 2D membrane. 




















2.7 3D MODEL 
  




3D gel systems have been commonly used in tissue engineering and mechanotransducion 
studies for many years, across a broad range of tissues including bone, cartilage and tendon 
[Fisher et al., 2004; Sakiyama et al., 1999; Yu et al., 1999; Blackshaw et al., 1997]. 3D 
gels are generally made of cross-linked natural base materials like agarose, collagen, 
laminin, fibrin or hyaluronic acid, with collagen type I commonly selected as the substrate 
of choice. Collagen is an abundant and important part of the ECM across various connective 
tissues and the most abundant protein in tendon [Artym and Matsumoto, 2010].  Also, collagen 
can be obtained from animal sources in a reliable and pure form, unlike other 3D gel substrates 
that may be supplemented with mixtures of other bioactive ECM proteins and growth factors 
(like fibrin gel that is formed by thrombin cleavage of fibrinogen– a serine protease) which can 
complicate experimental tests and results [Cheema and Brown, 2013; Sakiyama et al., 1999].  
Collagen gels take about 30 minutes to set at neutral pH and room temperature, giving the gel 
time to be moulded into the desired shape and/or seeded with cells. However, the method of 
3D collagen gel preparation, the collagen concentration, and density of the collagen gel all 
influence the final characteristics of the 3D collagen gel matrix produced, which in turn can 
affect how cells interact with the gel and thus result in distinct cell morphology and cellular 
response [Artym and Matsumoto, 2010]. Thus to avoid possible heterogeneity in results due to 
changes in collagen fibril morphology, one needs to follow the same conditions for 3D collagen 
matrix assembly for all gels used within any particular experiment.  
Collagen gels have a large amount of fluid (>99.5%) relative to collagen (0.5%), which is 
typically a considerably lower collagen density than seen in native connective tissues where 
collagen is about 25-30% of the wet weight [Cheema et al., 2007]. Collagen gels thus present 
poor mechanical properties relative to the tissues they mimic. However, Cheema and Brown, 
[2013] develop a method in which some fluid can be expelled from the gel, to increase the 
collagen density to >20% wet weight without cell damage. This process is called the plastic 
compression (PC) fabrication process. Plastic compression of collagen gels rapidly produces 
dense collagen sheets (100-200μm thick) with a tissue-like architecture, improved mechanical 
properties (approaching those of native tissue collagen) and biomimetic function (e.g. 
supporting high cell viability) [Cheema et al., 2012]. This process is versatile in terms of the 
volumes, densities, and shapes that can be produced (e.g. sheets can be layered or rolled up), 
thus creating the possibility to mechanically load the final scaffold structures.  




This section describes the production, and analysis of a rectangular collagen gel model (seeded 
with bovine tenocytes) which has previously been used successfully to investigate the effect of 
mechanical loading applied to cells by Cheema and Brown, [2013].  
2.7.2.1 CELL SEEDED COLLAGEN GEL 
Collagen gels were prepared as described by Phillips and Brown [2011]. Briefly, for forming 
one gel, a mix of 4ml Type I collagen solution from rat tail (First Link - 2mg/ml chloroform 
treated) and 0.5ml of 10X Minimum Essential Medium with phenol red (MEM – Life 
Technologies) was placed on ice and neutralised by drop-wise addition of sodium hydroxide 
(NaOH, 5µl at a time up to 20µl), to reach a pH of 7 as shown by the colour change indicator 
from yellow to citrus pink.  
Cells were cultured to P3, harvested by trypsinization, collected by centrifugation, and re-
suspended in 10% FBS media at a volume of 1 million cells per ml. 0.5ml cell suspension was 
added to the 4.5ml of collagen solution and well mixed, giving 5ml of solution, sufficient for 
one gel. Five pieces of absorbent whatman paper (grade 1: 11μm, 185mm diameter) were 
placed in a petri dish and a rectangular sterile mould (22 x 10 x 33 mm) placed on them. The 
final gel solution was pipetted into the rectangular mould and allowed to incubate at room 
temperature for 30 minutes to solidify and form a collagen gel with 90% liquid. 
Plastic Compression of collagen gels 
Once formed, gels were compacted to expel liquid and increase their mechanical strength and 
compliance following a modified version of the process described by Cheema and Brown 
[2013]. The rectangular mould was removed and a second set of absorbent Whatman filter 
paper (5 pieces) were placed on top of the gel. A 120g metal block was then placed on top of 
the Whatman filter papers, loading the gel. After five minutes of loading, the gel had been 
compressed to form a collagen sheet (100-200μm thick) protected between the absorbent 
Whatman filter papers (Figure 2.23).  




The compressed collagen gels were peeled away from the absorbent Whatman filter papers, 
then rolled up along their long axis, to form a cylindrical gel, roughly 33mm in length and 1mm 
in diameter.  As a cylinder, it was then possible to grip the gels within the loading chambers 
(section 2.2.1) for further experimental analysis. 
A series of experiments were carried out, to validate the 3D collagen gels for mechnobiology 
experiments. First, the mechanical behaviour of the gels during loading experiments was 
assessed, and cell viability for the duration of an experiment confirmed (Figure 2.24). 
 
FLUID OUT 
Metal pressure plate 
– 120g load 
Absorbent 
Whatman paper (x5 
on other side of the 
gel) 
Collagen gel 
Figure 2.23: A schematic showing the routine assembly for plastic compression of collagen gels. The 
collagen gel was compressed under fixed load so that rapid fluid removal (~99% fluid loss 
within five mins) was achieved. The compression produces collagen sheets of ~100-200µm 
thickness [procedure modified from Cheema and Brown, 2013]. 
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Figure 2.24: Flow diagram of experiments performed on 3D collagen gels. Samples were incubated for 24hrs before a cyclic strain period of 15mins 
at 1% ± 1% followed by 24hrs of static strain period (24hrs at 1% strain) to allow for cell response.  
3D Gel Experimental Set Up 
Cell viability 
n = 2 each 
Mechanical Characterisation: 
Failure test 
n = 10 
DNA 
Quantification  
n = 2 each 
Mechanical Characterisation 
during loading 
n = 3 each 
Maintained in 
chamber until 24hr 
DNA Quantification 
after 24hrs static strain 
n = 2 each 
Cell viability at 0, 12, 24 
or 48hrs 
n = 2 for each time point 
Incubated 3D gels for 24hrs 
for cells to attach 
Unstrained samples 15mins cyclic load @ 1Hz 15mins cyclic load @ 10Hz 
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2.7.2.2 GEL MECHANICS  
The purpose of this mechanical test was to characterize the mechanical response of the gel over 
the duration of a cell loading experiment, to ensure cells experienced strain for the duration of 
the test. In order to further mimic the load conditions seen during eccentric loading or ESWT, 
the duration of loading was reduced from 24 hours to a more physiologically representative 15 
minutes, as seen in a typical exercise or ESWT bout [Langberg et al., 2007; Jonsson and 
Alfredson, 2005] 
Load Relaxation 
A cyclic loading experiment, replicating the experimental strain conditions was performed on 
cell seeded 3D gels to analyse the extent of relaxation during loading, and confirm if the cells 
will experience strain throughout the experiment.  
The gels were then secured in the custom designed stainless steel loading chambers at a grip-
to-grip distance of 10 mm. The chambers were filled with DMEM, then sealed with the glass 
surround, maintaining full hydration. Each chamber was secured in the electro force loading 
system housed in an incubator to maintain samples in 5% CO2 at 37ᵒC as shown in Figure 2.3, 
and incubated for 24hrs to allow stabilisation. Loading was then applied, recording 
displacement, and maximum and minimum peak loads, throughout the period. The loading 
conditions assessed were: 
 High magnitude low frequency loading: 15mins cyclic strain at 1% ± 1% at 1Hz  
 High magnitude high frequency loading: 15mins cyclic strain at 1% ± 1% at 10Hz  
Failure Test 
A simple quasi-static failure test was also carried out on a number of samples, to determine if 
the loads experienced by the gel during the loading experiments were within the linear region 
of the gel stress-strain response. 
10 cell seeded 3D collagen gels were prepared as cylinders and left in a sterile container filled 
with DMEM for 24hrs in an incubator, to maintain samples in 5% CO2 at 37ᵒC, to allow for 
stabilisation. The gels were secured in chambers and were then pulled apart to failure at a speed 
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of 1 mm/s using the electro force loading system. Force and extension data were continuously 
recorded at 100 Hz. 
2.7.2.3 CELL VIABILITY TESTING  
In order to validate this model, it was essential to confirm that the cells in the 3D collagen gels 
remained viable, both in the presence or absence of mechanical load. Cell viability was 
assessed in cell seeded collagen gels in response to the following loading regimes:  
 Initial control condition (0hr) – immediately after preparation  
 Unstrained controls at 18, 24 and 48hrs  
 High magnitude low frequency loading: 15mins at 1% ± 1% at 1Hz followed by 1% 
static strain until the 24hr time point 
 High magnitude high frequency loading: 15mins at 1% ± 1% at 10Hz followed by 1% 
static strain until the 24hr time point  
Two different methods of analysing cell viability were used: Calcein AM and ethidium 
homodimer staining was used to assess spatial viability within the gels, whilst a more 
quantitative count of cell viability was carried out with trypan blue.  
 Cell Viability – Spatial Analysis: Calcein AM and Ethidium Homodimer Staining 
Tenocyte seeded 3D gels were stained using a Calcein AM and Ethidium homodimer dye mix, 
following the detailed protocol described in Chapter 2.2.1. Collagen gels were removed from 
the chambers, placed in a dye mix and incubated at 37°C for 30 minutes. After staining, the 
samples were rinsed in DMEM then unrolled so they were once again flat sheets, which could 
be placed on a microscope slide, ready to be viewed with a confocal microscope (Perkin 
Elmer). The sample was located and focused using bright field imaging, after which the 
live/dead stains were viewed using the fluorescence laser and a X10 optical lens. Live and dead 
cell numbers were counted in three regions across the width of the sample as shown in Figure 
2.25, to assess viability throughout the sample.  




Note: An imaging depth of approximately 50-70µm was adopted, and was consistent across 
the three image locations for a particular sample, but may have varied slightly between 
samples.  
Cell Viability – Quantitative Cell Count: Trypan Blue Staining 
Tenocyte seeded 3D collagen gels were washed in PBS, then digested in DMEM containing 
collagenase type IV (0.125%) at 37ᵒC for 30 – 45 minutes, until the gel had fully dissolved and 
the cells were left in suspension. The cells were collected by centrifugation and re-suspended 
in 10% FBS media. 15µl of the cell suspension was pipetted into a tube and 15µl of trypan blue 
added making a dilution factor of 2. The cell suspension and trypan blue mix was pipetted into 
a hemocytometer, which was then placed under a microscope and the cells counted following 
the cell count protocol detailed in Chapter 2.5.1.  
Cell Viability – DNA Quantification 
Cell numbers within the 3D collagen gels over the course of an experiment were assessed to 
ensure there was no cell proliferation, which may otherwise affect results. DNA levels were 
assayed fluorometrically with the Hoechst dye method.  
After loading, collagen gels were digested to release the cells and DNA content measured 
fluorometrically. DNA standards were made from a DNA stock solution of known 
concentration of 20µg/ml, which was diluted to make the concentrations in table 2.8 using 
  












Figure 2.25: Schematic of a collagen gel showing the positions where cell viability was 
taken for each sample. In the rolled state, ‘edge out’ is the outer exposed 
region whilst ‘edge in’ will be deep within the core of the sample. 
Unrolled Collagen Gel 
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digest buffer. The digest buffer was made from 5mM EDTA (0.731g) and 5mM Cysteine 
hydrochloride (0.439g) in 500ml PBS at pH 6. Serial dilutions were made as follows: 
Table 2.8: Serial dilution for DNA standards, 1:6 dilution, for standard curve used to calculate the 









S1 20 2000 980 20 µl of stock 
standard  
S2 15 1500 250 750 
S3 10 1000 500 500 
S4 5 500 750 250 
S5 1 100 800 200 
S6 0 0 1000 0 
100µl of either the test samples or standards were pipetted in duplicate into a 96 well plate to 
a planned layout. 100µl of Hoechst dye (stock of 1mg/ml of distilled water, previously prepared 
and sterilised by filtration through a 0.22µm filter and stored at 4ᵒC away from light, was 
diluted with the digest buffer to 1/1000) was then added to each well and mixed briefly using 
a pipette. The plate was transferred to a fluorescence spectrometer (Flurostar Galaxy 








2.7.3.1 GEL MECHANICS 
Load Relaxation 
Figure 2.26 shows the response of a typical sample subjected to 1% ± 1% cyclic strain at 10Hz 
over 900 loading cycles.  Samples behaved elastically under all applied load conditions (1% ± 
1% at 1Hz and 10Hz), with no stress relaxation behaviour, or changes to the stress-strain 
behaviour of the samples over the 15 minutes of loading. The 3D collagen gels showed a 
percentage load relaxation of zero in all instances. 
 
Failure Test 
The failure test data in Figure 2.27 showed that the collagen gels stretched to around 40% of 
their original length prior to failure and failed at stresses of around 2.5MPa. Gels showed non-
linear stress-strain behaviour, similar to that seen in many soft tissues, with a toe region of 
lower stiffness at low applied strains. 
Figure 2.26: Typical load behaviour during the loading period (1% ± 1% at 10Hz) monitored to 
ascertain the strains experienced by the cells. No stress relaxation of the gels was 
evident at any point during the 15mins loading period. 
0           200           400           600            800           1000 
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Cyclic load conditions used in the cell straining experiments, loaded the gels in the initial, fully 
























Figure 2.27: A) Typical strain to failure graph for a tenocyte seeded 3D collagen gel. The 
low stiffness toe region is evident up to approximately 10% strain. B) The 




















Table 2.9: Failure test results showing the failure load and strain in 3D collagen gels seeded with 
bovine cells  
Sample Max Failure load / N Failure Strain / % 
1 1.60 34 
2 2.24 49 
3 2.34 36 
4 2.65 45 
5 2.16 37 
6 1.96 44 
7 2.20 40 
8 2.96 55 
9 1.49 37 
10 2.18 45 
      
Mean 2.18 42.20 
STDEV 0.44 6.61 
 
2.7.3.2 CELL VIABILITY TESTING  
Cell Viability – Spatial Analysis: Calcein AM and Ethidium Homodimer Staining 
The unloaded samples showed a cell viability of 79-93% across the gel, with no evident 
decrease in cell viability over time nor differences in cell viability between the regions (table 
2.10).  
The loaded samples showed a cell viability of 74-91% across the gel and whilst there was a 
trend towards improved viability in the ‘edge in’ region, there were no significant differences 
in cell viability between the regions (table 2.11). 
Calcein AM staining of the cytoplasm of live cells also indicated that in strained cultures, the 
cells were predominantly aligned to the direction of loading (Figure 2.28B), whereas in non-
strained cultures no primary cell orientation was evident (Figure 2.28A).  




Table 2.10: Cell viability results showing the mean percentage of live cells in unloaded 3D collagen 
gels seeded with bovine cells at different time points as well as in loaded groups 
 Percentage viability (%) 
Mean ±STDEV 
Duration Edge out Middle Edge in 
0hrs 84±7.1 88±0.7 91±10.6 
12hrs 81±2.1 79±5.7 86±3.5 
24hrs 86±3.5 87±2.1 93±7.8 
48hrs 82±7.1 77±2.1 78±10.6 
24hrs incubation; 
15mins cyclic load, 1% 
static strain up to 24hr 
time point 
1% ± 1% at 1Hz 88±1.7 87±2.3 81±2.9 
1% ± 1% at 
10Hz 
87±1.1 84±1.6 90±9.6 
Figure 2.28: Typical images showing the viability of bovine tenocytes seeded in collagen gels. Cells were 
stained using Calcein AM (live cells – green) and Ethidium Homodimer (dead cells – red) with 
paired images from both channels shown. A) Non-strained, B) strained (1% ± 1% at 10Hz) 
A B 
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Cell Viability – Quantitative Cell Count: Trypan Blue Staining 
To further confirm cell viability within the 3D gels, an additional means to measure cell 
viability in a more quantitative manner was adopted using trypan blue. Cell viability calculated 
in this manner ranged from 79-85%, consistent with the ethidium homodimer and Calcein AM 
staining results.  
Table 2.11: Cell viability results showing the mean percentage of live cells in 3D collagen gels 
seeded with bovine cells after loading 
 Percentage viability (%) 
Duration Loading condition Mean ±STDEV  
48hr incubation No strain 79±0.7 
24hrs incubation; 15mins 
cyclic load, 1% static strain 
up to 24hr time point 
1% ± 1% at 1Hz 81±0.7 
1% ± 1% at 10Hz 85 ±0.0 
 
Cell Viability – DNA Quantification 
Changes in cell number during the course of an experiment were examined through 
quantification of DNA levels in samples.   
 
























Figure 2.29: Representative DNA assay standard curve 
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No differences in DNA levels were seen in any of the control or loaded samples, indicating 
consistent cell numbers for the duration of the experiment. 
 
 
These data (Figure 2.30 and 2.31) in conjunction with the visual evidence of maintained cell 
viability provides confidence that viable cells are successfully maintained within the collagen 
































Figure 2.30: DNA levels in unloaded samples at 0, 18, 24 and 48hrs showing no cell 
proliferation across the different samples and time points.  
Figure 2.31: DNA levels in loaded samples showing no cell proliferation across the 



































In these validation studies, the mechanical behaviour of the collagen gels was assessed, and 
cell viability throughout the construct was also confirmed. The mechanical response of the gel 
is important for elucidating cell matrix interactions at the microstructural level and hence to 
determine the overall mechanical environment experienced by the cells. The stress relaxation 
data in Figure 2.26, confirmed no stress relaxation in the gels during the applied cyclic strain 
period ensuring that the cells experienced consistent and easily defined strains throughout the 
loading experiments. A recent study on the mechanics of 3D collagen gels seeded with bone 
marrow stromal cells demonstrated stress relaxation in a range of different gel-cell materials 
[Chieh et al., 2014]. Collagen gels seeded with cells at concentrations of 0.1, 0.25, 0.5 or 1 x 
106 cells/ml all demonstrated stress relaxation but also showed that stress relaxation behaviour 
is reduced in gels with a greater cell concentration [Chieh et al., 2014]. These tests used a static 
strain stress relaxation protocol (8.6% strain for 90 seconds). Such a strain protocol is more 
aggressive than the cyclic loading applied in the current study, and the higher strains may be 
responsible for the stress relaxation reported.  
In order to confirm cell viability for the duration of the study, live/dead staining, trypan blue 
and DNA assay analyses were all conducted to give both a quantitative value and a spatial 
assessment of cell viability. The DNA assay combined with the trypan blue assay provided a 
quantitative confirmation that overall cell numbers did not change and that viability is 
maintained above 77%, while live/dead staining checked that viability was consistent across 
samples and confirmed that rolling the samples did not affect viability in the core. Table 2.10 
and 2.11 as well as Figure 2.30 and 2.31 show cell viability data for different time points, with 
and without strain. The ability of 3D collagen gels to maintain cell viability with or without 
strain application over time was also validated by Galie and Stegemann [2011]. They 
investigated cell viability in 3D collagen gels seeded with cardiac fibroblasts, both unstrained 
for a 120hr period and mechanically strained at 5% strain at 1Hz for 48hrs, 24hrs after seeding. 
Using a live/dead viability kit, the study demonstrated a viability percentage of 85 – 90% [Galie 
and Stegemann, 2011]. These data suggest that cells can be maintained in 3D collagen 
constructs and that application of strain does not compromise cell viability. 
These results are important for the use of this 3D collagen gel for the examination of cell 
response to loading under the proposed mechanical loading conditions.  
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2.7.5 MODEL SELECTION 
Each in vitro model investigated within this chapter possessed both advantages and 
disadvantages when considering its use for the current research project. Although there was 
regular supply of bovine tissue from which to obtain tendon explants, dissecting these samples 
resulted in explants with poor cell viability, which diminished further in response to loading, 
making bovine explants clearly unsuitable for investigating the cell response to loading. 
Explants from the rat model (tail fascicles or Achilles tendon) demonstrated far better cell 
viability at around 70% even after cyclic strain. However, tissue supply was limited to the point 
that adopting this model became high risk for the future progress of the project.  
Isolated cells were investigated in both 2D and 3D model systems, initially utilising the readily 
available bovine cell source. A 2D system was investigated owing to ease of set up and the 
simplicity of the resulting cell strain environment. However, it was established that cells were 
not able to survive the applied load regimes in this system, with cells detaching from the surface 
of the gel upon the application of cyclic strain. Accordingly, a 3D system was investigated, 
seeding isolated cells within a collagen gel. Cell viability was maintained in this system, even 
with the application of loading, and a mechanical characterisation of the gels confirmed that it 
was possible to confidently determine the local strain environment surrounding cells for further 
interpretation of data. Together, these data supported the use of 3D collagen gels for further 
cell mechanobiology studies. 
Furthermore, while the different loading models were under investigation, potential loading 
conditions were also explored. The initial cyclic strain condition (5% ± 5% at 1Hz or 10Hz for 
24hrs) used for the bovine tendon explant, was changed to 1% ± 1% at 1Hz or 10Hz for 24hrs 
for the rat tendon explant studies, as it was hypothesised that the strain used for stimulating the 
bovine tendon explants may have been too high and contributed to the cell death after strain 
application. Lower magnitude strains were maintained throughout the studies in isolated cells, 
reflecting research which has indicated that the strains experienced by tenocytes within tissues 
were of the order of 1-2% [Screen et al., 2014]. When working with isolated cells, the duration 
of 24hrs continuous loading  was also changed to 15mins, a decision made when reflecting on 
the duration of loading experienced by cells or tissues during either ESWT or an eccentric 














TENOCYTE RESPONSE TO LOADING 
  




Like other connective tissues, tendons experience varying loads in their natural environment and 
manage matrix metabolism accordingly. Under physiological loads, matrix metabolism is 
generally geared towards homeostasis but excess mechanical load or stress deprivation can both 
lead to a deleterious cell response [Gardener et al., 2008; Scott et al., 2005]. The mechanical 
loading variables (strain level, loading frequency, strain duration, repetition number) which 
determine cell response have been studied to some extent, but the optimal conditions to prevent 
injury or promote anabolic matrix response and repair are still unknown and likely differ across 
tendon types and species [Huisman, et al., 2014; Hsieh and Turner, 2001].  
Increased knowledge of the mechanical loading parameters which promote an anabolic matrix 
response in tenocytes provides an important input towards optimising exercise prescription for 
tendinopathic patients, considering that mechanical stimulation of tendons through exercise is a 
cornerstone to the treatment of tendinopathy [Chaudhry et al., 2015; Henriksen et al., 2009]. A 
number of studies have investigated the regulation of metalloproteinase and matrix genes in 
response to mechanical load using rat tissue or cells, however, very few studies have done the 
same using human samples or cells [Sun et al., 2010; Szczodry et al., 2009; Legerlotz et al., 
2007]. In addition, the majority of the studies have only been able to look at a few 
metalloproteinase and matrix genes, mainly focussing on MMP1, MMP2, MMP3, MMP13 and 
COL1A1 [Maeda et al., 2009; Asundi and Rempel, 2008]. 
A study by Legerlotz et al. [2013] investigated the effect of cyclically loading tendon explants 
in vitro using bovine fascicles. The tendon fascicles were subjected to cyclic tensile strain to 
30% or 60% of the strain at failure at 1Hz for 0hr to 5hrs, with data demonstrating that 
mechanical loading reduced explant failure stress and increased the expression of COL1A1 and 
IL6 [Legerlotz et al., 2013]. A different study was also able to investigate the effect of cyclically 
loading isolated tenocytes cultured onto 0.05% collagen type I silicone flasks and strained to 6% 
at 1Hz or 2Hz for 48hrs [Zaman et al., 2013]. This study demonstrated that loading at 1Hz 
increased MMP1 and fibronectin expression, whilst loading at 2Hz increased cell proliferation 
[Zaman et al., 2013]. Furthermore, tendon cells seeded in a 3D scaffold of poly(L-lactide-co-ε-
caprolactone)/collagen and cyclically strained to 2%, 4% or 8% at 0.3Hz, 0.5Hz or 1Hz for 3hrs 
per day demonstrated increased expression of COL1A1, tenascin-C, tenomodulin and scleraxis 
with loading [Xu et al., 2015]. These in vitro studies have concentrated on exploring the effects 
of low frequency and static mechanical loads using varied in vitro models, generally selected as 
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such loads are hypothesised to imitate those present in tendons during conventional physical 
activity (walking at  ̴ 1Hz).  
Chaudhry et al. [2015] showed that completing an eccentric exercise regime for the Achilles 
tendon generated tremor within the tendon at a mean frequency of 10Hz. This high-frequency 
(10Hz) mechanical stimuli was hypothesised to stimulate tendon repair [Chaudhry et al., 2015]. 
In bone, high-frequency (5–100Hz) mechanical load has been shown to be capable of stimulating 
bone cells to promote bone growth, doubling bone formation rates relative to unstimulated 
controls [Bacabac et al., 2006]. Taken together with the knowledge that tendinopathy is 
effectively treated by eccentric loading, it could be hypothesised that 10Hz loading is stimulatory 
for tendon cells. However, no study have investigated the response of tenocytes to 10Hz loading. 
This research hypothesises that 10Hz loading may lead to an anabolic stimulation of tendon cells 
The aim of this study was to determine the effects of 10Hz loading relative to the more commonly 
adopted 1Hz loading upon healthy and tendinopathic human tenocytes. 
  




3.2.1  SAMPLE COLLECTION AND PREPARATION 
Human tenocytes were collected from tendinopathic Achilles tendon [n = 3, Age: 21 ± 1 years] 
and healthy semitendinosus tendon (which will be referred to as hamstring tendon from here on, 
throughout this thesis) [n = 3, Age: 48 ± 3 years]. Cells were previously prepared by either 
explant outgrowth or collagenase digest respectively, and obtained from Dr. Graham Riley at the 
Bio-Medical Research Centre (BMRC) University of East Anglia (UEA). Cells were cultured in 
10% FBS media, the components of which are detailed in Table 3.1. Medium was replaced every 
three days until cells reached 80% confluent. Cells were passaged as described in Chapter 2.5.1. 
Cells at passage four to six were used in this research. 
Table 3.1: Component of 10% FBS media used for human cell culture 




DMEM (with sodium pyruvate, phenol red, 
glutamaxTM and low glucose) (ThermoFisher 
Scientific, 21885-025) 
500 500 
FBS (Sigma – Aldrich, F7524) 50 - 
Penicillin streptomycin (PS) (Sigma – Aldrich, P4333) 5 5 
When sufficient cells were available, cells were trysinized, centrifuged, re-suspended in fresh 
media and counted using a haemocytometer as described in Chapter 2.5.1. The cells were then 
seeded into a collagen gel as described in Chapter 2.6.1, and the gel fixed within the custom-
made chambers and filled with 1.5ml of loading media as shown in Figure 2.3. The loading 
media contained no FBS because FBS is an uncharacterised, variable derivative of cow blood 
containing an array of growth factors, enzymes and other macromolecules and micronutrients, 
thus to maintain consistency within samples and experimental groups, a controlled, FBS free 
loading media was adopted. 
In order to prepare for a loading study, comparing gene expression in response to 1Hz and 10Hz 
loading, a series of validation steps were carried out (Figure 3.1). First a stabilisation experiment 
was carried out using bovine tenocytes, to assess the time taken for gene expression to stabilise 
after samples were secured in the loading chambers. After this was ascertained, human tenocytes 
were used, to next review the time course for the load induced response of different genes, to 
determine the optimal time for carrying out gene expression analysis post loading. 






Gene stabilisation: Gels fixed within loading 
chambers and left incubated and unstrained for 
0, 18, 24 or 48hr 
n = 5 each time point
Cells used: Bovine tenocytes (Chapter 3.2.2)
fSelected genes were 
analysed to establish the 
necessary wait period for 
cell metabolism to 
stabilise post sample 
preparation.
EXPERIMENT 2
Time Course: Samples were subjected to a 
loading experiment; stabilisation, then 15mins 
cyclic loading (1% ± 1%) at  either 1Hz or 
10Hz, then held at 1% static strain until the 4, 
8, 12 or 24hr time point to determine the time 
course of gene expression changes 
n = 2 each time point
Cells used: Human tenocytes (Chapter 3.2.3)
A TLDA plate was used to 
look at a wide range of genes. 
Changes in gene expression 
over time were investigated to 
identify the optimal time 
point for future analysis.
EXPERIMENT 3
Loading experiment: Stabilisation, then 
15mins cyclic loading (1% ± 1%) at either 1Hz 
or 10Hz, then held at 1% static strain until the 
24hr time point to investigate cell response to 
the loading conditions, looking at gene 
expression of selected genes 
n = 4 each strain rate
Cells used: Human tenocytes (Chapter 3.2.4)
3D Collagen Gels 
Output 
Output 
Figure 3.1: Flow diagram of experiments performed on 3D collagen gels. Gene stabilisation was performed on unstrained samples 
using bovine tenocytes, followed by a time course experiment on human tenocytes seeded in collagen gel. Strained 
samples were left to incubate for 24hrs then cyclically strained. A loading experiment was then carried out on samples 
allowed to incubate for 24hrs and then cyclically strained. (TLDA – Taqman Low Density Array) 
3D Collagen Gels – Tenocyte strain response 
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3.2.2  3D COLLAGEN GEL GENE STABILISATION 
A time course analysis of selected genes (detailed in Table 3.2) was carried out to investigate 
how sample preparation, including securing gels in the loading chambers, altered gene 
expression over a 48hr period and to establish when samples had stabilised in preparation for 
loading experiments. Bovine tenocyte seeded collagen gels (n=20) were fixed in loading 
chambers and placed in an incubator to maintain samples in 5% CO2 at 37ᵒC. 5 samples were 
removed from the chambers at each time point of 0, 18, 24 and 48hrs. The gripped ends of the 
collagen gels were removed using a sterile scalpel and the mid-portion of the gel (10mm long), 
was placed into a cryotube and immersed in liquid nitrogen. After 3-5 minutes, the samples were 
removed from liquid nitrogen and stored at -80ᵒC for later gene analysis. RNA extraction, reverse 
transcription and qRT-PCR was then carried out as detailed in Chapter 2.3.1. 
Table 3.2: Bovine primer sequences (Forward and Reverse) used for real-time polymerase chain 
reaction 

































3.2.3  TIME COURSE ANALYSIS FOR GENE EXPRESSION CHANGES 
POST-LOADING 
A second time course analysis involving a wide range of genes was carried out, this time to 
investigate the time course for peak gene expression changes in response to loading. Healthy 
human hamstring tenocytes were seeded into collagen gels (n=18), fixed in loading chambers 
and placed in an incubator to maintain samples in 5% CO2 at 37ᵒC for 24hrs allowing gene 
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expression to stabilise. Samples were then subjected to one of the three different loading 
conditions and stopped at different times:  
 Unstrained (24hrs only) – Control group  
 High magnitude low frequency loading: 15mins cyclic loading (1% ± 1% at 1Hz) 
followed by 1% static strain until the 4, 8, 12 or 24hrs time points   
 High magnitude high frequency loading: 15mins cyclic loading (1% ± 1% at 10Hz) 
followed by 1% static strain until the 4, 8, 12 or 24hrs time points   
After loading, collagen gels were removed from the chambers and the gripped ends of the gels 
were removed using a sterile scalpel. The mid-portion of the gel was frozen and stored for later 
gene analysis as previously described (for full details see Chapter 2.3.1).  
RNA was quantitated, reverse transcribed and analysed using a Taqman Low Density Array 
(TLDA) qRT-PCR. A TLDA is a microfluidic card with 384-wells across eight ports, each port 
containing 48 connected wells. The primers and probe for each assay are preloaded and dried 
onto the designated duplicate wells, hence the TLDA card is useful to analysis a wide range of 
genes (48 genes) in 8 different samples in one single run, rather than running single PCR assays 
(significantly less sample is needed for a TLDA analysis). The TLDA (Life Technologies, 
Paisley, UK) was specifically designed to investigate tendon matrix genes, and covered 7 of the 
23 MMP genes as well as 8 of the 19 ADAMTS genes, all 4 TIMP genes, 4 interleukin genes, 
12 key proteoglycans and 10 collagen genes, as well as 3 endogenous control genes 18s, GAPDH 
and TOP1 (see Table 3.3 for the TLDA gene selection). 
Table 3.3: Cytokines, matrix genes, metalloproteinases & TIMPs selected for the Taqman Low 
Density Array primer sets 
Primer Probe Set Gene Abbreviation Full Name 
Hs00223332_m1 TNMD Tenomodulin 
Hs03054634_g1 SCXB;SCXA Scleraxis 
Hs01115665_m1 TNC Tenascin C 
Hs00164359_m1 COMP Cartilage Oligomeric Protein 
Hs00365052_m1 FN1 Fibronectin 
Hs01555410_m1 IL1B Interleukin 1 
Hs00174114_m1 IL2 Interleukin 2 
Hs00985639_m1 IL6 Interleukin 6 
Hs00174103_m1 IL8 Interleukin 8 
Hs00199608_m1 ADAMTS1 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 1 




A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 2 
Hs00610744_m1 ADAMTS3 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 3 
Hs00192708_m1 ADAMTS4 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 4 
Hs00199841_m1 ADAMTS5 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 5 
Hs01058097_m1 ADAMTS6 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 6 
Hs00229594_m1 ADAMTS12 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 12 
Hs01548449_m1 ADAMTS14 
A Disintegrin and Metalloproteinase with 
Thrombospondin Motifs 14 
Hs00899658_m1 MMP1 Matrix Metalloproteinase 1 
Hs01548727_m1 MMP2 Matrix Metalloproteinase 2 
Hs00968305_m1 MMP3 Matrix Metalloproteinase 3 
Hs01042796_m1 MMP7 Matrix Metalloproteinase 7 
Hs01029057_m1 MMP8 Matrix Metalloproteinase 8 
Hs00234579_m1 MMP9 Matrix Metalloproteinase 9 
Hs00233992_m1 MMP13 Matrix Metalloproteinase 13 
Hs00171558_m1 TIMP1 Tissue Inhibitor of Metalloproteinase 1 
Hs00234278_m1 TIMP2 Tissue Inhibitor of Metalloproteinase 2 
Hs00165949_m1 TIMP3 Tissue Inhibitor of Metalloproteinase 3 
Hs00162784_m1 TIMP4 Tissue Inhibitor of Metalloproteinase 4 
Hs00195140_m1 PRG4 Proteoglycan 4 
Hs00153936_m1 ACAN Aggrecan 
Hs00156076_m1 BGN Biglycan 
Hs00171642_m1 VCAN Versican 
Hs00370384_m1 DCN Decorin 
Hs00157619_m1 FMOD Fibromodulin 
Hs00300550_m1 LAMA1 Laminin 
Hs00164004_m1 COL1A1 Collagen I 
Hs00264051_m1 COL2A1 Collagen II 
Hs00943809_m1 COL3A1 Collagen III 
Hs00266237_m1 COL4A1 Collagen IV 
Hs00609133_m1 COL5A1 Collagen V 
Hs01095585_m1 COL6A1 Collagen VI 
Hs00932129_m1 COL9A1 Collagen IX 
Hs01097664_m1 COL11A1 Collagen XI 
Hs00189184_m1 COL12A1 Collagen XII 
Hs00964045_m1 COL14A1 Collagen XIV 
Hs99999905_m1 GAPDH Glycoraldehyde 3-phosphate Dehydrogenase 
Hs99999901_s1 18S 18s rRNA 
Hs00243257_m1 TOP1 Topoisomerase 1 
Ct values were collected for each gene, with undetected samples given a Ct value of 40. Relative 
expression levels of each gene of interest were analysed by normalising to the endogenous 
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control gene 18s (ΔCt [endogenous control gene Ct–gene of interest Ct]) and expressing the data 
as 2ΔΔCt. All data were normalised to the control group, which is represented by the baseline 
value of 1. 18s was chosen as the house keeper of choice over GAPDH or TOP1 because it had 
the most stable Ct values across the different groups. It is also less sensitive to strain than 
GAPDH and more sensitive to RNA degradation, making it a good marker of sample quality 
[Kuchipudi et al., 2012]. Statistical analysis was not performed as only a single exploratory 
TLDA analysis was carried out. The TLDA was analysed to select genes of interest for a more 
extensive investigation of tenocyte response to strain, and establish the most appropriate time 
point for a more detailed analysis utilising standard RT-PCR. 
3.2.4  TENOCYTE RESPONSE TO LOADING 
The tenocyte response to high frequency (10Hz) and low frequency (1Hz) loading was compared 
to investigate gene expression changes that may shed light on the efficacy of eccentric loading 




Gels seeded with 
healthy human 
hamstring tenocytes 
and allowed 24hrs for 
gene stabilisation pre-
loading (n = 12)
Gels seeded with 
tendinopathic human 
Achilles tenocytes and 
allowed 24hrs for gene 
stabilisation pre-
loading (n = 12)
Gene Expression 
Figure 3.2: Flow diagram depicting the experiments performed using 3D collagen gels, comparing the cell response to 10Hz 
and 1Hz loading. 
Tenocyte Response to Loading Experimental Set Up  
Unstrained Control  
(n = 4 each) 
Cyclically strained 
samples  
1% ± 1% at 10Hz 
(n = 4 each) 
Cyclically strained 
samples  
1% ± 1% at 1Hz 
(n = 4 each) 
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Collagen gels were seeded with either healthy hamstring tenocytes (n = 12) or tendinopathic 
Achilles tenocytes (n = 12). Gels were fixed into loading chambers and incubated for 24hrs to 
allow gene expression to stabilise, after which they were subjected to one of the three different 
loading conditions;  
 Unstrained (24hrs) – Control group  
 High magnitude low frequency loading: 15mins cyclic loading (1% ± 1% at 1Hz) 
followed by 1% static strain until the 24hrs time point 
 High magnitude high frequency loading: 15mins cyclic loading (1% ± 1% at 10Hz) 
followed by 1% static strain until the 24hrs time point 
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3.2.5  STATISTICAL ANALYSIS 
Statistical analysis was performed using a one way analysis of variance (one way ANOVA) 
looking for significant differences in the responses of tendinopathic and healthy cell types, when 
exposed to the different loading conditions. Tukey’s Honest Significant Difference (HSD) pot-








3.3.1  3D COLLAGEN GEL GENE STABILISATION CHECK 
A time course analysis of selected genes was carried out on bovine seeded 3D collagen gels, 
looking 0, 18, 24 and 48 hours after cells were secured in loading chambers, to determine when 
gene expression stabilised after gel preparation. 18s was confirmed stable throughout the 
experimental period, and gene expression changes were normalised to this house keeping gene. 
There was a notably large change in gene expression between 0 and 18hrs after which no further 
significant differences in gene expression were evident from 18 to 48 hours after sample 
preparation (Figure 3.3). 
 
3.3.2  TAQMAN LOW DENSITY ARRAY (TLDA) ANALYSIS 
A TLDA was carried out to ascertain a broad spectrum gene expression response to 1Hz and 
10Hz loading, to establish the peak response time across a range of relevant matrix genes. Of the 
analysed genes, MMP7, MMP8, ADAMTS3, COL2A1 and COL9A1 were not detected. The 
remaining genes showed a steady increase in gene expression for most genes with both high 






























Figure 3.3: Gene expression changes in bovine tenocytes after cells were seeded in 3D collagen gels and 
secured into loading chambers. Data was normalised to 18s and presented as fold changes relative 
to the 0 hour start of the experiment (2
∆∆Ct
) [mean ± SD]. The greatest changes were seen in the 
first 18hrs, after which expression largely stabilised. 
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particular note, the greatest upregulations of gene expression with loading were  seen in MMP1 
(7.3 fold), MMP2 (4.1 fold), MMP13 (5.1 fold), ADAMTS1 (7.0 fold), ADAMTS5 (10 fold), 
ADAMTS12 (27.8 fold), TIMP2 (4.9 fold), TIMP3 (13.2), TIMP4 (9.1 fold), IL6 (8.1 fold), IL8 
(5.4 fold), COL1A1 (6 fold), COL3A1 (5.4), and COL5A1 (566.3), for all other fold changes 
see Figure 3.4A and B. 
  








































































Figure 3.4A: Regulation of gene expression with mechanical load over the 24hrs loading period using human healthy tenocytes. 
Collagen gels were fixed to a custom-made chamber and subjected to a cyclic load of 1% ± 1% for 15mins then 
statically strained at 1% until the 4, 8, 12 or 24hrs time point. Matrix genes expression levels were measured using a 
Taqman Low Density Array. Data was normalised to 18s and expressed relative to the 0hr unstrained samples. The 
greatest changes in gene expression were seen at 24hrs.  
44hrs 48hrs 412hrs  24hrs 
10Hz          1Hz 10Hz   10Hz          1Hz 10Hz          1Hz 

































































Figure 3.4B: Regulation of gene expression with mechanical load over the 24hrs loading period using human healthy tenocytes.. 
Collagen gels were fixed to a custom-made chamber and subjected to a cyclic load of 1% ± 1% for 15mins then statically 
strained at 1% until the 4, 8, 12 or 24hrs time point. Matrix genes expression levels were measured using a Taqman Low 
Density Array. Data was normalised to 18s and expressed relative to the 0hr unstrained samples. The greatest changes in 
gene expression were seen at 24hrs.  
44hrs 48hrs 412hrs   24hrs 
10Hz       1Hz 10Hz       1Hz 10Hz      1Hz 
10Hz   
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3.3.3  CELL RESPONSE TO LOADING 
A comparison of cell response to 1Hz and 10Hz loading for selected genes demonstrated that 
gene expression changes were consistently more pronounced with loading at 10Hz compared to 
loading at 1Hz for both cell types (healthy and tendinopathic tenocytes) (Figure 3.5 and 3.6). 
Large error bars highlight the notable variability between biological replicates. However, paired 
analyses of data indicated significant differences only evident in the healthy tenocyte response, 
where MMP1 (p = 0.039),  IL6 (p = 0.026) and IL8 (p = 0.043) were all significantly more 
responsive to 10Hz than 1Hz loading, demonstrating consistent trends in cell behaviour. The 
gene expression profile of tendinopathic cells showed an upregulation of COL3A1 and 
downregulation of COL1A1 and COL5A1, while the healthy hamstring tenocytes showed 
upregulation of all analysed genes, highlighting the different cell phenotypes. It was also notable 
that substantially higher gene expression levels were seen in the healthy hamstring tenocytes 
compared to the tendinopathic Achilles tenocytes, suggesting that the healthy cells are maybe 
more mechano-responsive to these loading conditions. However, age and tendon type may also 
play a role in this response. 
 
Figure 3.5: Gene expression changes in healthy human hamstring tenocytes seeded in 3D collagen gels subjected to a cyclic 
load of 1% ± 1% for 15mins then held at 1% strain for 24hrs. Matrix genes were measured using standard qRT-
PCR. Data was normalised to 18s and presented as a fold change relative to the 24hr control (unloaded)  samples 
(2
∆∆Ct


















































































Figure 3.6: Gene expression changes in tendinopathic human Achilles tenocytes seeded in 3D collagen gels subjected 
to a cyclic load of 1% ± 1% for 15mins then held at 1% strain until the 24hrs time point. Matrix genes 
were measured using standard qRT-PCR. Data was normalised to 18s and presented as a fold change 
relative to the 24hr control (unloaded)  samples (2
∆∆Ct
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In Chapter 2, it was evident that preparing and securing explants within chambers altered their 
gene expression, therefore it was important to investigate the timeframe required for gene 
changes to stabilise within cells seeded with a 3D collagen gel prior to carrying out loading 
experiments. Figure 3.3 showed that gene expression was altered notably over the first 18hrs 
after sample preparation, but no significant differences were seen in the expression of any 
analysed gene after this point. Previous data (Tables 2.9, 2.10 and 2.11), confirmed that cell 
viability was maintained in constructs for 48hrs, hence a gene expression stabilisation period of 
24hrs followed by an experimental period of 24hrs was deemed appropriate to proceed to further 
experimental analysis.  
Studies have shown that the time frame over which different genes respond to loading is variable 
[Jones et al., 2013; Lesur et al., 2010], making it difficult to establish the most appropriate time 
point at which to investigate cell response to the applied loading conditions. In order to address 
this, a broad spectrum TLDA analysis of the time course of gene expression in response to the 
load regime of interest was carried out, helping to identify those genes most responsive to the 
applied strain and the most appropriate time at which to measure them for a future, more detailed 
analysis. Overall, the response to loading increased over time, peaking at 24hrs. However, it was 
notable that tenocytes initially appeared to respond more rapidly to 1Hz loading at 4hrs, but with 
a general trend towards downregulating gene expression before expression levels rose. The gene 
expression profile of this pilot study showed a general upregulation of ADAMTS and collagen 
relative to MMPs which may indicate a more anabolic response to mechanical load. Further 
experimental repeats with selected genes were then repeated using standard qRT-PCR analysis 
to investigate cell response to loading more closely. A tendinopathic cell group was also added, 
enabling a comparison of the metabolic response of these two populations.  
It is difficult to determine the actual load that human tenocytes undergo within the tendon matrix 
during eccentric loading or ESWT due to lack of human studies in this area. However, the loading 
condition applied (strain at 1% ± 1%) in this study may be deemed physiological. Data from 
Screen, et al. [2004] that used microscopic examination to visualise rat tail fascicles during strain, 
demonstrated that tenocyte strain is limited to less than 2%, and it can be expected that the 
vibrations caused by ESWT or eccentric loading are likely to be small magnitude. 
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In this current study, genes were chosen for more detailed qRT-PCR analysis on the basis that 
they were more responsive to the loading conditions from the TLDA study. Other studies have 
also pointed out that the selected genes are reportedly modified by mechanical load or 
tendinopathy [Jones et al., 2013; Legerlotz et al., 2012]. The data from the TLDA experiment 
could not be combined with standard qRT-PCR analysis because the target the amplicons of 
primer and probe sets were different on the TLDA compared to those used for standard qRT-
PCR. However, whilst gene expression levels with the TLDA and qRT-PCR were at variance, 
the changes and patterns were consistent, which increases confidence in the gene changes.  
Data from Figures 3.5 and 3.6 indicate that healthy and tendinopathic derived tenocytes respond 
to mechanical loading in a similar manner. Whilst substantial error bars are evident in the data, 
these were primarily a product of variability between biological repeats particularly in the 
tendinopathic cells, which is indicative of the inconsistency in tendiniopathic cells. It was also 
evident that healthy tendon derived cells showed a more marked pattern of response, suggesting 
that cells derived from tendinopathic tissues may be less responsive to mechanical load. 
Tendinopathic tenocytes showing a less responsive pattern to loading in comparison to healthy 
tencocytes was also observed by Jones [2012], where healthy and tendinopathic tenocytes were 
cyclically strain to 5% in collagen gels using a flexcell system. It is possible this is a contributing 
factor to why tendinopathy does not get better with other treatment options, as the cells do not 
respond to load. However, a contradictory pattern was observed by Patel [2015]. Here healthy 
and tendinopathic human tenocytes were seeded into a fibre composite construct made of 
polyethylene glycol (PEG) with cells seeded onto stiff PEG fibres and surrounded by a softer 
PEG matrix, so on loading, cells experienced both tension and shear. Under these conditions, a 
more responsive pattern was seen in the tendinopathic tenocytes compared to the healthy 
tenocytes [Patel, 2015]. The differences between both the studies could be a result of the scaffold 
material in which the cells were seeded on or the type of loading applied, with direct mechanical 
shear differentially stimulating the cells.  
The healthy hamstring tendon cells showed an upregulation of all genes analysed, which may 
indicate an anabolic response to mechanical loading [Sun et al., 2010], while the tendinopathic 
Achilles tendon cells showed a downregulation of COL1A1, the primary structural protein of 
tendon. The preferential upregulation of COL3A1 relative to COL1A1 and COL5A1 has 
previously been reported to denote an early healing response [Sun et al., 2010]. Type III collagen 
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has been identified as a major component of newly synthesized ECM in early tendon healing 
[Erisksen et al., 2002]. 
The cell response to 10Hz loading was constantly more marked than that seen with 1Hz loading, 
perhaps indicating a greater capacity for matrix turnover in response to the vibrations caused by 
eccentric loading. The difference in response to 10Hz and 1Hz loading was significant for 
MMP1, MMP2, IL6 and IL8 but only in the healthy cell population. The significantly greater 
response of these collagenases and cytokines with 10Hz loading may suggest that higher loading 
frequencies are better able to initiate matrix breakdown. However, when considered in 
conjunction with evidence of the upregulation of gene expression for collagen synthesis also in 
these samples, it may represent a greater capacity for matrix turnover, ultimately supporting 
repair. MMP1 and MMP13 are said to promote degradation of the ECM [Thorpe et al., 2014; 
Buono et al., 2013]. But, degradation can be important for healing and remodelling of damaged 
collagen fibres within the matrix. Therefore, increased MMP1 and MMP13 levels may induce 
active tissue remodelling or a healing response after injury [Hellio Le Graverand et al., 2000] 
especially when paired with new collagen production.  
IL-6 is a multifunctional inflammatory cytokine, which exhibits both pro- and anti-inflammatory 
actions, and is released in response to mechanical loading [Legerlotz et al., 2012; Skutek et al., 
2001]. IL-6 has also been shown to stimulate fibroblasts to induce collagen synthesis, with and 
without the presence of a mechanical stimulus, suggesting that IL-6 may be important for 
connective tissue health [Andersen et al., 2011]. In contrast, there are many studies reporting the 
role of IL-6 in tendon adaptation, suggesting it may promote negative effects [Nakama et al., 
2006; Mihara et al., 1995]. These conflicting arguments reveal the need for further research into 
healing pathways before extensive conclusions can be made. IL8 on the other hand, is generally 
considered a pro-inflammatory cytokine induced by mechanical loading, however, not many 
studies have looked into the effects IL8 in tenocytes in response to loading [Waugh et al., 2015]. 
Waugh et al. [2015] showed an upregulation of IL8 after mechanical loading provided by ESWT 
at 8Hz, and although no significant difference existed between healthy and tendinopathic 
patients, IL8 production was more pronounced within the patient group. The study also 
demonstrated increased expression of IL-1 and IL-2 which was not analysed by the current study 
but suggests an inflammatory response to ESWT.   
The TLDA demonstrated that IL8 expression begun to rise 24hrs after loading confirmed by 
further PCR. The application of cyclic strain has been shown to increase the production of IL6 
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and IL1β [Jelinsky, et al., 2011]. IL1β in turn increases the production MMPs [Waugh et al., 
2015; Tsuzaki et al., 2003b]. In addition, IL1 not only increases expression of MMPs but IL6 
also [Tsuzaki et al., 2003b; Archambault et al., 2002], suggesting that the IL1 signalling may be 
involved in the mechanotransduction pathways associated with load response. 
In conclusion, these findings have demonstrated for the first time that loading at a frequency of 
10Hz may enhance metabolic response in healthy tenocytes relative to loading at 1Hz. However, 
this response appears to be less pronounced in tendinopathic tenocytes. Further studies are 
needed to establish if the enhanced response to 10Hz loading is a result of the higher loading 
frequency or simply the increased overall mechanical stimulus, and additionally to investigate 
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Cells detect and respond to mechanical loading by altering their metabolic response through a 
variety of pathways [Lavagnino et al., 2015]. The deformation of tendon cells initiates the 
expression of genes responsible for catabolic and/or anabolic cellular and molecular responses, 
which affect tissue development and also homeostasis. Data from this study have shown that 
10Hz loading resulted in a significantly higher metabolic response in tenocytes than 1Hz loading. 
This Chapter aims to explore the mechanisms associated with the difference in cell response to 
the two frequencies, and the mechanotransduction pathways associated with the metabolic 
response.  
From a mechanobiological point of view, four factors of the applied strain may affect the 
adaptive response of tenocytes: magnitude, frequency, number of cycles and duration [Bohm et 
al., 2014]. In the experiments described in Chapter 3, the magnitude and duration of loading were 
the same for the different loading groups, whilst the loading frequency and total number of 
loading cycles were both altered. Indeed, a clear limitation of experiments investigating different 
loading frequencies is that it is not possible to keep all other factors constant between groups. 
Either the loading period or total number of cycles must be at variance. Data from Rubin and 
Lanyon [1984] suggests that number of cycles may play an important role in tissue remodelling. 
This study investigated the effect of applying 4, 26, 360 and 1800 loading cycles to isolated 
rooster ulna, showing that with more cycles, the bone mass was further increased in a turkey ulna 
model [Rubin and Lanyon, 1984]. An increase in tenocyte differentiation was also seen with 
increased number of cycles, on tenocytes seeded in a 3D collagen gel and mechanically strained 
from 0-10% at 0.1Hz for 10, 100 or 1000 cycles once a day for two weeks [Scott et al., 2011]. 
This study also demonstrated increased expression of scleraxis with increasing number of cycles 
of loading [Scott et al., 2011]. In the current study, it is difficult to determine if it is loading 
frequency or total number of cycles responsible for the differential response of test groups. 
However, this can be explored by repeating the experiment, but including a test group with a 
constant number of cycles.  
Tendon cells subjected to mechanical loading, activate mechanotransduction signalling 
pathways that are not fully understood. In normal conditions, these processes balance and 
maintain tissue homeostasis [Popov et al., 2015]. During mechanical loading, load is transmitted 
through the extracellular matrix to the cytoskeleton of the mechanosensitive tendon cells via 
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focal adhesion sites (such as integrins, ion channels, or growth factors) activating downstream 
proteins kinases [Lavagnino et al., 2015; Wang, 2006].  
Cell culture studies have shown that tenocytes respond to mechanical loading by increasing the 
production and secretion of certain genes such as growth factors and IL-1, which in turn act on 
the cell to induce expression of other genes [Bouchard, 2015]. Some of the other genes reported 
to respond to mechanical loading include collagens, MMPs and interleukins, seen across a range 
of experiments on human and animal cells [Gumucio et al, 2015; Wang et al., 2007; Heinemeier 
et al., 2007; Olesen et al., 2006].  
In general, the healing process of an injured or compromised tendon passes throughout three 
main phases containing distinctive cellular and molecular cascades (figure 4.1). Growth factors 
have been demonstrated to increase in response to mechanical loading which in turn increases 
metabolic activity essential to tendon healing [Zhang and Wang, 2013]. The tendon healing 
process is complexly orchestrated by a variety of secreted molecules [Docheva et al., 2015]. 
Initially, certain inflammatory cytokines, such as interleukin (IL)-6 and IL-1β, are produced by 
the invading inflammatory cells. Later, tissue repair is facilitated by a number of growth factors, 
which are released by cells located at the injury site [Docheva et al., 2015]. In particular, growth 
factors like transforming growth factor beta (TGFβ), connective tissue growth factor (CTGF), 
insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), platelet-derived 
growth factor (PDGF) and basic fibroblast growth factor (bFGF) are upregulated in different 
phases of the healing process, with diverse molecular effects during healing (figure 4.1) [Molloy 
et al., 2003]. TGFβ is upregulated in both gene expression and in protein form in all stages of 
tendon healing and is responsible for stimulating cell migration, regulation of proteinases, 
fibronectin binding interactions, termination of cell proliferation via cyclin-dependent kinase 
inhibitors, and stimulation of collagen production [Jones et al., 2013; Molloy et al., 2003]. A 
study by Jones et al. [2013] indicated that mechanical loading induces the TGFβ signalling 
pathway, and much of the strain induced mRNA expression in tenocytes occurred through this 
pathway. Therefore, in this thesis, TGFβ was investigated to establish if it was involved in the 
tenocyte strain response, and to investigate which genes may be associated with TGFβ 
expression. 




IL-1 family members have been intensely studied (especially IL-1α and IL-1β), unravelling their 
roles as proinflammatory cytokines in diseased tissues [Dinarello, 1996; Sun et al., 2008]. 
Studies that have investigated IL-1 in tissue healing suggest that IL-1 might contribute to 
stimulating expression and accumulation of MMPs and IL-6 in tendon matrix [Sun et al., 2008; 
Tsuzaki et al., 2003a]. IL-1 is secreted by macrophages and monocytes, and it is well known that 
MMPs are a group of enzymes released from macrophages [Tsuzaki et al., 2003a], Previous data 
from this thesis showed an upregulation of MMPs and IL-6 in healthy hamstring tenocytes 
subjected to cyclic load. Therefore, in this present study, IL-1 will also be investigated to 
establish if it may be involved in stimulating human tendon cells to express mRNA for MMPs 
and IL-6 in response to loading.  
A review of current understanding of the TGFβ and IL-1 signalling pathways is now provided. 
TGFβ Secretion and Activation 
Mature TGFβ is secreted by a cell after intracellular proteolytic cleavage of the TGFβ protein by 
the endopeptidase furin, that yields a dimer protein from the N-terminal called latency associated 
peptide (LAP) and a dimer protein from the C-terminal called mature TGFβ [Horiguchi et al., 
2012; Khalil, 1999]. The LAP protein facilitates the transit of TGFβ from the cell while also 
ensuring the TGFβ remains biologically inactive, also referred to as latent TGFβ protein (LTBP) 
[Khalil, 1999]. TGFβ and LAP together form small latent complex (SLC) but are not covalently 
  Figure 4.1: Key molecular, cellular and matrix changes occurring during the three main phases of tendon 
repair. Each healing stage is characterized by involvement of different growth factors, 
activation of certain cell types and production of essential matrix proteins, which collectively 
contribute to the replacement of the initial fibrous tissue with more a tendinous regenerate 
[Adaptaed from Docheva et al., 2015] 
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bonded [Horiguchi et al., 2012]. Within the endoplasmic reticulum (ER), SLC binds to LTBP 
via a disulphide bond through LAP to form large latent complex (LLC) which is released into 
the ECM for future activation (Figure 4.2) [Horiguchi et al., 2012].  
The LLC, contains a convenient store of TGFβ within the ECM which can easily be activated. 
Activation has been reported to occur by a variety of mechanisms which include proteases (such 
as MMP2, MMP3, MMP9, MMP13, MMP14, thrombin and plasmin) [Krstic and Santibanez, 
2014; Jenkins, 2008], thrombospondin-1 (TSP-1) [Murphy-Ullrich and Poczatek, 2000], 
ionizing radiation and reactive oxygen species (ROS) [Jobling et al., 2006] and mechanical 
stimulation via integrins [Jones, 2012; Shi et al., 2011; Wipff and Hinz, 2008]. These activators 
release active TGFβ either by degrading the LAP and/or LTBPs, or by modifying the 
conformation of the latent complex or by mechanical pulling of the LAP by integrins [Horiguchi 
et al., 2012].  The active TGFβ homodimer binds to TGFβ receptors III, II, and I to initiate the 
intracellular signalling cascade of SMAD phosphorylation (Figure 4.3). 
 
Figure 4.2: Schematic presentation of intracellular TGFβ synthesis, secretion and activation. TGFβ precursor contains N-
terminal pro-region (LAP), and a C-terminal region TGFβ protein. Both LAP and TGFβ exist as homodimers 
within the cell but remain non-covalently bonded forming the SLC. LLC containing a third component, LTBP, 
is linked to LAP by a single disulphide bond, is released into the ECM. The latent TGFβ can be activated by 
many factors to form free active TGFβ that binds to TGFβ receptors to initiate the intracellular signalling 
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TGFβ Signalling Pathway 
TGFβ is crucial in regulating cell physiology during tissue development. It stimulates and/or 
inhibits cell proliferation, differentiation, motility, adhesion or death, depending on cell type 
[Javeland and Mauviel, 2004; Shi and Massagne, 2003]. TGFβ is active in all cell types, 
functioning to regulate ECM proteins like collagens and fibronectin, and prevent ECM 
degradation by inhibiting MMPs through the upregulation of TIMPs [Heinemeier et al., 2009; 
Javeland and Mauviel, 2004]. It is considered a potent anabolic factor in the deposition and repair 
of connective tissue. Fenwick et al. [2001] showed that chronically injured tendon increased 
expression of TGFβ.  
TGFβ family ligands like bone morphogenetic proteins (BMPs), growth and differentiation 
factors (GDFs), anti-mullerian hormone (AMH), activins, nodal and TGFβ, signal by assembling 
to a heterodimer receptor complex [Weiss and Attisano, 2012]. The heterodimer receptor consist 
of a type I and type II receptor which are serine/threonine kinases, meaning they have a catalytic 
portion which adds a phosphate group to serine/threonine residues [Weiss and Attisano, 2012]. 
A third TGFβ receptor (TGFβRIII) enhances binding of active TGFβ to TGFβRII. When ligands 
bind to the receptors, activating the serine/threonine kinase of the type II receptor, they then add 
a phosphate group onto the serine/threonine domain of the type I receptor, propagating TGFβ 
signalling [Massague, 2012]. Consequently, R-SMAD protein (SMAD 2/3) is recruited. The 
SMAD 2/3 protein is phosphorylated by the serine/threonine kinase of the type I receptor. 
Receptor-phosphorylated SMAD 2/3 protein cleaves off the type I receptor to form a 
transcriptional complex with SMAD 4 that goes to the nucleus of the cell. The SMAD complex 
or transcription factor interacts with the DNA in the nucleus where transcription occurs.  
TGFβ signalling can also activate other SMAD-independent signalling pathways including 
mammalian target of rapamycin (mTORC), phosphoinositol 3-kinase (PI3K), SH2 domain-
containing transforming protein (SHC), extracellular signal-regulated kinase (ERK) and 
Rho/Rho associated protein kinase (ROCK), although the biochemical and structural bases for 
many of these links remain unknown [Massague, 2012]. 




IL-1 Signalling Pathway 
The IL-1α or IL-1β ligand binds to the type 1 receptor (IL-1R1), initiating the signalling process 
with the help of a co-receptor (Figure 4.4), IL-1 receptor accessory protein (IL-1RAP), to form 
a trimeric complex [Ozbabacan et al., 2014]. The Toll-/IL-1R (TIR) domains of the IL-1R1 and 
IL-1RAP receptors interact together, recruiting cytoplasmic adaptor proteins like myeloid 
differentiation primary response gene 88 (MYD88), Toll-interacting protein (TOLLIP) and IL-
1 receptor-associated kinase 4 (IRAK4) to form a stable complex [Ozbabacan et al., 2014]. The 
presence of MYD88 triggers the phosphorylation of IL-1 receptor-associated kinases 1/2/4 which 
in turn recruits and oligomerizes tumor necrosis factor receptor-associated factor 6 (TRAF6). 
TRAF6 and phosphorylated IRAK1/2 dissociate and migrate to the membrane to associate with 
TGFβ-activated kinase 1 (TAK1) and TAK1-binding proteins TAB1 and TAB2 [Ozbabacan et 
al., 2014]. The TAK1-TAB1-TAB2-TRAF6 complex migrates back to the cytoplasm, where 
TRAF6 is ubiquitinated and TAK1 is phosphorylated. From this point, the signal can propagate 
via two main paths: IKK – IkB – NF-kB and/or MKK – MAPK/JNK/ERK. In the first path, 
phosphorylated TAK1 activates the inhibitor of nuclear factor kappa-B kinase subunit beta 









Type II receptor 
phosphorylate and 
activates type I receptor 
Type I receptor 
propagates the 
signal process  
Type I receptor recruits 
and phosphorylates 
SMAD 2 or 3 protein 




  Figure 4.3: Overview of TGFβ receptor signalling through SMAD-dependent 
pathway [Adapted and motified from Motifolio, 2016] 
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(IKKb). The activated IKKb phosphorylates the nuclear factor kappa-B inhibitor (IkB) which 
gets degraded so that nuclear factor kappa-B kinase (NFkB) (p65 and p50 subunits) are released 
and migrate to the nucleus to act as a transcription factor [Weber et al., 2010]. In the second path, 
phosphorylated TAK1 activates mitogen-activated kinases (MAPK) p38, c-Jun N-terminal 
kinases (JNK) (a subunit of AP-1) and extracellular signal-regulated kinases (ERK1/2) by 
interacting with MAP kinase kinase (MKK) proteins [Risbud and Shapiro, 2014]. Downstream 
in this path, are transcription factors such as c-Jun, c-Fos, c-Myc and ATF2 [Ozbabacan et al., 
2014]. 




The aim of this current study is to further investigate the mechanosensitivity and 
mechanotransduction of tendon cells in 3D collagen gels, to determine the signalling pathways 
activated by load and the downstream matrix gene expression changes. The following specific 
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TRAF6 and phosphorylated 
IRAK1/2 dissociate and associate 
with TGfβ activated kinase and 
kinase proteins at the membrane  
Two signal propagating paths 
depending on MAPKs, or MKK 
kinases  
  Figure 4.4: Overview of IL-1 signalling pathway [Adapted and modified from Risbud and 
Shapiro, 2014; Ozbabacan et al., 2014] 
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1. The increased metabolic activity seen in tenocytes subjected to high frequency (10Hz) 
loading relative to low frequency (1Hz) loading is a response to the difference in loading 
frequency and not the number of loading cycles. 
2. The TGFβ signalling pathway is responsible for initiating an overall metabolic tenocyte 
response to both high and low frequency strain. 
3. The IL-1 signalling pathway is responsible for initiating a catabolic and inflammatory 
tenocyte response to both high and low frequency strain.  




In this Chapter, healthy human hamstring tenocytes were seeded into collagen gels and secured 
within custom-made chambers filled with loading media, with or without TGFβ or IL-1 inhibitor, 
depending on the experiment. 













DMEM (with sodium pyruvate, phenol red, 
glutamaxTM and low glucose) (ThermoFisher 
Scientific, 21885-025) 
500 500 500 
Penicillin streptomycin (PS) (Sigma – 
Aldrich, P4333) 
5 5 5 
Inhibitor  1 in 1000 1 in 100 
 
4.2.1  CYTOKINE ARRAY 
In order to first investigate the cytokine response to loading, 8 collagen gels were prepared, 
secured within custom-made chambers and filled with standard loading media in preparation for 
loading as outlined in figure 4.5.  




Two gels were assigned to each loading condition, to examine the cytokine response, utilising a 
cytokine array following previously described protocols [Khalfaoui et al., 2016]. However, these 
were immediately combined post-loading to ensure sufficient protein for the array. Firstly, the 
protein concentration for each group was determined using semi-quantitative western blot 
analysis in order to normalise protein expression across samples for cytokine analysis. A 
bicinchoninic acid (BCA) assay kit was used to quantify the protein in each group by colorimetric 
detection and quantification of total protein. Assay standards were made using a stock solution 
of 2mg/ml of Albumin and lysis buffer. To get a broad range of concentrations necessary to plot 




3D Collagen gels seeded with healthy hamstring tenocytes 
(n = 8) 
Gels were fixed into custom-made 
chambers and allowed to incubate 




for 24hrs to stabilise 
Figure 4.5: Flow diagram depicting the experiments performed on 3D collagen gels to investigate 
the cytokine response to the applied loading conditions of interest 
Cytokine Array 
Cyclically strained at 1% ± 1% 
Control – 
unstrained 24hrs 
 n = 1 
Low freq (1Hz) 
for 15mins      
n = 1 
High freq (10Hz) 
for 15mins    
  n = 1 
Low freq (1Hz) 
for 150mins     
n = 1 
Held at 1% strain until 24hr time point 




Table 4.2: Serial dilution of protein standards for BCA assay, 1:7 dilutions for standard curve used 
to calculate the protein concentration of a sample 
Standard Protein standard 
(µg/ml)  
Volume of 2mg/ml 
Albumin (µl) 
Volume of lysis 
buffer (µl) 
Blank 0 0 100 
S1 20 1 99 
S2 100 5 95 
S3 250 12.5 87.5 
S4 500 25 75 
S5 900 45 55 
S6 1400 70 30 
S7 2000 100 0 
Following the manufacturer’s instructions, the BCA working reagent that reacts with protein, 
was prepared at a ratio of 50:1 of BCA reagent A and BCA regent B respectively. 25µl of protein 
standards or samples were pipetted into the wells of a 96-well microplate in duplicate, and 200µl 
of BCA working reagent was added to each well and mixed thoroughly using a plate shaker for 
30 seconds. Subsequently, the plate was incubated for 30 minutes at 37ᵒC. After 30 minutes, the 
plate was removed from the incubator and allowed to cool at room temperature. Protein 
concentration was measured using a plate reader at an absorbance of 562nm. In order to ensure 
a consistent protein concentration across all samples, samples were then diluted in order to match 
the lowest concentration.   
For cytokine expression analysis, the cytokine human membrane antibody array ab133998 
(Abcam, Cambridge, UK) was used, performed predominantly according to the manufacturer’s 
instructions. Cytokine antibody array membranes were placed into 4 of the 8-well trays provided 
in the kit, and incubated for 30 minutes at room temperature with 2ml 1X blocking buffer also 
provided in the kit. The blocking buffer was aspirated, then 1ml of sample was pipetted into each 
well containing a membrane. Samples were incubated over night at 4ᵒC then washed thrice with 
2ml wash buffer I, and twice with 2ml wash buffer II; both proprietary wash buffers provided in 
the kit. Cytokine detection was carried out by adding 1ml biotin-conjugated antibody to each 
well, and incubated for 1 hour, after which the antibody was pipetted out and the membranes 
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washed thrice with 2ml wash buffer I, and twice with 2ml wash buffer II. 2ml IRDye-labelled 
streptavidin solution was pipetted into each well and incubated for 45 minutes, after which the 
dye solution was removed and the membranes washed thrice with 2ml wash buffer I, and twice 
with 2ml wash buffer II. Membranes were scanned using an Odyssey imager with the following 
scanning parameters; resolution – 84µm, quality – medium, focus offset – 0.0mm, and intensity 
– 5. Evaluation was made by densitometry for a semi-quantitative comparison using image studio 
lite 5.0, which calculated signal intensity proportional to the amount of analyte bound. Samples 
signal were normalisation to the positive control, and the overall protein concentration of each 
loaded sample group was compared relative to the unstrained control. The method detects the 
following cytokines:  




ENA-78 Epithelial neutrophil-activating protein 78 
GCSF Granulocyte colony stimulating factor 
GM-CSF Granulocyte macrophage colony stimulating factor 
GRO Growth regulated oncogene 
GRO-α Growth regulated oncogene-alpha 
I-309 Inflammatory cytokine  
IL-1α Interleukin-1 alpha 













MCP-1 Monocyte chemoattractant protein-1 
MCP-2 Monocyte chemoattractant protein-2 
MCP-3 Monocyte chemoattractant protein-3 
MCSF Macrophage colony-stimulating factor 
MDC Macrophage -derived chemokine 
MIG Monokine induce by interferon 
MIP-1b Macrophage inflammatory protein-1 beta 
MIP-1δ  Macrophage inflammatory protein- 1 gamma 
RANTES Regulated on Activation, Normal T Cell Expressed and Secreted) 
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SCF Stem cell factor 
SCDF-1 Stromal cell-derived factor 1 
TARC Thymus and activation-regulated chemokine 
TGF-β1 Transforming growth factor-beta 1 
TNF-α Tumour necrosis factor alpha 
TNF-β Tumour necrosis factor beta 
EGF Epidermal growth factor 
IGF-1 Insulin-like growth factor 
Angiogein  
Oncostatin M  
Thrombopoietin  
VEGF Vascular endothelial growth factor 
PDGF-BB Platelet-derived growth factor 
Leptin  
BDNF Brain-derived neutrophic factor 
BLC B-Lymphocyte chemoattractant 
Ck β 8-1 Chemokine-beta 8-1 / Chemokine (C-C motif) ligand 23 
Eotaxin-1 Chemokine (C-C motif) ligand 11 
Eotaxin-2 Chemokine (C-C motif) ligand 24 
Eotaxin-3 Chemokine (C-C motif) ligand 26 
FGF-4 Fibroblast growth factor – 4 
FGF-6 Fibroblast growth factor – 6 
FGF-7 Fibroblast growth factor – 7 
FGF-9 Fibroblast growth factor – 9 
Flt-3 Ligand Flt-3 Ligand 
Fractalkine Fractalkine / Chemokine 3 (C-X-C motif) ligand 1 
GCP-2 Granulocyte chemoattractant protein-2 / Chemokine (C-X-C motif) ligand 6 
GDNF Glial cell-line derived neurotrophic factor 
HGF Hepatocyte growth factor 
IGFBP-1 Insulin-like growth factor binding protein - 1 
IGFBP-2 Insulin-like growth factor binding protein - 2 
IGFBP-3 Insulin-like growth factor binding protein - 3 
IGFBP-4 Insulin-like growth factor binding protein - 4 
IL-16 Interleukin-16 
IP-10 Interferon gamma-induced protein 10 / Chemokine (C-X-C motif) ligand 10 
LIF Leukaemia inhibitory factor 
LIGHT LIGHT / tumour necrosis factor superfamily member 14 (TNFSF14) 
MCP-4 Monocyte chemoattractant protein - 4 
MIF Macrophage migration inhibitory factor 
MIP-3α Macrophage Inflammatory Protein-3 / Chemokine (C-C motif) ligand 20 




Osteoprotegerin Osteoprotegerin (OPG) 
PARC Pulmonary and Activation-Regulated Cytokine 
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PIGF Placenta growth factor 
TGF-β2 Transforming growth factor-beta 2 
TGF-β3 Transforming growth factor-beta 3 
TIMP-1 Tissue inhibitor of metalloproteinases - 1 
TIMP-2 Tissue inhibitor of metalloproteinases - 2 
 
4.2.2  GENE EXPRESSION ANALYSIS 
The effects of number of loading cycles and also possible signalling pathways initiated by the 
loading conditions were investigated. In preparation for testing, 30 type I collagen gels were 
made and secured within custom-made chambers in preparation for loading. In order to 
investigate the TGFβ and IL-1 pathway involvement in the strain response, inhibitors of these 
cytokines were included within the media of some samples, as outlined in Figure 4.6, before 
samples were subjected to different loading conditions.  




Selected genes were analysed in samples, subjected to the different load conditions and 
inhibitors, with selection based on previous results and literature [Jones et al., 2013; Tsuzaki et 







(n = 12) 
3D Collagen gels seeded with healthy hamstring tenocytes 
(n = 30) 
Gels were fixed into custom-made chambers and allowed 




for 24hrs to stabilise 
Figure 4.6: Flow diagram depicting the experiments performed on 3D collagen gels to 
investigate the gene expression changes to the applied loading conditions with and 
without the addition of an inhibitor 
Gene expression 
(qRT-PCR) 
Cyclically strained at 1% ± 1% 
Control – 
unstrained 24hrs  
n = 3 
Low freq (1Hz) 
for 15mins                
n = 3 per group 
High freq (10Hz) 
for 15mins    
 n = 3 per group 
Low freq (1Hz) 
for 150mins       
n = 3 per group 
Held at 1% strain until 24hr time point 
Loading media + 
TGFβR1 inhibitor 
n = 9 
Loading media + 
IL-1R inhibitor  
n = 9 




Table 4.4: Genes analysed for the different sample groups 
 
4.2.3  STATISTICAL ANALYSIS 
Statistical analysis was performed using a one way analysis of variance (one way ANOVA) 
looking for significant differences in the response of healthy cell types to different loading 
conditions and to the effects of the inhibitors. Tukey’s Honest Significant Difference (HSD) pot-





Samples with loading 
media 
Samples with loading 
media + TGFβ Inhibitor 
Samples with loading 
media  + IL-1 Inhibitor 
HUMAN 
18s √ √ √ 
MMP1 √  √ 
MMP13 √  √ 
COL1A1 √ √ √ 
COL3A1 √ √  
COL5A1 √ √  
ADAMTS5 √   
IL6 √ √ √ 
IL8 √   




4.3.1  CYTOKINE ARRAY 
For each sample, data were displayed as western spots blots (Figure 4.7) which were subjected 
to digital densitometry to determine the differences in cytokine expression in each sample 
relative to the unstrained control. Positive controls are labelled by blue frames, while negative 
controls are labelled by red frames (Figure 4.7). 
Signal intensity for each cytokine under each loading condition was plotted relative to the control 
in log base 10, so as to respond to skewness towards large values (where a few points are much 
larger than the bulk of the data), making it easier to identify the changes between groups (Figure 
4.8). However, a few of the cytokine patterns, where the control sample had no signal, were set 
to 1, in order to directly compare each cytokine.  
 
  
Figure 4.7: Typical overview of the cytokine panel and the locations of the 80 cytokines including the internal assays controls 
and representative spot blots for the control group. Blue letters and boxes indicate the positive controls, red 
letters and boxes indicate the negative controls. 




































































































































































































































































































































































Raw Signal Intensity of Cytokine Expression
Control 10Hz for 15mins 1Hz for 15mins 1Hz for 150mins
Figure 4.8: Raw data of a semi-quantitative analysis of cytokine expression patterns across the different loading groups, expressed in log
10
.  

































































































































































































































































































































































Quantitative analysis of cytokine expression relative to the unstrained control group 
10Hz for 15mins 1Hz for 15mins 1Hz for 150mins
Figure 4.9: Semi-quantitative analysis of cytokine expression patterns across the different loading groups, expressed in log10 relative to unstrained controls. Normalisation was performed against the 
assay internal controls and compared to the total protein content relative to the unstrained control. 
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The cytokine array reflects pathway activity patterns with the upregulation of the different 
cytokines with loading (Figure 4.8 and 4.9). Some cytokines were upregulated exclusively in the 
presence of mechanical loading, and not present in unloaded controls, this include IL-1α, IL-5, 
IL-6, IL-10 and MIG.  
Of the listed cytokines, some showed a similar response comparing 10Hz loading for 15mins 
and 1Hz loading for 150mins, including, GCSF, IL-2, IL-16, MCP-2, IGF-1, IGFBP-2, TGFβ2, 
TGFβ3 and NAP-2. However, the expression of some cytokines seem to be triggered specifically 
by high frequency (10Hz) loading, for example GCSF, IL-2, IL-4, IL-16, MCP-2, Angiogein, 
IGFBP-2, FGF-6, TGFβ2, TGFβ3 and NAP-2. There were also a few genes that were more 
expressed with increased number of cycles at low frequency (1Hz) loading, relative to both other 
conditions, for example IL-10, MIF, Eotaxin, Oncostatin M, and Leptin, and some that were 
more expressed specifically with 1Hz loading at 15mins, including I-309, IL-6, MDC, MIP-1δ, 
MIP-3α, and TIMP1.  
Overall, data indicates that 10Hz loading differentially alters gene expression relative to either 
1Hz loading group. However, this was investigated further by additional experimental repeats, 
using standard RT-PCR, to compare the effects of loading cycles and loading frequency on some 
of those genes seen in Chapter 3 to respond differentially to 10Hz. 
Furthermore, to investigate the possible involvement of the IL-1 and TGFβ signalling pathways 
in the tenocyte response, inhibitors were introduced to the loading media to determine their effect 
on cell response to loading. Of the interleukins, IL-1α was most highly expressed with the 
different loading conditions. For the growth factors, of the IGFBPs, IGFBP-1 was most 
responsive to the loading conditions irrespective of the frequency or loading cycles applied; of 
the FGFs, FGF-4 was most responsive to the loading conditions; EGF, HGF and PIGF were not 
very responsive to the loads; of the TGFβ, all the three isoforms, TGFβ1, TGFβ2 and TGFβ3, 
were all responsive to the different loading conditions. In addition, the data from Chapter 3 
(Figure 3.5) gene expression profiling of healthy hamstring tendon cells also showed an increase 
in genes related to IL-1 and TGFβ signalling. Therefore, IL-1 and TGFβ were selected for the 
signalling pathway analysis. 
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4.3.2  GENE EXPRESSION 
Hypothesis 1: Effect of number of loading cycles on cell response 
Selected genes were analysed to provide a thorough investigation into the effect of loading on 
cell response looking at different number of cycles of loading relative to loading frequencies. 
 
The data showed no significant difference between 10Hz and 1Hz loading for collagen genes 
(COL1A1, COL3A1, COL5A1) and also demonstrated no significant or notable difference with 
number of cycles. However, considering the genes that were significantly different between 
10Hz and 1Hz loading in Chapter 3 (MMP1, IL6, and IL8), these genes also showed significant 



































Figure 4.10: Gene expression changes in healthy human hamstring tenocytes seeded in 3D collagen gels subjected to a cyclic 
load of 1% ± 1% for 15mins then held at 1% strain until the 24hr time point. The response to 10Hz and 1Hz loading is 
compared with number of cycles of loading. Matrix genes were measured using standard qRT-PCR. Data was 
normalised to 18s and presented as a fold change relative to unloaded controls (2
∆∆Ct
) [mean ± SD]. * means p < 0.05, 
** means p < 0.01, *** means p < 0.001. 
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Hypothesis 2 and 3: TGFβ and IL-1 signalling pathway involvement 
A few genes were selected to investigate the response to loading with and without TGFβ or IL-
1 cytokine inhibitors, to determine their likely involvement in tenocyte response to the applied 

























10Hz + Inhibitor 
of TGFβRI 
1Hz + Inhibitor 
of TGFβRI 
1Hz 
Figure 4.11: Gene expression changes in healthy human hamstring tenocytes seeded in 3D collagen gels subjected to 
a cyclic load of 1% ± 1% for 15mins then held at 1% strain until the 24hr time point. The response to 10Hz 
and 1Hz loading is compared with and without the addition of an inhibitor of TGFβRI. Matrix genes were 
measured using standard qRT-PCR. Data was normalised to 18s and presented as a fold change relative 
to unloaded controls (2
∆∆Ct
) [mean ± SD]. 




The addition of the TGFβR1 inhibitor made no significant difference to the load induced 
upregulation of collagen genes, COL1A1, COL3A1 and COL5A1. However, a notable reduction 
in IL-6 expression, with a p value of 0.0513 seen in TGFβR1 inhibited samples at 10Hz 
frequency. 
Inhibiting IL-1 resulted in a pronounced downregulation of the load induced MMP expression, 
(MMP1 and MMP13) in addition to a reduction in IL-6 expression. Differences were significant 
for MMP1 in both loading conditions (p = 0.001 for 10Hz loading and p = 0.016 for 1Hz loading) 
and IL-6 (p = 0.049) with high frequency (10Hz) loading.  
With the addition of the inhibitor, the expression of some genes fell below the control 
demonstrating a reduction in gene expression relative to the unloaded control.   
   
10Hz 
1Hz + Inhibitor 
of IL-1R 1Hz 
10Hz + Inhibitor 
of IL-1R 
Figure 4.12: Gene expression changes in healthy human hamstring tenocytes seeded in 3D collagen gels subjected 
to a cyclic load of 1% ± 1% for 15mins then held at 1% until the 24hr time point. The response to 10Hz 
and 1Hz loading is compared with and without the addition of an inhibitor of IL-1R. Matrix genes were 
measured using standard qRT-PCR. Data was normalised to 18s and presented as a fold change relative 
to unloaded controls (2
∆∆Ct




































Based on the findings in Chapter 3, which demonstrated that high frequency (10Hz) loading 
initiated a greater metabolic response in tenocytes seeded in 3D collagen gels than low frequency 
(1Hz) loading, it was necessary to investigate further, to determine whether the response 
observed with 10Hz loading was as a result of the frequency of loading or the fact that loading 
at 10Hz applied 10 times the number of cycles to the cells compared to 1Hz loading. Figure 4.10 
explores the effect of number of cycles of loading relative to frequency of loading, showing that 
10Hz loading of tenocytes resulted in greater expression of metabolic genes irrespective of the 
number of loading cycles. This was also the case with the cytokine data in Figure 4.9, which 
demonstrated that although some cytokine expression levels were similar for 10Hz loading for 
15mins and 1Hz loading for 150mins, in general 10Hz loading for 15mins resulted in greater 
expression of interleukins, growth factors and angiogein expressed compared to 1Hz loading for 
150mins. Overall, a greater metabolic response appear to preferentially take place at higher 
frequency (10Hz) loading, in parallel with an enhanced inflammatory effect. This may reflect 
the wound healing environment in vivo whereby early events of tenocyte proliferation and matrix 
deposition take place in a mechanically unstable environment prior to tendon healing [Yu et al., 
2015]. Other studies have also demonstrated that higher frequency loading (4Hz compared to 
1Hz and 0.2Hz compared to 0.02Hz) relative to number of cycles of loading maintained tendon 
tissue biomechanical properties [Yamamoto et al., 2005] and accelerated tendon healing 
response [Takai et al., 1991] respectively. Therefore, these studies are supportive of the current 
data that higher frequency loading induces a metabolic response in tenocytes that may play a role 
in improving matrix turnover. 
This Chapter, additionally adopted a cytokine array, to investigate the effects of 10Hz and 1Hz 
loading conditions on a wide range of cytokines and matrix proteins. The data in Figure 4.8 and 
4.9 demonstrated that cytokine expression was upregulated in response to load. The data 
presented endogenous expression of cytokine molecules such as GCSF, IL-1α, IL-2, IL-4, IL-
5, IL-6, IL-8, IL-10, IL-16, MCP-2, TNF-α, VEGF, Eotaxin, FGF-4, IGFBP-1, NAP-2, TGFβ1, 
TGFβ2, and TGFβ3 in vitro, in tenocytes seeded in 3D collagen gels in response to the applied 
load. It was observed that different cytokines responded differently to different loading 
conditions. However, overall, it was also notable that high frequency (10Hz) loading for 
15mins upregulated expression of substantially more cytokines than seen in response to low 
frequency (1Hz) loading for either 15mins or 150mins, perhaps indicating both a more 
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inflammatory response and a greater upregulation of growth factors responsible for stimulating 
angiogenesis, cell migration, proliferation and tissue remodelling [Molloy et al., 2003]. Whether 
these cytokines play a role in the early proliferative phase of tendon healing with the applied 
loading conditions in this study is presently unknown. However, in human tendon repair, the 
local signalling events surrounding inflammation and early proliferative activity remain poorly 
defined [Ackermann et al., 2013]. 
Figure 4.8 showed that of the growth factors explored, four were highly expressed with loading 
(TGFβ, VEGF, FGF and IGFBP). Numerous in vitro studies have indicated that growth factors 
like TGFβ, VEGF and FGF are associated with tendon remodelling and increase with loading, 
however they have also been correlated with tendinopathy [Andarawis-Puri et al., 2015]. Growth 
factors have previously been reported to influence expression of TIMP3, collagens [Zhang et al., 
2013], and of the growth factors, TGFβ is likely the most important factor in tendon pathology, 
since it plays a major role in tissue repair [Fenwick et al., 2001]. TGFβ expression in human 
Achilles cells was upregulated in response to increased mechanical loading or loading frequency 
with increases of 7%, 49% and 14% seen in TGFβ1, TGFβ2, and TGFβ3 respectively [Zhang et 
al., 2013]. Another study also demonstrated strain dependency in the TGFβ response to loading, 
showing that high strains of 10% – 12% at 0.1 Hz for 24 h stimulated TGFβ upregulation which 
in turn promote collagen synthesis for tissue healing [Yu et al., 2015]. These studies have 
hypothesised that mechanical strain may regulate TGFβ signalling and promote differentiation 
responses to TGFβ via a mechanotransduction pathway. However, Jones et al. [2013] 
investigated the relationship between load and TGFβ in greater detail, observing no increase in 
TGFβ expression with load, but more specifically significant upregulation in TGFβ activity after 
48hrs loading. A number of TGFβ mediated cell and molecular changes have been documented 
in tendinopathy and TGFβ has also been shown to promote collagen synthesis important during 
the early stages of tissue repair [Gumucio et al., 2015; Corps et al., 2004; Fenwick et al., 2001]. 
A study by Fenwick et al. [2001] demonstrated that TGFβ isoforms have differential roles in 
tissue healing. The study evaluated the expression of the different TGFβ isoforms in healthy and 
pathological Achilles tissues and found a high expression of TGFβ2 and TGFβRII in pathological 
tissues with the absent of TGFβI. However, TGFβ requires both type I and type II receptors to 
propagate its signal as discussed in the introduction [Massague, 2012]. Therefore, this study 
concluded that chronic tendon lesions fail to resolve due to the absent of TGFβI and suggests 
that the addition of exogenous TGF-β would have little effect on chronic tendinopathy [Fenwick 
et al., 2001].  
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To determine the effect of TGFβ in this current study, a TGFβRI inhibitor was used. The 
inhibition of the TGFβ signalling pathway not only abrogated the strain-induced changes in 
mRNA for IL-6 but led to levels below the basal level, indicating the presence of TGFβ signalling 
in non-strained cultures. This may be due to the tensional forces present across the tenocyte 
seeded collagen gel in the absence of cyclic loading. By contrast, the collagen mRNA levels 
were unchanged with the addition of TGFβRI inhibitor. This demonstrated that TGFβ may not 
be involved in collagen expression in this study. However, this result may simply be due to the 
period of applied strain or time point for investigating cell response.  A study by Zhang et al. 
[2004] demonstrated that inhibiting TGFβ by the addition of a neutralizer in rabbit cells cultured 
for three days, reduced the expression levels of collagen I. Further, a recent study by Jones et al. 
[2013] demonstrated that TGFβ abrogated the strain response of COL1A1 after 48hrs of strain 
application on isolated human Achilles cells. The contradiction between the current experimental 
data and the literature may be attributed to difference in in vitro experimental conditions and 
models. 
Figure 4.8 and 4.9 also demonstrated an upregulation of a number of interleukins and TNF-α. 
From the literature, it is known that TNF-α induces production of IL-1β, IL-6, IL-8, and IL-10 
[John et al., 2010]. In the current data set, IL-1α is the most expressed of all the interleukins in 
all loading conditions, as seen in Figure 4.9 with response to loading. IL-1 is a pro-inflammatory 
cytokine that can cause matrix destruction and loss of tendon biomechanical properties by 
inducing inflammatory mediators such as cytosolic phospholipase A2 (cPLA2), cyclooxygenase-
2 (COX-2) and prostaglandin E2 (PGE2) [Zhang et al., 2015]. There have been reports of a 
synergistic effect of mechanical load and IL-l [Yu et al., 2015; Tsuzaki et al., 2003b], which 
supports current data that inflammatory mediators like IL-1 were upregulated with loading. IL-
1 is thought to contribute to the positive metabolic activity necessary for tissue repair by 
stimulating increased expression of matrix metalloproteinases (MMPs) such as MMP1, MMP3 
and MMP13 in tenocytes [Zhang et al., 2015; Tsuzaki, et al., 2003a]. Furthermore, IL-1 may 
induce secondary interleukins like IL-6. Therefore, IL-1 was evaluated in this study to determine 
if it is a contributing factor to the upregulation of MMPs and interleukins observed in healthy 
hamstring tenocytes with loading.  IL-1Ra regulates both IL-1α and IL-1β pro-inflammatory 
activity by competing with them for binding sites of the receptor. Therefore, IL-1Ra was used to 
inhibit IL-1 signalling and its subsequent gene changes.  
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Inhibiting IL-1, demonstrated its relationship with MMP1, MMP13 and IL-6, abrogating the 
expression of the genes in response to loading. Although, the enzyme activity itself was not 
evaluated, this study provides initial evidence of possible catabolic behaviour in tendon cells in 
response to loading through IL-1. It also confirms the literature that IL-1 stimulates MMPs and 
IL-6 [Sun et al., 2008; Nagase and Woessner, 1999]. In summary, this study has shown that 
tenocytes respond to loading, particularly high frequency (10Hz) loading, by regulating 
inflammatory and matrix turnover related genes, suggesting that the IL-1 signalling pathway is 
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5.1 GENERAL DISCUSSION 
Tendons are subjected to high mechanical loads during daily activities, and must undergo 
continuous repair to maintain their functional properties. When subjected to mechanical stimuli, 
tendons are known to undergo endogenous changes in cell morphology, tissue remodelling, and 
mechanical properties, with effects shown in animal models and in humans [Wang, 2006]. 
Mechanical stimuli are necessary for appropriate tendon development and maintenance, 
modulating the extracellular environment through the formation and degradation of matrix 
proteins [Popov et al., 2015; Galloway et al., 2013].  
Given the importance of mechanical stimulation to maintain tendon functional properties, 
investigators have shown that exposure to either excess loading, or load deprivation can result in 
tendinopathy [Wang et al., 2006]. Over the years, eccentric exercise has stood out as one of the 
most effective treatment option for tendinopathy [Rees et al., 2008; Alfredson and Cook, 2007]. 
However, despite evidence supporting the efficacy of eccentric exercise for its treatment, the 
mechanism through which this is achieved remains unknown [Chaudhry et al., 2015; Rompe et 
al 2007]. Chaudhry [2012] showed that perturbation occurred within the Achilles tendon at 8-
12Hz during eccentric loading, leading to a hypothesis that these perturbations may provide a 
repair stimulus for tendon. Indeed, one of the other treatments shown to be effective for treating 
tendinopathy is ESWT, in which shockwave are administered at around at 8Hz. ESWT leads to 
an immediate inflammatory and catabolic response in the tendon [Waugh et al., 2015; Mani-
Babu et al., 2014], suggesting that mechanical stimuli in the region of 8-12Hz might aid tendon 
remodelling by promoting degradative processes that are associated with removing damaged 
matrix constituents.   
This study aimed at investigating the underlying effects of high frequency (10Hz) loading on 
tendon cells (chapter 3) as well as two possible mechanotransduction pathways involved in the 
tenocyte response (chapter 4). These data may provide further indication if the 10Hz vibration 
seen in tendon during eccentric loading is an important driver of tendon repair.  
5.1.1  LOAD FREQUENCIES                                                                        
The current study hypothesised that high frequency (10Hz) loading might facilitate repair in 
tendinopathic tissue. A loading frequency of 10Hz was explored as the typical frequency seen 
across the range of eccentric exercise or ESWT studies which have measured this parameter 
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[Chaudhry et al., 2015; Waugh et al., 2015; O’Neil et al., 2015; Galloway et al., 2013; Lorenz 
and Reiman, 2011; Alfredson and Cook, 2007]. The current study investigated both rat explant 
tissue (Figures 2.15 and 2.16) and isolated cells seeded in a 3D collagen gels (Figures 3.5 and 
3.6), showing that gene expression levels were higher in response to 10Hz loading than they 
were in response to low frequency (1Hz) loading. This relationship was consistent across all 
experimental work, and was also seen in Figure 3.4A and B where the response of a broad 
spectrum of genes was investigated over time using a TLDA analysis and additionally in chapter 
4, where 80 cytokines were explored, showing that substantially more genes were further 
upregulated with 10Hz loading relative to the 1Hz loading condition.  
Whilst the response to loading was consistently more pronounced, it was interesting to note that 
there was downregulation of most genes with load in the explant models contrary to the isolated 
cells seeded in 3D collagen gels. The underlying reason for such an outcome remains unknown 
requiring further investigation. However, this may be a result of the load magnitude, as only 
small deformations were applied, and previous studies have indicated that low loaded explants 
may perceive stress deprivation conditions [Thornton et al., 2008], which can lead to a catabolic 
cell response and even tendinopathy.  
By contrast, the data from the cells seeded in 3D collagen gels points in the direction of Waugh 
et al. [2015] findings, in which the cell response to ESWT was examined in vivo. Both studies 
demonstrated inflammatory and catabolic cell responses, which are generally associated with 
removing damaged matrix constituents. The isolated cell study highlighted significant 
upregulation of MMPs and interleukins with 10Hz loading relative to 1Hz loading. Markers of 
anabolism were not investigated in the ESWT study. However, the current data additionally 
suggested a possible anabolic process for the synthesis of new ECM with the upregulation of 
COL3A1. The symmetry between the in vivo ESWT and in vitro collagen gel study gives 
confidence that this model offer some benefit for probing cell mechanobiology in this simplified 
manner.  
Previous studies on bone have shown high frequency loading regimes (between 10–50 Hz) to be 
effective in promoting bone anabolic effects [Wehrle et al., 2015; Ozcivici et al., 2010; Torcasio 
et al., 2008; Rubinacci et al., 2008]. By contrast, very few studies have investigated the effects 
of loading frequency in tendon.  
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Explant studies on rat tendon fascicles investigated the effect of varying frequency (0.017, 0.17 
or 1Hz) on tendon cell response. The study demonstrated that cyclically straining tendon can 
maintain the tissue homeostasis depending on the applied frequency [Lavagnino et al., 2003]. 
Low amplitude (1%) cyclic strain at 0.017 Hz was found to significantly inhibit, but not 
completely eliminate MMP1 expression but increasing the frequency to 0.17Hz or 1Hz 
completely eliminated MMP1 expression [Lavagnino et al., 2003]. The mechanical properties of 
tendon fascicles were also maintained with higher frequency loading, of 4Hz relative to 1Hz, 
when rabbit patellar tendon fascicles were cyclically stressed to 2MPa for 1hr or 24hrs at 1Hz or 
4Hz [Yamamoto et al [2005]. These studies highlight that not only the amplitude, but also the 
frequency of strain is also important in instigating a healing response in tendon cells. However, 
the exact mechanism for this improvement (i.e. inhibition of catabolism or stimulation of 
anabolism) was not determined. Two studies have investigated tendon response to higher 
frequency loading. However, these studies investigated response at a single frequency, so can 
only be considered in isolation. Nevertheless, cyclic loading of 0.06 ± 0.01N at 20Hz over a five 
day period (1hr a day), increased the mechanical properties and elastic moduli of rat fascicles 
after a 2 day rest [Adekanmbi et al., 2013]. A similar effect was observed when 30Hz sinusoidal 
vibrations were applied to intact flexor carpi ulnaris tendons in rats using a whole-body vibration 
table and electromagnetic shaker [Sandhu et al., 2011]. In this study, the authors reported 
increased tendon cross-section area and stiffness after vibration simulation for 20 mins per day 
for 5 days a week for 5 weeks. These findings suggest that the increased metabolic activity seen 
with higher frequency loading may be beneficial for increased matrix turnover, to improve the 
mechanical properties of tendinopathic tendons.  
Considering isolated cell studies, Xu et al. (2015) seeded tendon derived stem cells (TDSCs) 
from rat Achilles tendons on poly(L-lactide-co-𝜀-caprolactone)/collagen (P(LLA-CL)/collagen) 
scaffolds (1 x 105 cells/scaffold) for 3D culture in a bioreactor, and cyclically strained them with 
different parameters [strains (2, 4 or 8%) and frequencies (0.3, 0.5 or 1Hz)] for 3hrs/day over a 
7 day loading period. They demonstrated increased cell proliferation and increased expression 
of type I collagen, tenascin-C, tenomodulin and scleraxis at 4% strain with an optimal frequency 
at 0.5Hz. Tenascin-C is used as a tendon marker as it is expressed in embryonic tendon as well 
as in developed tendon during repair/remodelling [Midwood and Orend, 2009]. Expressions of 
scleraxis and tenomodulin are frequently analysed to confirm differentiation towards a tenocyte 
lineage as they lead to the eventual formation of tendon tissue [Shukunami et al., 2006]. 
Increased cell proliferation and increased type I collagen expression with loading was also 
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observed in human patellar tendon fibroblasts cultured on microgrooved silicone surface (2 x 
105 cells/surface) and subjected to 4% or 8% cyclic strain at 0.5Hz for 4hrs followed by 4hrs rest 
[Yang et al., 2004]. The study also demonstrated increased expression of type III collagen and 
TGFβ1 with the loading conditions [Yang et al., 2004]. 
However, in contrary data, Jones et al. [2013] demonstrated that human Achilles tenocytes 
seeded in 3D collagen gels (3 x 105 cells/gel) and strained from 0-5% at 1Hz for 24hrs or 48hrs 
reported increased expression of ADAMTS2/4/16, MMP24, TIMP3 and type I collagen at both 
24 or 48hrs loading time period. A pilot study investigating the effects of cell density on loading 
response indicated that metabolism depended on cell density, as it demonstrated that scaffold 
with a higher cell density had a greater response [Jones et al., 2013]. These findings suggest that 
the effects of frequency on the isolated tendon cell response is dependent on cell density, duration 
of loading and possibly the applied strain. Nonetheless, why higher frequencies have not been 
explored for isolated cells models cannot be explained. However, such studies are more 
technically challenging to perform, with many experimental set ups unable to operate this 
rapidly. Therefore, this study is the first to investigate the effect of frequency as high as 10Hz on 
isolated cells using 3D collagen gels. 
Overall, the studies demonstrated that loading at 1Hz and above stimulated a more anabolic 
response in tendon in vitro models, explants and isolated cell models (with cell density over 3 x 
105 cells/gel), which was consistent with the hypothesis and findings of this study that high 
frequency loading initiated increase metabolic activity.  
5.1.2  DIFFERENT STRAIN MODALITIES 
Tendon cells are able to detect mechanical signals from deformation of their cellular membrane, 
irrespective of the frequency at which strain is applied [Ingber, 2006]. A wide range of in vitro 
studies using explants or isolated cells, have investigated cell response to different strain 
modalities or magnitudes, and changes in tenocyte gene expression have been demonstrated 
following exposure to mechanical strains ranging from 1 to 20% [Xu et al., 2015; Mousavizadeh 
et al., 2014; Huisman et al., 2014; Scott et al., 2005; Goodman et al., 2004; Lavagnino et al., 
2003]. In the current study, preliminary work applied strains of 5% ± 5% to bovine tendon 
explants. However, the magnitude of vibrations caused by eccentric loading or ESWT is likely 
smaller than this, so a perturbation of 1% ± 1% was adopted. Considering in vitro work 
investigating local tendon strains and the likely cell strain environment in situ, tenocytes are 
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known to experience tensile strains of around 1-2% within a loaded tissue, so a strain protocol 
of 1% ± 1% strain was adopted for future studies. Initial validation studies adopting this protocol 
confirmed that cell viability was maintained at over 70% for both rat tendon explants (table 2.5) 
and isolated cells seeded within 3D collagen gels (table 2.10). Whilst this protocol lead to a 
general upregulation of gene expression in isolated cells, it was noted that loading explants to 
1% ± 1% lead to the downregulation of the majority of genes after loading, perhaps indicative 
of a tendinopathic response. 
The different response of the cells in these two model systems is not fully understood. An explant 
study on bovine tendon fascicles suggested tendon adaptation to loading with increased gene 
expression of type I collagen and IL6 following a 7% cyclic strain at 1Hz for 1hr followed by 
2% cyclic strain at 1Hz for a further 6hrs [Legerlotz et al., 2013]. Another study demonstrated 
that cyclic strain at 0.17Hz to 1, 3 or 6% strain, all inhibited catabolism and supported tissue 
homeostasis with increased ratio of TIMP1/MMP13 in rat tail fascicles [Gardner et al., 2008]. 
These data would suggest that any magnitude of cyclic applied strain would initiate an anabolic 
tenocyte response. However, other studies have indicated that gene expression is modulated by 
magnitude of cyclic tensile strain [Lavagnino et al., 2003]. In this study, 1% strain inhibited 
MMP1 gene expression at a frequency of 0.017Hz but the expression was completely eliminated 
when the strain was increased to 3 or 6% at the same frequency of 0.017Hz [Lavagnino et al., 
2003]. However, this study also demonstrated an interrelationship between strain magnitude and 
frequency, as when strain frequency was increased to 0.17Hz, 1% cyclic strain completely 
eliminated MMP1 expression. By contrast, other studies have investigated cell response to very 
high strains [Scott et al., 2005]. Cyclic strains of 20% at 1Hz for 6hrs resulted in cell apoptosis. 
Taken together, these data highlight the complexity associated with testing explants, but suggest 
that applied strains need to be of a minimum magnitude to ensure a homeostatic or anabolic 
response, but excess strain can lead to catabolism and matrix breakdown. 
Studies in isolated cells also show considerable variability in response. Isolated cells from a 
chicken flexor digitorum tendon, seeded in a 3D construct and strained to 1% at 1Hz, 1hr/day 
for 7 days, demonstrated increased expression of type I/III/XII collagen, aggrecan, and tenascin 
[Garvin et al., 2003]. Another study on human Achilles tenocytes, cultured in 2D on a 
polystyrene dish, and cyclically strained to 1, 5 or 8% strain at 1Hz for 60min/day for 3 days 
demonstrated increased gene expression of MMP9/13/14, fibromodulin, lumican and versican 
independent of the applied strain [Popov et al., 2015]. This study suggested the optimal strain 
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was 8%, with higher upregulation of collagen-binding integrins (α1, α2 and α3) and activation 
of downstream kinases p38 and ERK1/2 [Popov et al., 2015]. Yet by contrast, Xu et al. [2015], 
investigating cyclic strain response on tendon derived stem cells (TDSCs), seeded in 2D on 
P(LLA-CL)/collagen scaffolds, demonstrated the highest anabolic cell response with 4% cyclic 
strain comparing 2, 4 or 8% strain at 0.3, 0.5 or 1Hz for 3hrs/day over a 7days. The difference 
in ultimate strain between the two studies [Popov et al., 2015 and Xu et al., 2015] may be 
attributed to the different scaffold materials used and other varied experimental conditions, but 
suggest more strain is not necessarily better. Micro-mechanics experiments in explants indicate 
that few of the strain conditions adopted are physiologically relevant, as tenocyte strains rarely 
exceed 2% seen in vivo [Screen, et al., 2004]. Nevertheless, some researchers applied even larger 
strains such as 10% at 1Hz for 24hrs, applied to healthy human hamstring tenocyte 
[Mousavizadeh et al., 2014]. Although the authors demonstrated that such high strain can be 
tolerated by the cells, the cells responded with an inflammatory signature, and increased 
expression of angiogenic genes (COX2, VEFG, FGF2) in the first 4hrs of loading after which,  
by extending the time course of cyclic strain, the expression of these same genes was 
subsequently downregulated [Mousavizadeh et al., 2014]. The data suggest that at such high 
strain at short burst of cyclic strain may initiate cell proliferation and tissue formation while 
prolong cyclic strain potentially contribution to the progression of tendon degeneration. 
The current study demonstrated that a cyclic strain of 1% might be low for explants but was 
probably more physiological for isolated cells.  
5.1.3  DURATION OF LOADING AND NUMBER OF CYCLES 
Gene expression changes in response to loading can be assessed at varying time points, ranging 
from hours to days to weeks. A standardised appropriate time point for investigating gene 
expression post loading cannot be defined, not least because response time will be influenced by 
the load protocol adopted, but also as the time course for the upregulation of different genes can 
be highly variable. Selecting a time point for analysis is always a compromise, and it is too 
complex and expensive to do multiple time points in all experiments generally. The most 
appropriate time to investigate gene expression changes post-loading was investigated for both 
the explant model and the isolated cell model, and found to be 24hrs.  
As the collagen gel model was selected for further study, it was additionally characterised more 
fully, and the gene stabilisation post sample preparation was examined, using a TLDA analysis 
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at 4, 8, 12 and 24hrs time points after a 15mins loading episode relative to 24hr unloaded control 
(Figure 3.4A and B). The data in Figure 3.4A and B demonstrated fluctuations in gene response 
with time. At the first time point of 4hrs, on average, gene expression levels were reduced in 
loaded samples relative to unloaded samples, particularly with 1Hz loading. Levels steadily 
increased to around basal levels at 8hrs, with most genes upregulated relative to controls by 
12hrs. Owing to insufficient wells to run all sample groups, the response to 1Hz loading at 24hrs 
was unfortunately not investigated. However, based to the steady increase in expression and 
maximum response with 10Hz loading at 24hrs, this was selected as the time point for analysis 
in future experiments.   
In a study by Eliasson et al. [2012], the gene expression changes in rat Achilles tendon after a 
30mins single burst of loading were strongly regulated at 3hrs after loading, compared to 12, 24 
and 48hrs after loading. 86 genes were strongly upregulated, mainly wound healing associated 
genes, and 64 genes were strongly downregulated, mainly proteoglycans, COLVIII and COLXI. 
This could also possibly explain why the rat explants showed downregulation of all the analysed 
gene except for MMP13 to loading after 24hrs. There is also the possibility that the loading time 
was not enough for peak gene response.  
The gene expression profile in Figure 4.10 demonstrated cycle-independent tenocyte response to 
the applied loading condition. This study was carried out to determine if the increased metabolic 
response seen in tenocytes in response to 10Hz loading was driven by increased cycle number, 
but the findings highlighted that this was not the case. Such a result is at odds with some other 
studies, which showed that increased number of loading led to increased total collagenase content 
when an avian flexor digotorum profundus (FDP) was loaded at either 12MPa or 3MPa at 1Hz 
for 0, 7200, 43200, 79200 or 86400 cycles [Devkota et al., 2007]. Sun et al [2010] findings on 
in vivo rat patellar tendon loaded at 50% maximal load at 1Hz also demonstrated a higher 
response in high-cycle fatigue loading (7,200 cycles of loading), with magnified changes in gene 
expression in MMPs, TIMPs, and collagens associated with healthy response, compared to low-
cycle fatigue loading (100 cycles of loading). However, it is likely in samples subjected to more 
cycles, these studies are generating damage within the tendon and the increased cell response 
may be associated with this. 
These findings provide evidence that an appropriate strain duration and repetitive loading are 
essential components for an efficient adaptive stimulus for tendons cell response. 
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5.1.4  DIFFERENT CELL TYPES 
This current study showed increased metabolic activity with 10Hz loading relative to 1Hz 
loading, which is attributed to the loading frequency specifically. Of note, the upregulation of 
gene expression with load, and the relative differences between 1Hz and 10Hz loading were both 
greater in healthy than tendinopathic cells. This could be because of the cells phenotypic 
differences, but could also be due to the tissue source, as healthy tenocytes were obtained from 
hamstring tendons while tendinopathic tenocytes were obtained from Achilles tendons. In 
addition, some of the differences observed could also be associated to changes seen with 
tendinopathy. It is well known that cell culture can result in changes in cell phenotypic, as 
demonstrated by a study on human tenocytes, where there was a reduction in collagen type I and 
collagen type III gene expression after passage 3 and protein content after passage 4, and 
tenascin-C gene expression after passage 5 [Mazzocca et al., 2012]. The current study used cells 
between passage 3 and passage 5, so as to limit cell phenotypic changes. However, it is notable 
that clear metabolic differences between the cells remained evident at this point, indicating that 
not all phenotypic differences between the cell types have been lost through culture. 
Considering other studies looking specifically at injured tendon, a recent study explored the 
effects of cyclic mechanic load of 0-0.06N at either 20Hz or 1Hz, relative to static load, for 
1hr/day for 5 days. Data demonstrated increased metabolic activity with high frequency load 
[Adekanmbi et al., 2016]. However, the study only looked at damaged rat tail tendon fascicles, 
where a cut was made along the length of the fascicles using a needle. The study demonstrated 
significantly higher tangent modulus and increase in metabolic activity with 20Hz loading, 
relative to the unloaded damaged controls, the 1Hz loaded group, and the static load. However, 
it is difficult to clarify the load effects without an uninjured control [Adekanmbi et al., 2016].  
Another study directly comparing healthy and tendinopathic tenocytes was performed by Patel 
et al. [2014], who seeded the cells into a specially designed fibre composite construct and applied 
cyclic multi-modal tensile and shear load to the cells for 24hrs. The study showed tendinopathic 
tenocytes to be more mechano-sensitive than healthy tenocytes under shear-tension load contrary 
to this current study [Patel et al., 2015; Patel et al., 2014]. Interestingly, these studies utilised 
exactly the same cells as the current study, suggesting that either the material, how the cell 
interacted with the material or the shear loading condition could contribute to the difference seen 
between the studies. Application of tension and shear load in vivo is determined by the tendon 
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tissue solid (collagen matrix) and fluid components between fascicles in the IFM [Lavagnino et 
al., 2008], therefore exposing tenocytes to both tension and shear during tendon loading might 
initiate a different response. So, to obtain a comprehensive understanding of tenocyte 
mechanobiology, a combined stimulus of tenocytes response to fluid shear stress and cyclic 
tensile strain is needed.  
The application of controlled shear has been achieved in some studies through the use of fluid 
shear. A study by Lavagnino et al. [2008] was able to create a multiscale computational tendon 
model composed of both matrix and fluid phases to examine how tensile and shear loading may 
affect stresses and strains at the cellular level. The study was able to generate a simplified model 
of tendon able to demonstrate that both fluid-flow induced shear stress and matrix-induced cell 
deformation are able to independently alter rat interstitial collagenase gene expression at varying 
strain rate and amplitudes. A recent study by Maeda et al. [2013] developed a system to apply 
simultaneously, tensile strain and fluid shear stress to tenocytes. The system applied tension to a 
flexible cell seeded microgrooved membrane, with the microgrooves present to keep cells 
isolated in rows. Fluid was then moved across the surface of the cells at a controlled speed, with 
both tension and fluid flow applied in a uniaxial direction. The study pointed out that the 
combination of shear and tensile strain significantly increased tenocytes mechanotransduction 
response relative to unloaded controls [Maeda et al., 2013]. 
These findings suggest that the difference in response in cell types might be linked to the loading 
condition applied, stimulating a more or less mechanosensitive response from the cells. 
5.1.5  PATHWAY INVESTIGATIONS 
Chapter 4 presented preliminary evidence to indicate that the IL-1 signalling pathway was 
activated with mechanical strain. This correlates with the mRNA data from chapter 3, which 
showed high levels of expression of MMPs and interleukins (Figure 3.4A and B) from a TLDA 
analysis and high expression of MMP1, MMP2, MMP13, IL6 and IL8 (Figure 3.5) from qRT-
PCR analysis. The current study also provides some evidence (Figure 4.12) that collagens are 
not regulated through this IL-1 pathway, as there was no significant difference between the non-
inhibited and IL-1 inhibited samples when COL1A1 gene expression was analysed. Interestingly, 
collagens did not appear to be regulated through the TGFβ pathway either, as there was no 
change in the gene response for COL1A1, COL3A1, and COL5A1 in Figure 4.11. 
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The current study made use of inhibitors developed to block signalling at the receptor level (IL-
1Ra and TGFβR1) thereby interfering with the binding of the protein to its receptor thus blocking 
intracellular signalling. Many other TGFβ pathway inhibitors have been investigated in the 
preclinical setting, while some are still in clinical development and can be sub-divided into three 
groups.  
a. Inhibition at the ligand level – involves an antisense oligonucleotide delivered into the 
immune cells intravenously, targeting TGFβ2 to prevent TGFβ synthesis [Neuzillet et al., 
2015]. 
b. Inhibition at the ligand-receptor level – involves a monoclonal antibody targeting 
different signalling receptors (for example TGFβRII) to prevent ligand-receptor 
interaction [Nagaraj and Datta, 2010]. 
c. Inhibition at the intracellular level - used in this study, to target the kinase domain of 
TGFβRI thereby interfering with the binding of TGFβ to its receptors, blocking 
intracellular signalling, and antisense oligonucleotides [Nagaraj and Datta, 2010]. 
To fully investigate genes that may be regulated through TGFβ pathway, further investigations 
would be required, adopting the other two forms of inhibitors to confirm findings.  
The data from Figure 4.11 indicates that whilst the inhibition of TGFβ might not have directly 
influenced collagen gene expression, it did mediated IL6 gene expression, with the gene 
expression level falling below the basal level on addition of the TGFβ inhibitor. This may suggest 
that the TGFβ signalling pathway regulated IL6 expression, whilst collagen gene expression 
might be regulated by another pathway. On the other hand, although Figure 4.12 demonstrate 
that MMPs and IL6 are regulated by IL-1 pathway, this can be further clarified by using other 
IL-1 inhibitors with similar function as the IL-1Ra used in this study. IL-1 pathway inhibitors 
have been investigated using Anakinra, an IL-1 receptor blocking antibody, which function in 
the same manner as the IL-1 receptor antagonist (IL-1Ra) to block the activity of both IL-α and 
IL-1β [Dinarello et al., 2012]. This will provide further confirmation to the data. 
Studies have stated that cell signalling pathways depend on the initiate trigger and extensive 
communication with other signalling pathways either directly or indirectly or as part of a 
feedback loop, leading to synergistic or antagonistic effects and eventually desirable biological 
outcomes [Guo and Wang, 2009]. However, the nature of such signalling cross-link is 
overwhelmingly complex and context-dependent.  Therefore, in-depth mechanistic studies are 
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necessary to distinguish the cause from the consequence and to identify the specific convergence 
point of possible pathways. 
5.1.6  LIMITATIONS 
Although this research provided some insight into the response of healthy and tendinopathic 
tenocytes to 10Hz loading, there are a number of limitations which should be kept in mind when 
interpreting the results.  
Firstly, the healthy and tendinopathic cells were from two different tendon types, hamstring and 
Achilles tendons respectively, so may have phenotypic differences associated with their 
functions. However, evidence suggests that both the tendons of the musculotendon hamstring 
system and the Achilles tendon exhibit energy-storing capability, making them a reasonable 
functional match [Shepherd et al., 2014]. However, the cell extraction method for both 
populations were also different (Chapter 3), which may also have had an impact on the results. 
The healthy hamstring tendon cells were isolated via enzymatic digestion (collagenase digest) 
while the tendinopathic Achilles tendon cells were obtained via explant outgrowth. Enzymatic 
digestion involves subjecting finely chopped tendon tissue to proteolysis using an enzyme - 
collagenase, whereas explant outgrowth involves placing a fragment of tendon tissue, a tendon 
explant, on a solid interface with culture media, and allowing it to adhere, and the outgrowth of 
cells from the explant collected by trypsinization and subcultured. Cells isolated by explant 
outgrowth would contain selective cells from the tissue, depending on their ability to migrate out 
of the explant and adhere which is not the case for collagenase digest [Lanza et al., 2007]. Studies 
have demonstrated that cell extraction method can affect cell yield, proliferation rate and gene 
expression [Gittel et al., 2013; Souza et al., 2010]. Extraction of mesenchymal stromal cells 
(MSCs) from equine subcutaneous adipose tissue, superficial digital flexor tendon, and umbilical 
cord matrix by enzymatic digestion or explant outgrowth resulted in significantly higher MSC 
yields and higher expression levels of scleraxis with enzymatic digestion compared to explant 
outgrown MSCs [Gittel et al., 2013]. Although Gittel et al. [2013] showed no significant 
differences in cell proliferation, studies comparing cells from the two cell isolation methods have 
found that cells digested from tissue generally exhibit higher proliferation rates [Souza et al., 
2010; McDuffee, 2012]. However, findings have indicated that both extraction methods are 
effective in isolating cells and that cell passaging favours cell proliferation and each passage 
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increases growth fraction until the third passage where it exceeds 90% [Lanza et al., 2007; Jing 
et al., 2011]. 
Furthermore, there was age difference between the healthy hamstring tendon cells (21 ± 1) and 
the tendinopathic Achilles tendon cells (48 ± 3) used in this study. Studies have highlighted that 
tendon mechanical and structural properties diminish with age, demonstrating matrix damage, 
increased fibre sliding, and reduced matrix turnover making them more prone to injury [Thorpe 
et al., 2014; Thorpe et al., 2016c]. A number of studies have explored the mechanical properties 
of human tendons with age, considering 27-33 years as young and 65-80 years as old [Stenroth 
et al., 1985; Birch et al., 2001; Carroll et al., 2008; Magnusson et al., 2008]. These studies 
reported reduced ultimate tensile strength, reduced viscoelastic properties, lower tendon stiffness 
and increased cross-sectional area with aging. Although these changes observed in the tendon 
matrix with age are similar to changes observed in degenerated tendon, the age of the 
tendinopathic cells used in this study are referred to as middle-aged by Lewis and Shaw, [1997], 
making the data comparable as the changes expected to be observed from the tendinopathic cells 
will likely be due to tendinopathy and not age.  




Published work has focused on exploring the effects of mechanical loading at frequencies 
between 0.017 to 1Hz in tendon, at both in vivo and in vitro levels. In Chapter 2, this study 
explore various in vitro models for mechanically loading tenocytes. The 3D collagen gel stood 
out as the most effective model for this study, as it provided a 3D environment for cell to cell 
communication, and an elastic material for loading the cells. It also maintained cell viability at 
above 74%, and did not promote cell proliferation over the 48hr time period required for both 
gene stabilisation and subsequent loading.  
In Chapter 3, this study documented mechanical regulation of a wide range of matrix related 
genes a using TLDA analysis. The time course of gene expression changes was investigated (4-
48 hours) under 1% ± 1% cyclic loading at 1Hz and 10Hz. The data showed that mechanical 
loading regulates a wide range of metalloproteinase, matrix genes, TIMPs and cytokines. Gene 
responses were more pronounced in cells subjected to 10Hz loading, indicating that 10Hz loading 
prompted a more responsive effect in the cells. This observation lead to a focus on few genes to 
further analysis the effect of frequencies on healthy and tendinopathic cells. The findings 
demonstrated that not only do cells respond more to 10Hz loading, but the effects were more 
pronounced in the healthy cells, perhaps indicating why tendinopathy is so difficult to treat.  
These generated questions concerning the mechanotransduction signalling pathways involved in 
the cellular response to the applied mechanical loading. In Chapter 4, a broad spectrum cytokine 
array was first carried out to explore potential pathways. A number of cytokines were increased 
with loading, particularly with 10Hz loading, but of these, TGFβ and IL-1 stood out. Therefore, 
this study went further to look specifically at the potential role of the TGFβ and IL-1 signalling 
pathways in the mechanoregulation of gene expression. The result suggested that the 
mechanoregulation of tenocyte gene expression in this system is mediated via the IL-1 signalling 
pathway, which involves NFkB or c-Jun translocation to the nucleus and consequent 
transcriptional regulation.  
Overall, the results obtained from this study provided more insight on tenocyte metabolism and 
response to loading, confirming that the application of 10Hz loading to tenocytes within the 3D 
collagen gel model may promote or initiate a healing response, and that tendinopathic tenocytes 
respond differently to healthy tenocytes. It also shows that the mechanical loading induced the 
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IL-1 signalling pathway. Moreover, inflammation, might be influenced by loading in a way that 
leads to improved healing.  
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5.3 FUTURE WORK 
Whilst this study has indicated that 10Hz loading, adopted as a model of eccentric loading, 
resulted in a more pronounced cell response, the research has raised additional questions for 
future work. 
1. Verification of cell response to 10Hz loading by 
a. Exposing the cells to 2 sets of 15mins cyclic strain over the 24hrs (more closely 
replicating a typical eccentric loading response)  
b. Evaluating the protein expression  
 
2. Mechanical loading 
a. To determine the effect of an increased strain magnitude, as explored by other 
studies, at 10Hz frequency to determine how this may impact cell response 
b. To determine the effect of combined shear and tensile strain at 10Hz on the cell 
response  
 
3. IL-1 characterisation: Validation of the role of IL-1 in the mechanoregulation of gene 
expression to strain, and how it is affected by alteration of loading frequency, thereby 
providing more insight into the role of this cytokine in inflammation and its relevance to 
tendon healing by: 
a. Adding IL-1 to determine its effect to the cells in response to loading 
b. Inhibiting the IL-1 pathway by blocking IRAK1 phosphorylation using curcumin 
[Jurrmann et al., 2005], or by inhibiting the processes that regulate IL-1 
maturation and release by blocking the plasma membrane receptor for 
extracellular ATP, the P2X7 receptor, thereby inhibiting the triggering of IL-1 
maturation and exteriorization [Christopher et al., 2006]. 
 
4. TGFβ characterisation: Validation of the role of TGFβ in the mechanotransduction of 
gene expression to strain and frequency by exploring it effects on other genes aside from 
the selected genes in this study. As discussed in Chapter 4, TGFβ is generally secreted in 
a biologically latent form called either small or large latent-TGFβ. Therefore, the most 
relevant information reported on TGFβ is TGFβ activity, which is based on whether or 
not TGFβ is biologically active or latent.  
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2-Propanol Sigma – Aldrich, I9516 
Anti-IL1 alpha antibody Abcam, ab9614 
Calcein AM Cambridge Bioscience, BT80011 
Collagenase from Clostridium histolyticum Sigma – Aldrich, C5138 





Sigma – Aldrich, CLS3291 
Sigma – Aldrich, CLS3290 
Sigma – Aldrich, CLS3289 
Corning CellBIND cell culture multiwall 
plates (6 well culture plate) 
Sigma – Aldrich, CLS3335 
Corning 15ml centrifuge tubes Sigma – Aldrich, CLS430791 
Corning 50ml centrifuge tubes Sigma – Aldrich, CLS430291 
Corning costar stripette serological pipetes, 






Sigma – Aldrich, CLS4487 
Sigma – Aldrich, CLS4488 
Sigma – Aldrich, CLS4489 
Chloroform  Sigma – Aldrich, C2432 
Collagen gel First Link UK, 6030810 
Cytokine antibody array (Membrane, 80 
targets) 
Abcam, ab133998 
DMEM (1X) Life Technologies, 11880-036 
DMEM, low glucose ThermoFisher Scientific, 21885-108 
dNTPs, 10mM Promega, U1515 
Dulbecco’s phosphate buffered saline Sigma – Aldrich, D8537 
Ethanol, 200 proof Sigma – Aldrich, E7023 
Foetal Bovine Serum  Sigma – Aldrich, F7524, Batch number: 
111M3395 
Glycogen (5mg/ml) Life Technologies, AM9510 
HEPES Solution (1M) Sigma – Aldrich, H0887 
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MEM (10X) Life Technologies, 11430-030 
MEM Non-essential amino acid solution 
(100X) 
Sigma – Aldrich, M7145 
Nuclease-Free water (not DEPC-Treated) Life Technologies, AM9937 
Penicillin-Streptomycin 
10000 units penicillin and 10mg streptomycin 
per ml 
Sigma – Aldrich, P4333 
Phase lock gel heavy (2ml) 5 Prime, 2302830 
Pipette filter tips sterilised (1000ul) Gilson, F171803 
RNaseZap RNase decontamination wipes refill Life Technologies, AM9788 
RNaseZap RNase decontamination solution Life Technologies, AM9780 
Sodium bicarbonate Sigma – Aldrich, S8875 
Sodium hydroxide pellets Sigma – Aldrich, S8045 
SuperScript II Reverse Transcriptase Life Technologies, 18064-014 
Taqman Universal PCR Master Mix 
No AmpErase UNG 
Life Technologies, 4324018 
TGFβ inhibitor Sigma – Aldrich, SB431542 
Trizol Reagent  Sigma – Aldrich, T9424 
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Trypsin-EDTA solution (1X concentration) Sigma – Aldrich, T4049 
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